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In 2010, over one billion people in low- and middle-income countries (LMICs) were living with 
hypertension. With the steadily rising global burden of non-communicable diseases, a vital 
responsibility of local and national health systems within the universal health coverage agenda is 
to provide services that can effectively manage chronic diseases, such as hypertension. Cost-
effective interventions at the primary health care level can avert over one million hypertension-
related deaths per year in LMICs, however there is a paucity of evidence on how to assess a 
health system’s ability to provide hypertension management services of sufficient quality to 
improve population health. This dissertation expands upon previous research and develops new 
methods to advance the measurement of effective coverage of hypertension management 
services in LMICs.  
 
The thesis reviews published works that describe the effective coverage of hypertension 
management services or the quality of these services received at a population level (Chapter 2). 
Findings from this review inform the development of a measurement framework – the expanded 
hypertension cascade of care – which describes barriers to achieving effective hypertension 
management in LMICs. The expanded hypertension cascade of care is applied to rural Bihar (one 
of India’s poorest states with a rural population of 92 million people) to assess these barriers in a 
real-world setting (Chapter 3). Barriers to hypertension management highlighted in the first two 
studies inform the development of a comprehensive index metric to describe the effective 
coverage of hypertension management services in rural Bihar (Chapter 4). Nested within a larger 
assessment of the primary health care system in rural Bihar, data collection includes a household 
survey on care-seeking behaviors with a sample of 39,486 individuals from 343 villages, as well 
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as a provider assessment comprising of a facility readiness survey, clinical vignettes (including 
one on hypertension diagnosis and management), and direct patient observations with a sample 
of 390 public and private primary care providers across 70 villages.  
 
We found eight separate attempts to define effective coverage for hypertension management 
services, and 12 additional studies which reported population-level receipt of quality 
hypertension management services. From these articles, common barriers to hypertension 
management in LMICs were (i) screening populations for high blood pressure, (ii) linkage to 
hypertension care that adhered to clinical guidelines, and (iii) adhering to prescribed treatment. 
Measurement following the expanded hypertension cascade of care identified nearly 6.6 million 
undiagnosed hypertensive individuals over the age of 30 in rural Bihar, 2.1 million of which 
have never had their blood pressure measured before. Although nearly all diagnosed 
hypertensive individuals were able to seek care, as few as one-fifth sought care from providers 
who demonstrated sufficient knowledge on how to diagnose and appropriately treat 
hypertension. While the coverage of key hypertension management services was 70%, the 
quality-adjusted coverage of these services was 31% across the state. 
 
Results from this dissertation reflect the urgent need to improve the quality of hypertension 
management services available in rural Bihar and other LMIC contexts. Expanding (and 
measuring) service coverage alone is not enough to reduce the burden of disease in LMICs. 
Tracking the effective coverage of hypertension management services is an important component 
of evaluating health systems performance, and highlights a different set of interventions that are 
needed to improve population health in the non-communicable disease era. This research can 
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help to bridge the gap between health systems metrics and improved lives for people living with 
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Chapter 1: Introduction 
 
 
Since the end of the Second World War, international development has largely been synonymous 
with economic growth. A modern, holistic version of international development considers 
broader approaches to improve the lives people can lead by removing barriers, or “un-freedoms” 
rather than a limited concentration on expanding economic wealth. According to Amartya Sen, 
“among the most important freedoms that we can have is the freedom from avoidable ill-health 
and from escapable mortality” (Sen 1999).  Global health, or collaborative trans-national 
research and action that promotes health for all, contributes to holistic development through 
numerous pathways (Beaglehole and Bonita 2010). Achievements such as the eradication of 
smallpox, drastic reduction in polio incidence, and widespread administration of HIV/AIDS 
therapeutics have afforded freedom from avoidable morbidity and mortality to millions around 
the world. Despite the undeniably positive impacts of disease-centered global health initiatives, 
true freedom from ill-health is only gained when populations have access to comprehensive 
health services that can address a range of potential health issues.   
 
Global health priorities have long reflected the tension between meeting immediate health needs 
of populations and removing structural barriers that contribute to poor health. Scholars have 
identified shifting priorities throughout the history of global health as a “pendulum” swinging 
between vertical disease control initiatives and health systems strengthening approaches that aim 
to provide comprehensive preventive and curative care to communities (Uplekar and Raviglione 
2007; Hafner and Shiffman 2013; Packard 2016). Health systems are comprised of the people, 
institutions, and resources that contribute to the production of health in a certain population. 
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When health systems are organized to ensure that everybody in a society has access to high-
quality and acceptable health services they need and can use them without incurring excessive 
costs, the vision of Universal Health Coverage (UHC), freedom from ill-health is achieved. 
Achieving UHC is therefore the global health community’s health-services oriented platform for 
promoting holistic development in the twenty first century.  
 
While there is a clear global consensus on the importance of strengthening health systems to 
achieve UHC in low- and middle-income countries (LMICs), there is a lack of agreement on the 
exact definition of what UHC entails (O’Connell, Rasanathan, and Chopra 2014; Latko et al. 
2011; Abiiro and De Allegri 2015). Broadly, achieving UHC is a multi-dimensional concept 
based in the legal right to health which encompasses health-related social security systems, 
financial protection, and access to quality health care according to need (Abiiro and De Allegri 
2015). At the local level, health systems that achieve UHC provide equitable access to quality 
and affordable services that address the community’s health needs. Measuring progress towards 
such a complex end-goal is difficult. Currently, UHC progress is tracked by two indicators: one 
that quantifies the extent of financial protection in a community, and one that measures the 
effective coverage of key health services (Hogan et al. 2018; Boerma, Eozenou, et al. 2014; 
Wagstaff et al. 2018; World Health Organization and World Bank 2015). For the latter 
measurement to be an appropriate indicator of health systems performance, the services provided 
must respond to the health needs of populations. Unfortunately, there is a major gap in the 
measurement of health system ability to prevent and manage non-communicable diseases 
(NCDs) in LMICs.  
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Over the past 50 years, the burden of disease in LMICs has shifted from acute conditions to 
NCDs and chronic illnesses (World Health Organization 2009). Despite accounting for over 31 
million deaths in LMICs in 2019 (more than HIV, tuberculosis, and maternal deaths combined) 
NCDs have not yet been prioritized in the global health agenda (Zuccala and Horton 2020; 
World Health Organization 2019). Hypertension, or high blood pressure, is the leading risk 
factor for global cardiovascular mortality and morbidity, which causes a third of all deaths 
globally (The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration 
2014). Although there are relatively simple and cost-effective interventions for detecting and 
controlling high blood pressure at the primary health care level, progress towards successful 
hypertension management is not well conceptualized or tracked within the UHC monitoring 
framework, resulting in a de-prioritization of health system-level intervention for hypertension 
management.  
 
Health systems and delivery strategies in LMICs designed to address the previously 
overwhelming burden of communicable diseases and maternal conditions are not optimally 
organized to deliver the continuous, complex, multi-sectoral, and sustained services required to 
prevent and manage chronic conditions, such as hypertension, over the life course (Martin 2007; 
C. D. Willis et al. 2013; Clarke et al. 2017; Goudge et al. 2009; Bhojani et al. 2014). To improve 
and track health system ability to deliver continuous care for chronic conditions, countries 
increasingly need tools to evaluate the performance of health systems and services delivery 
arrangements that influence the health of populations suffering from chronic diseases. Within the 
UHC measurement framework, effective coverage is the primary indicator for assessing 
performance related to health services delivery (Ng et al. 2014; World Health Organization and 
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World Bank 2017; Boerma, AbouZahr, et al. 2014). Effective coverage can be defined as the 
fraction of potential health gain actually delivered to a population in need, and is a widely 
accepted indicator for understanding a health system’s capacity to deliver specific (or a package 
of) services (Ng et al. 2014; Hannah H Leslie et al. 2017; Jannati et al. 2018). Few studies have 
attempted to describe the concept of effective coverage in the context of hypertension 
management, and fewer still have done so in resource-constrained settings (López-López, 
Gutiérrez-Soria, and Idrovo 2012; Charoendee et al. 2018). Academics and the World Health 
Organization (WHO) alike have acknowledged the shortcomings in current measurement of 
effective coverage of chronic disease measurement services and have called for advances in 
these methods (Lozano and GBD 2019 Universal Health Coverage Collaborators 2020; 
Agyepong and Murray 2018; World Health Organization and World Bank 2017, 2019). Without 
appropriate methods for measuring effective coverage of services to manage chronic diseases, 
health systems performance for addressing NCDs cannot be adequately assessed or improved.  
 
There is an urgent need to understand and address challenges associated with providing services 
to manage NCDs in LMICs. This thesis seeks to improve the evaluation of health systems 
performance in managing chronic diseases in a low-resource setting by improving the 
measurement of effective coverage of hypertension management in rural Bihar, India. The 
remaining sections in this chapter describe (i) the goals and potential impact of this research, (ii) 
the need for this research at the global level, (iii) the study site, Bihar, India, (iv) the 
contextualization of global challenges within the study site, (v) the study aims, (vi) the 
conceptual framework underpinning this research, (vii) the parent study and its design, and (viii) 
the outline for presenting the remainder of the dissertation.    
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Thesis Goals and Potential Impact   
 
Quantifying health systems performance in terms of preventing and managing NCDs is a matter 
of immediate concern for governments and must be addressed with urgency. There is remarkably 
little information on methods to measure effective coverage of services to manage chronic 
conditions in LMICs. It is essential that advances are made in this field to identify and address 
service bottlenecks so that populations can access chronic disease management services. This 
thesis will inform improvements in population health by demonstrating how the application of an 
effective coverage framework can advance measurement of health system performance for NCD 
management.  
 
The objective of this thesis is to improve measurement of health systems performance related to 
chronic disease management in a resource-constrained setting. The study first conducts a scoping 
literature review to develop a framework for measuring barriers to achieving effective coverage 
of services to manage hypertension in low-resource settings (called the expanded hypertension 
care cascade). This framework is then applied to quantify supply- and demand-side barriers 
along the pathway towards reaching effective coverage of these services in rural Bihar, India. 
Finally, a new index metric, informed by the largest identified bottlenecks, is developed to 
comprehensively assess the effective coverage of hypertension management services in rural 
Bihar and LMICs globally. The findings from this study can inform policy to improve global 
measurement of chronic disease management services and specifically to improve hypertension 
management in Bihar. The full research process can be applied to other chronic diseases and/or 
resource-limited settings to further improve chronic disease management. 
 
 6 
Improved methodologies to measure effective coverage of chronic disease management services, 
including hypertension management, are desperately needed. This thesis will help address this 
need by proposing a framework for measuring effective coverage of hypertension management 
services. The expanded hypertension care cascade can be used to inform the design and data 
collection of future studies that measure hypertension burden in populations. The effective 
coverage index can be incorporated into future aggregate measures of effective coverage to more 
appropriately represent health system ability to manage hypertension. Specifically, incorporating 
the proposed index measure of effective coverage for hypertension management services into the 
UHC service coverage index would better reflect coverage of chronic disease management 
services than current measurements. Further, the methods described for developing the 
measurement framework for hypertension management can be adapted for other chronic 
diseases, such as diabetes, cancers, and mental illness. Applying the expanded hypertension care 
cascade and the effective coverage index to assess health system performance has implications 
for improving population health in LMIC settings. 
 
Especially where resources are limited, it is essential for health systems to maximize the 
marginal benefit of each dollar spent on health. The application of the expanded hypertension 
care cascade helps public health officials in rural Bihar to quantify the largest systemic 
constraints (on both the supply- and demand-side) to achieving the effective coverage of 
hypertension management services. This analysis essentially allows policymakers in Bihar to 
prioritize interventions to improve hypertension management in the state. Finally, the effective 
coverage index will allow health officials to prioritize certain aspects of service delivery (e.g. 
expanding coverage or improving quality of services). Taken together, these studies will inform 
 7 
a suite of interventions that can be used to improve hypertension management in rural Bihar. The 
methodology used to apply the framework and conduct this analysis can also be applied to other 
LMIC settings to identify options for improving hypertension management.  
 
In summation, this thesis addresses gaps in existing methods to measure health systems’ ability 
to provide services for NCD management in LMICs. It provides a new measurement framework 
(the expanded hypertension care cascade) for measuring effective coverage of hypertension 
management services, which can inform global discussions on NCD management that are 
pertinent to tracking and achieving UHC. A comprehensive index for measuring effective 
coverage of hypertension management services is also proposed to advance the methods 
available for monitoring health systems performance. The thesis applies the expanded 
hypertension care cascade and calculates effective coverage index for a low-resource health 
system (Bihar, India) to inform local policy to improve hypertension management services.  
 
Measuring Effective Coverage for NCDs Globally 
 
Effective coverage is a useful framework for assessing health system performance, and progress 
towards UHC, because it links the quality (effectiveness) of services delivered with the health 
outcomes achieved by a population, conditioned on the need for such services. The motivation 
for this thesis is not to improve measurement of effective coverage for the sake of effective 
coverage alone, but rather because the measure is a critical component of tracking UHC and 
making progress towards better health for all. This section provides necessary background 
information for understanding the relevance of this thesis to the global discussion on UHC and 
the role of the effective coverage framework in measuring health system performance related to 
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providing services to manage NCDs, specifically, hypertension. It also presents the challenges 
associated with current methods for measuring effective coverage of hypertension globally. 
 
 
Universal Health Coverage 
 
According to the WHO, achieving UHC means that all individuals and communities receive the 
health services they need without suffering financial hardship (World Health Organization n.d.). 
Progress towards UHC is generally conceptualized at the national level across three dimensions: 
i) expanding access of services to more of the population, ii) increasing the number and quality 
of services offered, and iii) reducing fees and cost sharing among the population (Kutzin 2013). 
It is generally the responsibility of the State to provide the leadership and governance necessary 
to achieve UHC at local levels, with the support of actors from non-government organizations 
(NGOs), the private sector, and the international development community. The importance of 
community empowerment and the role of community organizations in achieving UHC cannot be 
overstated: strong primary health care systems drive progress towards UHC. Fortunately, local 
communities are beginning to receive high-level national political support for UHC.  
 
Building on previous initiatives like Health for All and the Alma-Ata Declaration, achieving 
UHC is becoming a focal point in global health policy, especially in LMICs. As of September 
2015, all United Nations member states had committed to achieving UHC through the adoption 
of the Sustainable Development Goals (SDGs), especially the goal for inclusive health (Goal 3) 
by 2030 (United Nations 2015b). The largest globally coordinated effort to achieve UHC falls 
under the SDGs, particularly goal 3.8 which aims to “achieve universal health coverage, 
including financial risk protection, access to quality essential health-care services and access to 
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safe, effective, quality and affordable essential medicines and vaccines for all” by 2030 (United 
Nations 2015a). Recognizing shortcomings in their predecessors, the Millennium Development 
Goals (MDGs), the SDGs reflect progress that has been made in global health since 2000, 
including a growing focus on preventing and treating non-communicable diseases and improving 
the quality of health interventions rather than expanding coverage alone (Nugent et al. 2018; 
Kruk, Larson, and Twum-Danso 2016; Sobel, Huntington, and Temmerman 2016). In 2019, 
world leaders adopted a high-level United Nations Political Declaration on UHC, furthering their 
commitments to accelerate progress towards UHC. Towards this end, studies have shown that at 
least 75 countries have implemented legal frameworks and systems for UHC (Feigl and Ding 
2013). These frameworks are the necessary underpinnings of the systemic reforms required to 
achieve UHC in a country.  
 
Reaching UHC requires intervention across the health system. A health system consists of all the 
organizations, institutions, resources, and people whose primary purpose is to improve health 
(World Health Organization 2007). Organizing or strengthening health systems to achieve UHC 
is an overarching goal, as this contributes to resilience, enabling societies to adapt to emerging 
health threats, such as non-communicable diseases (NCDs) or pandemics (Kruk et al. 2015). The 
coronavirus disease (COVID-19) pandemic has intensified efforts to build resilient health 
systems that are responsive to local needs and resistant to external shocks. Accordingly, within 
national health systems, comprehensive primary health systems are generally seen as the catalyst 
for achieving progress towards UHC. This is due in part to the fact that around 90% of all health 
needs can be met at the primary health care level (Doherty and Govender 2004). However, 
comprehensive primary health goes beyond providing clinical care. It also involves addressing 
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social determinants of health, changing contexts to positively influence behavioral determinants 
of health, and promoting primary prevention and care, including counseling and education 
(Frieden 2010). Common barriers to achieving UHC span the components of the health systems 
building blocks (World Health Organization 2007). Inadequate basic infrastructure, insufficient 
and maldistributed human resources, poor quality health services, shortages of essential 
medicines and health products, a lack of local participation, insufficient health information 
systems, and ineffective financing often plague LMICs attempting to achieve UHC. With the 
large number of system components involved in achieving UHC, measuring progress is a 
complex task. 
 
Unlike disease-focused global public health initiatives such as eradicating polio, no simple 
indicator exists for monitoring progress towards UHC. Vertical programs often serve as the 
bedrock for providing essential health services (e.g. polio and child immunization platforms), 
however achieving UHC requires comprehensive, system-wide action. Five years into the SDG 
era, there remains confusion on how to measure health system progress towards achieving 
universal coverage of key health services, including hypertension management. The UHC 
monitoring framework within the SDG declaration is a useful starting place for understanding 
how UHC is conceptualized by global experts. Two indicators were adopted by the UN 
Statistical commission in 2017 to monitor progress towards UHC: i) achieving coverage of 
essential health services (indicator 3.8.1) and ii) ensuring financial protection against excessive 
health expenditure in countries (indicator 3.8.2).  
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The first indicator is a composite index which aims to demonstrate both the quality and coverage 
of a representative range of essential services from across the health system. Tracer indicators 
indicating the effective coverage of four categories (reproductive, maternal, newborn, and child 
health; infectious disease control; non-communicable disease control; and service capacity) were 
selected based on standardized criteria (Boerma, AbouZahr, et al. 2014). 1 When combined, these  
contribute to an index that demonstrates progress towards providing the basic services deemed 
necessary under UHC (Table 1.1). Scores for each indicator are calculated from the relevant 
household surveys, administrative systems, and surveillance systems available in each country. 
The index is calculated by taking the geometric mean across indicators within each of the four 
categories and then taking the geometric mean of the four overall category means to obtain the 
final service coverage index (Hogan et al. 2018). The resulting index is reported on a range from 
0-100, with 100 being the maximum (and ideal) score. The effective service coverage index has 
been calculated for 183 countries as a baseline in 2015, in 2017, in 2019, and retroactively using 
available data for 1990 and 2000 (Hogan et al. 2018; World Health Organization and World 
Bank 2019; Lozano and GBD 2019 Universal Health Coverage Collaborators 2020).  
  
 
1 These selection criteria include epidemiological relevance, whether the intervention is proven to be cost-effective, 
measurability of numerators and denominators, existence of a clear target, whether disaggregation is possible for 
equity considerations, quality of intervention, whether the indicator can be compared, ease of communication, data 
availability, inclusion in international initiatives, and parsimony  
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Table 1.1: Indicators for tracking essential service coverage in SDG 3.8.1 
Domain Tracer Area 
Tracer 
Indicator 
Type Rationale, Limitations, and possible refinements 
Reproductive, 
maternal, newborn, 
and child health 




who are married 
or in-union who 








Demand satisfied with a modern method is SDG indicator 3.7.1. However, it has 
a relatively complex denominator derived from multiple survey questions, and 
data collection often focuses on women in unions, as opposed to all sexually 
active women.  
Pregnancy and 
delivery care  
Percentage of 
women aged 15-
49 years with a 
live birth in a 
given time period 
who received 
antenatal care 




The number of antenatal care visits captures the amount of contact with the 
health-care system but does not capture quality of care received and might not 
lead to a reduction in mortality. Skilled attendance at birth (SDG indicator 3.1.2) 
is a preferred alternative; however insufficient standardized measurement of 
skilled health-care personnel makes cross-country comparisons difficult. Efforts 
to improve reporting on SDG 3.1.2 should resolve these comparability issues 
and allow 3.1.2 to replace four or more visits to antenatal care in the index.  
Child immunization  Percent of 
children aged 1 
year who have 
received three 
doses of a 
diphtheria, 
tetanus, and 
pertussis vaccine  
Service 
coverage  
Three doses of diphtheria, tetanus, and pertussis vaccine, which is identical to 
coverage with pentavalent vaccine in most countries, is an indicator of routine 
infant immunization system. However, several other vaccines, such as those for 
measles (second dose), pneumococcal pneumonia, and rotavirus diarrhea, 
typically have lower coverage and the fraction of children receiving all vaccines 
in a national schedule is typically much lower (although not possible to measure 
directly with existing data systems in most countries). Once metadata for SDG 
3.b.1 are defined, an indicator consistent with 3.b.1 could be used in the index in 
place of the diphtheria, tetanus, and pertussis vaccine measure.  
Child treatment  Percentage of 
children under 5 





breathing not due 
to a problem in 
the chest and a 
blocked nose) in 
the two weeks 
preceding the 
survey taken to 
an appropriate 




Pneumonia is a leading cause of child illness and death. Suspected pneumonia is 
identified on the basis of a series of survey questions about illnesses in the past 2 
weeks, which might include mild respiratory illnesses. However, the indicator 
does not currently capture the quality of care received as a mother’s recall of 
treatment specifics can be poor. The main alternative indicator for child 
treatment that is widely measured is use of oral rehydration solution therapy for 
child diarrhea, which is also a leading cause of child death. The inclusion of the 







cases that are 
detected and 
success- fully 





This indicator combines two more common ones—the rates of case detection 
and of treatment success—to estimate the proportion of all people with 
tuberculosis who successfully complete treatment. Calculation of the case 
detection rate requires estimates of incident cases (including those not identified 
by the health-care system). Treatment success is measured through 
administrative data, and includes all patients who successfully completed 
treatment without bacteriological evidence of treatment failure.  






therapy (ART)  
Service 
coverage  
Provision of antiretroviral therapy averts a substantial number of deaths in high-
burden HIV countries and can be a marker of how well a health system reaches 
marginalized populations with higher HIV prevalence in countries with lower 
HIV burden. Recent surveys have begun to measure effective coverage of 
antiretroviral therapy by obtaining data on viral load suppression. The 
numerator— people taking antiretroviral therapy—is generally obtained from 
health facility data, whereas the denominator is estimated from HIV 
epidemiological data.  
Malaria prevention  Percentage of 
population in 
malaria-endemic 
areas who slept 
under an 
insecticide-
treated bed net 
(ITN) the 
previous night  
Service 
coverage  
Insecticide-treated bed net distribution is a major program in malaria-endemic 
countries. Coverage estimates should account for geographical heterogeneity in 
malaria risk when analyzing national household surveys. Because the nets 
deteriorate over time, effective coverage can decline without resupply.  
Water and sanitation  Percentage of 
households using 
at least basic 
sanitation 
facilities   
Service 
coverage  
Although access to clean water and safely managed sanitation are not always 
implemented by the health sector, these interventions are important to public 
health. The current indicator of at least basic sanitation typically has lower 
coverage than access to at least a basic water source, and therefore is used as the 
tracer indicator for this area. This tracer indicator could be replaced with SDG 









Proxy  Hypertension is the leading risk factor for cardiovascular disease. The 
prevalence of normal blood pressure is the sum of the percentage of individuals 
who do not have hypertension and the percentage of individuals whose 
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Domain Tracer Area 
Tracer 
Indicator 
Type Rationale, Limitations, and possible refinements 
pressure among 
adults aged 18 
and older, 
regardless of 
treatment status  
hypertension is controlled by medication. The absence of hypertension is a result 
of prevention efforts via promotion of physical activity and healthy diets, and 
other factors. Hypertension controlled with medication is a result of effective 
treatment. This indicator is therefore a proxy for both effective health promotion 
and effective medical services. This indicator will be replaced with treatment 






for adults aged 
18 years and 
older  
Proxy  Mean fasting plasma glucose can be reduced through effective treatment of 
individuals with diabetes and through diabetes prevention with effective 
promotion of protective behaviors and diets. However, diabetes treatment 
guidelines do not recommend lowering blood glucose to non-diabetic 
concentrations for all patients, meaning that a population with a high prevalence 
of diabetes should not necessarily attain a low mean fasting plasma glucose. 
This indicator will be replaced with the proportion of people with diabetes 
receiving treatment once data become available.  
Cancer detection 
and treatment  
Percent of 
women aged 30-






Data on this indicator are obtained in some household surveys, although these 
data are not yet available widely enough to be used for global monitoring. The 
indicator does not reflect whether effective treatment is available. This indicator 
was chosen over other potential cancer screening indicators, such as for breast or 
prostate cancer, because of clearer guidelines for cervical cancer, and because 
cervical cancer screening is the only cancer screening indicator included in the 
core indicator set of the non-communicable diseases global monitoring 
framework.  
Tobacco control  Age-standardized 
prevalence of 
adults aged 15 
years and older 
not smoking 
tobacco in last 30 
days  
Proxy  Prevalence of smoking (SDG indicator 3.a.1) is a proxy for adoption and 
enforcement of effective anti-tobacco measures. This indicator could be replaced 
with an indicator of implementation of tobacco control measures.  
Service Capacity and 
Access 
Hospital access  Hospital beds per 
capita, relative to 
a maximum 
threshold of 18 
per 10,000 
population   
Proxy  This indicator is a proxy for access to essential inpatient services. It has more 
data available in low-income and middle-income countries than number of 
inpatient hospital admissions, with which it is highly correlated (ρ=0·84 in low-
income and middle-income countries). A threshold is used to capture only low 
capacity levels because high values might represent overcapacity or inefficient 
allocation of resources.  







capita, relative to 
maximum 
thresholds for 
each cadre   
Proxy  Comparable data on patient use of outpatient facilities are not readily available 
in low-income and middle-income countries. Physician density, part of SDG 
indicator 3.c.1, is included as a proxy for access to outpatient services that are 
not captured by tracer indicators included elsewhere in the index. Nurses and 
midwives are currently excluded because of limited comparability between 
countries in existing global databases. The density of psychiatrists is a proxy for 
availability of mental health services, and surgeon density is a proxy for access 
to surgical and emergency care. As with hospital beds per capita, a threshold is 
used to capture low densities for all three cadres.  







core list of 
essential 
medicines  
Proxy  Medicines are the main intervention resulting from clinical services, and their 
availability provides a proxy for access to services beyond mere contacts with 
professionals. This tracer will be included once data become widely available.  





which is the 
average 
percentage of 
attributes of 13 
core capacities 
that have been 
attained at a 
specific point in 
time   
Proxy  Because many health risks are rare, preparedness must be measured to capture 
health security. This indicator—SDG 3.d.1—is currently based on key informant 
reports to WHO, but could be informed by Joint External Evaluations in the 
future.  
 
The second indicator measures the incidence of financial hardship caused by health payments, 
also known as catastrophic health expenditure. The official indicator calculates the proportion of 
households in a country with large expenditures on health (greater than either 10% or 25%) as a 
share of total household consumption or income. Initial studies have reported that the global 
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incidence of catastrophic health spending at the 10% threshold has increased from 9.7% in 2000 
to 11.7% in 2010 (Wagstaff et al. 2018). Although financial protection is an important metric of 
health system performance, this thesis primarily focuses on the first component of UHC, 
effective service coverage.  
 
The aforementioned service coverage index is not a definitive list of the services that must be 
included within systems that have achieved UHC, nor is it the only way to track service coverage 
for UHC. However, the service coverage index has been adopted by the SDG monitoring group, 
by WHO, and by the World Bank, ensuring that it is the primary way that progress towards UHC 
is measured globally. As such, each tracer indicator within the service coverage index should 
reflect progress towards ensuring coverage of the basic services that have the largest impact on 
improving health. The WHO acknowledges that while all of the indicators in the service 
coverage index should ideally reflect effective coverage, for many health areas, indicators of 
effective coverage are not available either “due to lack of investment in data collection or 
difficulties around defining an operational indicator for a particular health service” (World 
Health Organization and World Bank 2017). In cases where indicators for effective coverage are 
not used, the index relies on service coverage indicators and proxy indicators. Service coverage, 
or contact coverage, indicators are those which describe the percent of individuals in need of a 
service who receive that service, but do not account for the quality of the service. Proxy 
indicators are upstream or downstream services correlated with the provision of health services 
to those in need. Service coverage or proxy indicators are used to track NCDs, mental health, and 
routine health examinations in the official SDG 3.8.1, presenting problems for measuring health 
system performance. Without incorporating a measure of quality, service coverage is only 
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weakly linked to the health benefits received by a population (Amouzou et al. 2019). Proxy 
indicators are further removed from the population’s health benefits. Therefore, effective 
coverage, rather than service coverage, of essential health services is the preferred metric for 
tracking progress towards UHC. The lack of effective coverage metrics currently being used to 
calculate coverage of hypertension and other NCD management services within the UHC 
monitoring framework represents a major gap between the methods used to track health system 
performance and the services actually needed by populations.   
 
Effective Coverage and Chronic Diseases 
 
Effective coverage is a promising metric for evaluating program and health system success 
because it captures whether individuals are experiencing the improvements in health that are 
possible from medical and behavioral interventions. For this reason, the service coverage tracer 
indicators for monitoring progress towards UHC were designed to ideally capture effective 
coverage of specific interventions (Ng et al. 2014). Calculating effective coverage is based on a 
framework that incorporates three dimensions: (i) need: the proportion of a population in need of 
an intervention; (ii) use: the proportion of those in need who receive (and use) the service; and 
(iii) quality: the proportion of those receiving a service that is capable of resulting in the desired 
health benefit (Shengelia et al. 2005; Tanahashi 1978). Its calculation is often represented 
through the following equation: 
 
Effective Coverage = Utilization X Quality | Need = 1 
 
 
Where utilization takes a value of either 0 or 1 (1 representing an individual in need who 
receives a service), quality takes a value between 0 and 1 based on intervention effectiveness (1 
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representing optimally effective services), and need takes a value of either 0 or 1 (1 representing 
an individual in need of a service). Hence, effective coverage can range from 0 to 1 at the 
individual level, depending largely on the quality of the service provided. Effective coverage can 
be aggregated across individuals to derive estimates for population groups and/or geographic 
areas, and can be aggregated across multiple interventions to reflect overall health system 
performance (Shengelia et al. 2005). Without the quality adjustment, the calculation reflects a 
simple service coverage estimate of an intervention, therefore the effective coverage metric is 
often interchangeably described as “quality-adjusted coverage”. Studies have demonstrated large 
gaps between the crude and quality-adjusted coverage of reproductive, maternal, and child health 
services, ranging from 10 to 38 percentage points (Amouzou et al. 2019). This means that even if 
an intervention achieved 100% service coverage, only 62 to 90% of individuals received health 
services of sufficient quality to improve health. This result highlights the importance of striving 
to measure effective coverage of health services that lead to improvements in population health, 
rather than the crude coverage of health services. Such measurements require considerations of 
service quality and often entail linking household- and facility-based surveys to understand the 
impacts of quality of care on health outcomes (Munos et al. 2018). While these studies are being 
conducted with more frequency for interventions related to improving maternal and child health, 
no such study has yet been conducted to explore quality-adjusted care for chronic diseases. This 
shift from measuring service coverage to effective coverage must occur for high burden diseases 
across all contexts.   
 
Combining the reach of health services with population health gains makes the effective 
coverage framework a parsimonious measurement tool for assessing health systems 
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performance. However, few studies have attempted to describe the entire effective coverage 
framework (i.e. need for services, use of services, and quality of services) in the context of 
chronic disease management, and fewer still have done so in resource-constrained settings. 
Whereas others have measured effective coverage for acute conditions, or for screening services 
for chronic diseases, measuring dimensions of effective coverage for the ongoing management of 
a chronic diseases is not well conceptualized or measured (Charoendee et al. 2018; López-López, 
Gutiérrez-Soria, and Idrovo 2012). This is a significant shortcoming due to the epidemiological 
differences between maternal and child health conditions and chronic diseases. Efforts to 
improve infant and child survival primarily rely on discrete points of contact between individuals 
and health systems to achieve health gains (e.g. four ANC visits during pregnancy, delivering a 
child at a health facility, or three visits for a full schedule of DTP immunization). Conversely, 
effective treatment for chronic diseases requires consistent monitoring, management, and 
developing relationships between patients and providers over a long time horizon.  Examining 
the three components of effective coverage (need, use, and quality) in the context of chronic 
disease management demonstrates potential complications for applying the framework to such 
diseases and underscores the need for further research in this field.  
 
According to the framework proposed by Shengelia et al., effective coverage can be defined as a 
product of service use and quality (effectiveness), conditioned on need for that service 
(Shengelia et al. 2005). Defining a need for services is an often-overlooked component of 
measuring effective coverage, however it has important implications for effective coverage 
calculations, as the number of individuals in need constitutes the denominator used to assess the 
percent of population reached. In his seminal paper, Bradshaw described a taxonomy of need, 
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which included; (i) normative need, which the expert defines as need in a given situation; (ii) felt 
need, which is equated with want; (iii) expressed need, which is defined as those people who 
demand a service; and (iv) comparative need, which studies characteristics of the population 
receiving a service and if there are people with similar characteristics not receiving a service, 
then they are in need (Bradshaw 1972). In the context of certain chronic diseases, such as mental 
illnesses or chronic lung disease, individuals may not be aware that they have a health problem. 
In this case, while the individual may have a normative need for mental health or chronic 
respiratory disease management services, she likely cannot want for nor demand these services. 
These examples demonstrate the finding that service coverage, and therefore effective coverage, 
conditioned on actual need can be less than any coverage measure conditioned on perceived need 
(Shengelia et al. 2005). Furthermore, felt or expressed need for services can vary over time with 
recurring or progressive chronic diseases, meaning that the same individual can be classified as 
in need or not in need of a variety of services depending on when their need is assessed. An 
individual with undiagnosed diabetes has completely different health service requirements than 
an individual with later-stage diabetes (i.e. the first individual requires screening and diagnosis, 
the second individual requires treatment). This example of shifting definitions of need represents 
a stark difference when compared to defining need for effective coverage of services like 
receiving a full schedule of DTP immunization (every one-year old child needs 3 doses) or 
receiving antenatal care (every pregnant mother needs 4 visits). Therefore, defining the need for 
services is complicated by the duration and nature of chronic diseases versus the relatively 
straightforward needs of users of maternal and child health services.  
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Utilization of chronic disease management services has several dimensions. Patient-provider 
interactions can take many forms, including screening, diagnosis, initial care planning, periodic 
check-ups (and treatment adjustments), and disease management. Yet another dimension of 
utilization is adherence to treatment and self-management over time, which are vital components 
of chronic disease management (Barr et al. 2003; Lall et al. 2018). Systematic reviews have 
identified barriers to adherence and interventions to improve medication adherence in high 
income settings, but there is limited evidence available in LMICs (Conn et al. 2015; Dennis et al. 
2011). In LMICs, access to health services, especially those to manage NCDs, is generally low, 
resulting in low service utilization (O’Donnell 2007). Previous authors have described a 
typology of access, encompassing availability, accessibility, affordability, and acceptability of 
services (Penchansky and Thomas 1981). Others have since expanded on these typologies to 
identify various supply- and demand-side barriers associated with each of these access-related 
domains (D. H. Peters et al. 2008; Jacobs et al. 2012). These barriers to access can each play a 
role in preventing individuals from receiving the chronic disease management services they 
need. For example, stockouts may inhibit the availability of chronic disease medications, long 
distances to health facilities with dialysis equipment reduce accessibility of treatment for kidney 
failure, prices of medicines may be prohibitive for patients to adhere to treatment, and services 
may not be acceptable to people if they are not educated about chronic diseases or if treatments 
are culturally inappropriate. The concept of service utilization needs to be further considered in 
the context of chronic diseases, where service provision is not a one-time event, and often 
requires action from the patient long after an interaction with a provider.  
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Those receiving chronic disease management services may not achieve the desired health 
benefits of treatment if the quality of care is substandard. Quality of care has been defined by 
Donabedian as having three interrelated components; structure, process, and outcomes (Box 1.1) 
(Donabedian 1966, 1988). Donabedian argues that these three components of quality build on 
each other. In other words good structure increases the likelihood of good process, which in turn 
increases the likelihood of a good outcome (Donabedian 1988). He continues to note that while 
structural quality is furthest removed from health gains, neither the measurement of process nor 
the measurement of outcomes is superior for indicating service quality, and rather suggests that 
there are benefits to measuring both constructs depending on the needs of the study (Donabedian 
1988). In the context of effective coverage, quality is generally equated to the effectiveness of an 
intervention (Shengelia et al. 2005). In most cases, measures of outcome quality, or health status, 
are incorporated as the quality dimension of effective coverage metrics (e.g. the proportion of 
tuberculosis cases that are successfully treated). Some chronic diseases can never be cured or can 
reemerge after remission, so outcome measures of quality may vary over time along with an 
individual’s health status. When quality cannot easily be equated to the effectiveness of an 
intervention, standards to which quality is compared should be contextually relevant. In other 
words, when outcome quality cannot be measured, structure and process quality should be 
compared to locally-defined best practices to assess whether best practices were followed in 
providing care. This can complicate efforts to define measures of quality across various settings. 
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Box 1.1: Dimensions of Quality According to Donabedian 
 
There are several challenges and complications associated with measuring the individual aspects 
of effective coverage of services to manage chronic diseases. Effective coverage of chronic 
disease management services in LMICs is largely understudied, yet requires immediate attention 
in order to appropriately monitor progress towards reaching UHC. Due to its global prevalence, 
severe economic impact on society, ability to be managed as a chronic disease at the primary 
care level, and lack of a current measure of effective coverage, hypertension is a key chronic 
condition that requires additional research. This thesis will explore issues in measuring effective 
coverage for hypertension management services to improve monitoring of health systems 
performance and progress towards UHC. 
 
Hypertension and Effective Coverage 
Hypertension, or high/raised blood pressure, is a common condition in which the long-term force 
of blood pushing against artery walls is high enough that it may eventually cause health 
problems, especially cardiovascular disease. It is estimated that some 1.4 billion people globally 
Structure – attributes of the setting in which care occurs, including: 
• Material resources (e.g. facilities, equipment, and money) 
• Human resources (e.g. number and qualifications of personnel) 
• Organizational structure (e.g. medical staff organization, methods of reimbursement) 
 
Process – what is actually done in giving and receiving care, including: 
• Patient’s activities in seeking care and carrying it out (e.g. adherence) 
• Provider’s activities in making a diagnosis and recommending or implementing 
treatment 
 
Outcome – the effects of care on the health status of patients and populations, including 
• Health benefits accrued by the patient 
• Improvements in patient’s knowledge and changes in behavior 
• Patient’s satisfaction with care 
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are living with hypertension, including 1.0 billion hypertensive individuals living in LMICs 
(Mills et al. 2016). High blood pressure is a complex phenomenon influenced by individual 
behavior, nutrition, and environments throughout the life course. Factors that can influence blood 
pressure levels include fetal and early childhood nutrition (Victora et al. 2008), obesity (Institute 
of Medicine (US) 2010), sodium and potassium consumption (Sacks and Campos 2010; Du et al. 
2014; He, Pombo-Rodrigues, and Macgregor 2014), illicit drug and/or alcohol use (Taylor et al. 
2009), smoking (Virdis et al. 2010), physical activity (Institute of Medicine (US) 2010), air 
pollution (Liang et al. 2014), lead exposure (Navas-Acien et al. 2008), excessive noise (van 
Kempen and Babisch 2012), prolonged stress, and the use of blood pressure lowering medication 
(U. O. Andersen and Jensen 2010; Ezzati et al. 2015). Chronic hypertension can harden arteries, 
decreasing the flow of blood and oxygen to the body’s essential organs, especially the heart, and 
can contribute to complications such as chest pain (angina), heart attack, and/or heart failure. It is 
the leading risk factor for global cardiovascular mortality and morbidity, resulting in 9.8 million 
deaths in LMICs per year, and also significantly increases the risks of stroke, kidney failure, and 
other diseases (World Health Organization 2019). Hypertension cannot be cured, but it can be 
managed and controlled with lifestyle modifications and medical treatment. Fortunately, a slight 
reduction in systolic blood pressure (5 mm Hg) has been associated with lower likelihoods of 
mortality, including reductions of 14% from stroke, 9% from heart disease, and 7% from all 
causes (Whelton et al. 2002). Starting treatment is conditional on the identification of 
hypertension, which varies based on the definition used by a clinician. 
 
There are many guidelines for defining hypertension, however, individuals are generally 
diagnosed by comparing multiple measures of systolic (pressure during contraction of heart 
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muscle) and diastolic (pressure when heart muscle is between beats) blood pressure to a set 
target for a population subgroup (Table 1.2). Physician use of these guidelines varies: in India, 
for example, 63.85% of physicians used guidelines established by the Joint National Committee 
(JNC8), 14.23% referred to Indian Guidelines on Hypertension, 8.46% followed more than one 
guideline, and 6.93% used their own approach (Hiremath et al. 2016). Studies have demonstrated 
the significant impact of using various blood pressure control guidelines on hypertension 
management. In Iran, the prevalence of hypertension was sharply increased from 29.9% to 
53.7% of the population over age 25 when switching from the JNC8 guidelines (140/90 mmHg) 
to the 2017 ACC/AHA (130/80 mmHg) guidelines (Mahdavi et al. 2020). The same study found 
that the percent of population previously diagnosed as hypertensive that had achieved control 
decreased by over one half, falling from 39.1% under JNC8 guidelines to 19.6% under 2017 
ACC/AHA guidelines (Mahdavi et al. 2020). Explicitly choosing a standard guideline is essential 
in order to set targets for blood pressure management in a particular population. Regardless of 
hypertension definition, over time, hypertension prevalence has shifted from primarily high-
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Legend: ACC= American College of Cardiology; AHA = American Heart Association; ESC = European 
Society of Cardiology; ESH = European Society of Hypertension; IGH = Indian Guidelines on Hypertension; 
ISH = International Society of Hypertension Global Practice Guidelines; JNC 8 = Eighth Joint National 
Committee 
 
From 2000 to 2010, the age-standardized prevalence of hypertension decreased by 2.6% in high-
income countries but increased by 7.7% in LMICs (Mills et al. 2016). Today, the majority of the 
global NCD burden is felt in LMICs, where people on average develop hypertension at a 
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younger age (40-59 years old) than in high-income countries (60 and older) (Zhou et al. 2017; 
Sarki et al. 2015).  Within LMICs, hypertension prevalence does not always significantly vary 
across income groups, however wealthier populations are more likely to be aware of their 
condition and be receiving treatment than poorer groups (Palafox et al. 2016). In addition to 
health services not reaching the poor in LMICs, the cost of continued treatment is prohibitive for 
up to 31% of households in low-income countries (Attaei et al. 2017). A review of the cost of 
medical hypertension treatment found that the average monthly cost of hypertension 
management in LMICs is US$22 (Gheorghe et al. 2018). This equates to 38% of the monthly 
income for those living at or below the $1.90-per-day international poverty line, 23% of income 
for those living at or below the $3.20 poverty line for lower-middle-income countries, and 13% 
of income for those living at or below the $5.50 poverty line for upper-middle-income countries. 
Therefore, in all low- and middle-income countries, the average cost of managing hypertension 
therefore qualifies as catastrophic health expenditure (at the 10% level) for individuals living at 
or below the poverty line. Thus, hypertension is a common chronic condition contributing to 
major disease burden and its management can cause massive economic losses in resource-
constrained settings. Improvements in the effectiveness and efficiency of hypertension 
management in LMICs can save lives and contribute to the financial protection of vulnerable 
people.  
 
Unlike some other chronic conditions which require more advanced procedures to diagnose and 
treat, hypertension diagnosis and management does not require significant resources. Blood 
pressure can be measured, hypertension can be diagnosed, and treatment can be initiated at low 
cost in the primary care setting by both doctors and non-physician health workers (World Health 
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Organization 2010). The WHO recommends lifestyle changes to prevent the development and 
progression of hypertension, followed by pharmacologic therapy (World Health Organization. 
2016). Evidence-based lifestyle changes to lower blood pressure include improving diet 
(particularly by reducing sodium intake), increasing exercise, losing weight, stopping smoking, 
and reducing alcohol consumption and these changes can lower blood pressure between 3-
11/2.5-5.5 mm Hg depending on the intervention (Oza and Garcellano 2015; Saseen et al. 2005). 
Following, or in tandem with lifestyle changes, there are a range of drug therapies and guidelines 
for their use in lowering blood pressure in various clinical settings and patient conditions. These 
guidelines are often country-specific and based on availability of drugs, thus consideration of 
context is essential, especially when measuring need for and relative quality of hypertension 
management services. 
 
Resource-constrained countries facing a rising burden of hypertension increasingly need tools 
that can measure health system performance in improving the health of those suffering from high 
blood pressure. Within the current UHC monitoring index, global progress towards improved 
hypertension management is measured by national rates of “Age standardized prevalence of non-
raised blood pressure (systolic blood pressure < 140 mm Hg and diastolic blood pressure < 90 
mm Hg) among adults aged 18 years and older” (World Health Organization and World Bank 
2019). This indicator is classified as a proxy of effective medical services to manage 
hypertension and its shortcomings as a measure of hypertension management are widely 
acknowledged (World Health Organization and World Bank 2015, 2017, 2019). Although proxy 
indicators are supposed to be positively correlated with downstream measures of coverage, in 
low- and lower-middle income countries, the prevalence of non-raised blood pressure in adults 
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has a weak negative relationship with service and effective service coverage (Figure 1.1). The 
WHO and World Bank have acknowledged the shortcomings of this indicator in each of the 
global monitoring reports on UHC and have also indicated their ideal replacement indicator 
(Table 1.3). The current indicator will be replaced by a service coverage indicator (percent of 
hypertensive individuals receiving treatment) once sufficient data is available (World Health 
Organization and World Bank 2017). Even once the proposed hypertension treatment coverage 
indicator is adopted, since service quality is not incorporated, it will not be a measure of effective 
coverage.  As previously noted, without accounting for the quality of health services, the 
coverage of treatment services is not closely associated with population health gains (Amouzou 
et al. 2019). Therefore, additional research must be done to advance understandings of 
methodologies for measuring effective coverage of hypertension management services.  
 




Table 1.3: Evolution of measuring effective coverage of hypertension management services 
Document Year Tracer Indicator Discussion on 
Indicator 








2015 (Proposed but not 
adopted): Adults 18 
years and older 
currently taking 
antihypertensive 
medication / Adults 18 
years and older taking 
medication for 
hypertension, with 
systolic blood pressure 
≥ 140 mmHg, or with 
diastolic blood pressure 
≥ 90 mmHg 
Defines the indicator as 
a treatment coverage 
indicator. Defines  
effective coverage as 
the proportion of 
people on blood 
pressure medication 
with blood pressure 
below 140/90  
Recognized in the 
context of HIV 
effective coverage. 
States that “in cases 
where the end-point 
of the effective 
coverage cascade 
cannot be measured, 
earlier steps along the 









2017 Prevalence of normal 
blood pressure, 




indicator as a proxy for 
both effective health 
promotion and effective 
medical services. States 
that the indicator will 
be replaced with a 
measure of treatment 
coverage among people 
with hypertension, once 














raised blood pressure 
(systolic blood pressure 
< 140 mm Hg and 
diastolic blood pressure 
< 90 mm Hg) among 
adults aged 18 years 
and older  
 
Recognizes that the 
age-standardized 
prevalence of blood 
pressure is not a good 
predictor of treatment 
coverage and effective 
coverage in LMIC. 
 
States that measuring 
treatment and control to 
assess effective 




cascades as tools for 
measuring quality of 
care which start from 
the number of people 
in need and include 
the successive steps 
of seeking care, 
receiving appropriate 
care (quality of care), 
controlling or 
preventing disease, 
and survival and well-
being. Calls for 
quality  measures that 
determine whether 





There are several aspects related to the epidemiology of hypertension and the current 
conceptualization of effective coverage that complicate the measurement of effective coverage for 
hypertension management services. Primarily, hypertension is representative of the dynamic and 
time-varying nature of chronic diseases which has not been accounted for in effective coverage 
measurement. While an individual who is formally diagnosed with high blood pressure will always 
be considered to be hypertensive, with effective treatment and lifestyle changes, blood pressure 
can be lowered to normal levels that reduce additional risk of adverse health effects associated 
with hypertension. Over time, the health services required by a hypertensive patient vary: from 
education and awareness in pre-hypertensive patients to screening and diagnosis to detect 
hypertension in its early stages, to treatment and management advice over the rest of the life course. 
Thus, the definition of the services needed within the broader effective coverage metric varies over 
the course of managing an individual patient’s hypertension. The guidelines for classifying 
individuals as hypertensive influence not only the need for services, but also the quality of services 
when using health outcomes as a quality metric (i.e. when high blood pressure has been effectively 
controlled). Once a patient is diagnosed with hypertension and linked to treatment, in many cases, 
finding an effective combination of drug therapy and lifestyle advice requires several iterations 
and interactions with providers before blood pressure is lowered to healthy levels (Calhoun et al. 
2008). Even if a patient is prescribed with a treatment regimen that could lower blood pressure, if 
adherence to treatment is inconsistent, then blood pressure status can fluctuate between normal 
and high levels over time. Thus, both patient- and provider-side characteristics of hypertension 
management must be considered in order for services to be classified as “used” if they are to result 
in health gains for a patient. Finally, defining what constitutes “quality” services in hypertension 
management is complex. Measuring whether a hypertensive individual is normotensive at a certain 
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time point indicates some level of outcome quality, however the same individual’s blood pressure 
may fluctuate over time, resulting in different indications of quality depending on when the 
measurement is taken. White-coat hypertension, or temporarily elevated blood pressure in a 
clinical setting, and misclassification based on the ability to measure blood pressure further 
complicate the use of blood pressure levels at a single time point as a measure of outcome quality. 
Standardizing a measure to indicate the quality of the process of hypertension management is also 
difficult since appropriate care is highly specific to the individual patient. Since treatment 
guidelines can vary based on a patient’s age, comorbidities, and reaction to first- and second-line 
treatments, it may be difficult to judge a provider’s process quality for hypertension  management 
(Whelton et al. 2018). Patient adherence to treatment also plays a major role in determining the 
ultimate quality of hypertension management services, introducing additional components for 
potential measurement. While the current conceptualization of effective coverage is insufficient to 
capture all of the components related to need, use, and quality of hypertension management 
services, more flexible and comprehensive measurement frameworks exist.  
 
Care cascades are tools which attempt to incorporate the quality of care into the measurement of 
service coverage, thereby measuring constructs similar to effective coverage. Care cascades 
generally start with the number of people in need of a service and include the successive steps of 
seeking care, receiving a service, receiving appropriate care (process quality), user adherence, 
and then the health gains achieved (Amouzou et al. 2019). These cascades are perhaps most 
recognizably used in global public health to monitor HIV/AIDS control, but they have also been 
developed for a range of maternal and child health interventions and services to manage other 
diseases such as tuberculosis, hepatitis C, and diabetes (Gardner et al. 2011; Amouzou et al. 
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2019; Ali et al. 2014; Safreed-Harmon et al. 2019; Alsdurf et al. 2016). Hypertension 
management also has a cascade of care with steps commonly described at the prevalence of high 
blood pressure, percent of hypertensives formally diagnosed, percent of hypertensives receiving 
treatment, and percent with controlled blood pressure (Figure 1.2). This hypertension care 
cascade framework has been used to describe hypertension control in populations in the United 
States since at least the 1980s and in India since at least 1990 (Cummings et al. 1982; National 
Heart Blood and Lung Institute 1985). In LMICs, the largest barriers to hypertension 
management are the diagnosis of individuals with high blood pressure, and the ability to achieve 
non-elevated blood pressure levels among individuals receiving treatment (Geldsetzer et al. 
2019).  
 
Figure 1.2: Standard hypertension care cascade across 44 low- and middle-income countries 
 
Legend: Hypertensive population are undiagnosed individuals with mean systolic BP ≥ 140 mm Hg or a mean 




































There is substantial overlap between the measurement of effective coverage and the use of care 
cascades (Table 1.3). Each step on a care cascade is necessary in order for effective coverage of 
services to be attained. Therefore, the major barriers (and interventions to remove these barriers) 
between steps on a care cascade will also inhibit (or improve) effective coverage of the same 
service. This concept is well reflected in Tanahashi’s generic model of service coverage, as 
bottlenecks are identified along various stages on the pathway to coverage of effective services 
(Tanahashi 1978).  However, the existing cascade framework for hypertension does not 
encompass enough of the factors related to the quality of care that result in effective 
hypertension management services. Namely, the existing care cascade does not account for the 
structure or process quality of hypertension management services, including capturing screening 
services, provider knowledge of quality treatment, ability to administer quality treatment, and 
patient adherence to treatment. Furthermore, hypertension management is influenced by several 
factors beyond the health system including individual, community/social, and environmental 
characteristics. By primarily focusing on outcome quality (the percent of previously diagnosed 
hypertensives with non-elevated blood pressure), existing effective coverage measures for 
hypertension and hypertension care cascades both place undue emphasis on factors that may be 
beyond the influence of the health system and suffer from the inability to identify where care is 
breaking down within a health system.  
 
An expanded care cascade for hypertension management could contribute to an understanding of 
major barriers to achieving effective coverage of hypertension management services by 
highlighting gaps in the process of providing treatment at the population level. The care cascade 
contributes to filling the need for a global indicator for measuring effective coverage of 
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hypertension management services if it can be applied in low-resource settings. Additionally, if 
the gaps found to be most important within the care cascade can be incorporated into a single 
effective coverage metric, this could help to improve monitoring of health system performance, 
including progress towards UHC. Studies are therefore needed to develop and measure 
dimensions of an appropriate hypertension care cascade in LMIC contexts that have a 
burgeoning prevalence of hypertension. There is also a need to improve metrics for assessing 
effective coverage to account for characteristics of chronic diseases like hypertension. Such 
research would advance the current understanding of effective coverage of hypertension 
management services to achieve progress towards UHC. The concepts developed in this 




India is home to some 1.3 billion people, making it the world’s second most populous nation. 
The country is comprised of 28 states and 8 union territories, between and within which exist 
huge disparities in income and health status. India’s richest state, Goa has a per capita net state 
domestic product (equivalent of net domestic product, the gross domestic product minus 
depreciation on a country’s capital goods) that is over 10 times greater than it’s poorest state, 
Bihar (Ministry of Statistics and Programme Implementation 2020). In 2016, the average life 
expectancy at birth for an Indian born in Kerala was 11.3 years longer than that of an Indian born 
in Assam (76.4 in Kerala compared to 65.1 in Assam) (India State-Level Disease Burden 
Initiative Collaborators et al. 2017). All states in India are undergoing epidemiological transition, 
with a rising burden of non-communicable diseases and a decreasing proportion of infectious and 
maternal and child health associated diseases. In fact, from 1990 to 2016, the share of disability-
adjusted life years (DALYs) lost due to non-communicable diseases increased from 30.5% to 
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55.4% across India (Indian Council of Medical Research, Public Health Foundation of India, and 
Institute for Health Metrics and Evaluation 2017). As chronic diseases gain prominence in Indian 
society, the Indian health system must adapt its the changing epidemiological profile in order to 
mitigate severe health and economic losses. Cardiovascular disease alone is estimated to cost the 
Indian economy US$2.25 trillion between 2012 and 2030 in direct health costs and lost labor 
(Bloom et al. 2013). Health is a state subject in India, meaning that state governments are 
responsible for both health services provision and the production of good health. Focusing this 
thesis on improving measurement of hypertension management services in a single state, Bihar, 
will provide relevant lessons for improving and organizing health services in Bihar and other 
Indian states because of the similar epidemiologic profile and growing burden of hypertensive-
related diseases across India and LMICs globally.  
 
Bihar is a state in northeast India with a population of about 100 million, making the state more 
populous than all but 14 countries in the world. The state covers a total area of about 95,000 
square kilometers (about the same size as Portugal, or the American state of Indiana) and is 
geographically dominated by the Ganges River and its floodplains. Despite its immense 
population in a relatively small geographic area, 88.7% of the population is considered to live in 
rural areas (Office of the Registrar General & Census Commissioner 2011). Bihar is comprised 
of 38 districts and has an economy largely dependent on agriculture, with a population that often 
migrates to other Bihari districts, Indian states, and countries in the region to perform seasonal 
labor. As much as 5.6% of the population (6.7 million people) were residing out of the state in 
2007, the vast majority of which were men seeking employment (N. Kumar and Bhagat 2012; 
Mistri 2015). The population is mostly young (19% are under the age of 6 and 58% are under the 
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age of 25) and Hinduism is the majority religion (83% of the population), although there is a 
large Muslim presence in the state (17% of the population translating to over 17.5 million 
people) (Office of the Registrar General & Census Commissioner 2011). Bihar is well known as 
a center of power, learning, and culture in India’s history, and continues to produce influential 
national political leaders. However, in recent decades, Bihar has had some of the worst health 
outcomes among Indian states, and is plagued by high levels of corruption and poor governance.  
 
The Bihari public health system is impaired by unequal access to healthcare, high inequity of 
services, insufficient institutional capacity and human resources, and deficient public health 
spending resulting in high out of pocket expenditure (Berman, Bhawalkar, and Jha 2017). The 
hierarchy of the public health services delivery system is supposed to entail one sub-health clinic 
per 3,000 population, one primary health center (PHC) per 20,000 population, one community 
health center (CHC) per 4 PHCs, one subdivision hospital per 500,000 people, and one district 
hospital per district (Berman, Bhawalkar, and Jha 2017). Although government records state that 
there are about 1,800 PHCs in Bihar, in reality, the majority of these lack infrastructure and/or 
staffing and are not functional (Berman, Bhawalkar, and Jha 2017). Even if all 1,800 PHCs in the 
state were functional, these would represent only 36% of the PHCs required to serve Bihar’s 
population at government-prescribed per capita rates. There are 534 blocks in Bihar, of which 
455 have PHCs that are open at all times and providing a full suite of services. To address 
constrained capacity in Bihar’s public health sector, the Government of Bihar (GoB) receives 
technical support from the international NGO, CARE to improve population health and nutrition 
outcomes under the Bihar Technical Support Program (BTSP). With over $170 million in 
funding from the Bill and Melinda Gates Foundation (BMGF), the BTSP has been in place since 
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2011, and is a key program within Bihar’s public health system. In addition to the public health 
sector, the private health sector plays an important role in providing services in Bihar. 
 
As in many other states in India, Bihar has a pluralistic health system in which both allopathic 
and homeopathic systems of medicine are practiced. Most providers (86%) of either system of 
medicine practice in the private sector, which has been described as “dominant” in Bihar, 
comprising the source of care for the majority of the population seeking care (Mackintosh et al. 
2016). In Bihar’s allopathic system of medicine, qualified providers are those considered to be 
doctors who have received a Bachelor of Medicine and Bachelor of Surgery (MBBS), however 
there is a huge shortfall in the number of qualified providers in rural areas, as they mostly 
concentrate in urban centers. Alternative medical practitioners with degrees in Ayurveda, Yoga, 
Unani, Siddhi, and Homeopathy (AYUSH providers) play a large role in Bihar’s private health 
marketplace and are also allowed to staff government-operated PHCs. In addition to these MBBS 
and AYUSH providers, there are a range of health care providers with no medical qualifications 
who often provide care in rural villages. These informal providers are often trusted members 
from the community in which they serve, charge nominal fees (generally 100 Rupees, or $1.37 
USD per consultation), and are an important source of primary care services in rural Bihar. 
Informal providers come from a range of backgrounds including having some experience 
working at clinics in a non-clinician role, having limited health training such as community 
health worker training, or having no health-specific training or experience. A recent nationwide 
study showed that in Bihar, 3.9% of villages had access to a public MBBS provider, 7.6% had 
access to any MBBS provider (public or private), and 96.2% of villages had access to any 
provider, including AYUSH or informal providers (Das et al. 2020). The same study found that 
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the quality of care provided between states varied more than the differences in the quality of care 
provided within states, which tended to be highly correlated across provider qualifications. In 
other words, the knowledge of an informal provider in a richer state like Gujarat was 
substantially higher than the knowledge of a fully-trained MBBS provider in Bihar (Das et al. 
2020). This means that people in rural Bihar are left with few options for receiving primary care 
from qualified providers, and that the quality of care they are receiving, regardless of their 
provider’s qualifications, is among the worst in India. Against this backdrop, the rising burden of 
non-communicable disease in the state will further exacerbate the state’s resources, placing 
additional burden on the health system.  
 
Bihar is currently experiencing epidemiologic transition and is suffering from a double burden of 
acute and chronic conditions (42.6% of disease burden is due to communicable disease, 47.6% is 
due to noncommunicable disease) (Indian Council of Medical Research, Public Health 
Foundation of India, and Institute for Health Metrics and Evaluation 2017).  Despite the fact that 
about 70% of the public state health budget is allocated for primary care, little has been done to 
quantify the state’s ability to effectively deliver services to manage chronic conditions at the 
primary care level (Berman, Bhawalkar, and Jha 2017). Further, the private sector is currently 
providing the majority of hypertension management services, as three times as many people avail 
such services from private providers than from government facilities in India (Biswas, Singh, 
and Singh 2016). Reasons for private sector preference in India in general include perceived poor 
quality of care in PHCs, a lack of available drugs and/or tests, long waiting times, and far travel 
distances to public options, however the reasons for private sector preference specific to 
hypertension care are not well known (Sengupta and Nundy 2005). One study found that quality 
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of care is an important determinant of facility choice among households with hypertension 
(Kujawski et al. 2018). This finding suggests that the perceived low quality of PHCs could be the 
factor driving individual preference for private sector providers for hypertension management in 
India. There is an urgent need to understand gaps in providing hypertension management 
services, as Bihar (and other LMICs) cannot afford to ignore the impact of chronic diseases such 
as hypertension.  
 
Measuring effective coverage of hypertension management services in rural Bihar 
Appropriate consideration of contextual factors is essential for ensuring internal and external 
validity of studies. There are several contextual factors in Bihar that may influence the 
measurement of effective coverage for hypertension management services and should be 
considered. Previous studies have considered contextual factors that influence evaluations in two 
main categories: impact-related factors, such as baseline levels and patterns of hypertension in 
the population that may influence changes in indicators, and implementation-related factors, such 
as the characteristics of existing health systems and programming (Victora et al. 2005). This 
section presents an overview of these impact and implementation-related contextual factors. 
 
Quantifying the burden of hypertension in Bihar is key to understanding the need for 
hypertension management services in the state. The best estimates of state-wide hypertension 
burden come from the National Family Health Survey (NFHS), conducted about every five 
years. Only the two most recent rounds of the NFHS, conducted in 2015-2016 (NFHS-4) and 
again in 2019-2020 (NFHS-5), contain estimates of hypertension burden. During these surveys, 
trained enumerators measured systolic and diastolic blood pressure of respondents three times 
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(using a portable Omron blood pressure monitor, model HEM-8712) with five minutes of sitting 
before the first measurement and at least five minutes between each measurement (Prenissl et al. 
2019). Individuals were classified as hypertensive if mean systolic blood pressure was ≥ 140 mm 
Hg or  mean diastolic blood pressure was ≥ 90 mm Hg or if respondents answered yes to either 
being told by a health worker at least two times that they had high blood pressure or that they 
were currently taking a prescribed medicine to lower blood pressure. Results from the NFHS 
demonstrate that the prevalence of hypertension among those 15 – 49 years old has steadily 
increased for both men and women in rural Bihar (Table 1.4). Several statewide and national 
studies have reported hypertension prevalence based on the results of the NFHS surveys 
(Prenissl et al. 2019; S. Ghosh and Kumar 2019). Other studies have attempted to quantify the 
burden of hypertension at a sub-state level.  
 
Table 1.4: Change in hypertension prevalence in Bihar among those age 15-49 over time 
 NFHS 4 (2015-2016) NFHS 5 (2019-2020) Percent Increase 
 Urban Rural Total Urban Rural Total Urban Rural Total 
Men 13.5% 10.5% 12.3% 10.4% 11.1% 12.3% -23% 6% 0% 
Women 7.8% 8.3% 8.2% 9.1% 8.8% 8.9% 17% 6% 9% 
Legend: Hypertension prevalence is defined as having a mean systolic BP ≥ 140 mm Hg or a mean diastolic 
BP ≥ 90 mm Hg or currently taking blood pressure-lowering medication 
 
 
Literature searches in SCOPUS, PubMed, and Google Scholar have returned limited studies that 
quantify the prevalence of hypertension in Bihar. The oldest studies on hypertension in Bihar 
come from 2010. One 2010 study found the prevalence of hypertension in a rural block of the 
Patna district to be 23.7% among adults aged 30 and older (Singh et al. 2011). Also in 2010, 
researchers found that the prevalence of hypertension was relatively low (11.4%) among adults 
over age 20 in a majority Muslim block in rural Bihar (A. Ghosh et al. 2013). Since then, studies 
have assessed hypertension prevalence in specific sub-populations. A 2015 study found a high 
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prevalence of pre-hypertension (10.9%) and hypertension (4.6%) among school-going 
adolescents in Patna (P. Kumar et al. 2017).  Among the elderly, a 2017 community-based study 
in rural Katihar district found that 47.7% of individuals over the age of 80 had hypertension (Al 
Adil 2018). These studies suggest that the prevalence of hypertension may fluctuate 
geographically across Bihar. The scarcity of available information suggests that more research is 
needed to assess and improve hypertension management in the state.  
 
Several contextual factors influence the impact of interventions to improve hypertension 
management services. In Bihar, there is a high prevalence of factors that contribute to increased 
risk of raised blood pressure in individuals. The most ubiquitous risk factor is the high level of 
air pollution in the state. Both short- and long-term exposure to air pollutants are significantly 
associated with higher incident hypertension (Giorgini et al. 2015; Prabhakaran et al. 2020). 
Residents of Bihar have the third highest exposure to air pollution across Indian states, and have 
exposure to some of the highest levels of ambient particular matter and household air pollution in 
the region (Balakrishnan et al. 2019). Causes of poor air quality in the state include crop residue 
burning, widespread use of solid cooking fuels in households, and construction and other, often 
unregulated, industry. At the individual level, risk factors for hypertension include alcohol and 
tobacco use (Ezzati et al. 2015). Measuring alcohol use in Bihar is complicated since it is a “dry” 
state which has implemented an alcohol-prohibition policy. Over half (53.5%) of all adults use 
tobacco, and only 15.0% of users had been advised to quit by a health care provider (World 
Health Organization 2011). Although we found no published research on the subject, the 
minimal receipt of tobacco cessation advice could be representative of low levels of public (and 
provider) knowledge towards hypertension risk factors. These individual and environmental risk 
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factors for high blood pressure are influenced by dynamics which exist beyond Bihar’s health 
system and complicate the measurement of non-elevated blood pressure as an indicator of health 
system performance. In addition to risk factors and patterns of hypertension burden, Bihar’s 
pluralistic health system provides implementation-related contextual factors that influence 
evaluations of hypertension management services. 
 
As previously discussed, the reliance on private, and often unqualified, providers in Bihar 
complicates efforts to assess health system performance for provision of hypertension 
management services. AYUSH systems of medicine are often preferred to allopathic treatment 
and multiple studies in Bihar have attempted to demonstrate the health benefits of AYUSH 
treatment for chronic diseases (Rudra et al. 2017; Sharma et al. 2019). The prevalence of 
multiple systems of medicine obfuscates the assessment of quality of processes to treat 
hypertension since the content of care is likely different across these systems. Further, patient 
preference for informal providers for chronic care presents methodological issues when 
researching the quality of care people receive (Raza et al. 2016). Informal providers, who are 
often demonized by the public sector and physician associations, can be hesitant or unwilling to 
participate in research efforts, as they are generally suspicious of government motivations. These 
informal providers can provide essential health services but if they are neglected by government 
and other formal actors, as in the case of COVID-19 response, the entire community may suffer 
(Rao et al. 2021). Although there have been some efforts to integrate informal providers into the 
public health system, there are serious gaps in the state’s comprehensive response to the rising 
burden of hypertension. 
 
 42 
The Government of Bihar is not currently prioritizing chronic disease management. While 
India’s central government has initiated a National Programme for Prevention and Control of 
Cancers, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) as the primary intervention 
for NCD control, the program requires adequate financing at the state level. Bihar spends $7 per 
capita on NCD prevention and control, the second lowest among Indian states and only one fifth 
of the national average spending (I. Gupta and Ranjan 2019). The combination of weak 
government programming to provide NCD management services, strong presence of 
homeopathic and informally trained providers, and the high rate of hypertension risk factors 




This thesis will inform health systems performance measurement in the context of chronic 
disease management through the following aims: 
 
Aim 1: Develop a measurement framework for tracking effective coverage of hypertension 
management services in resource-limited settings. A scoping review of published literature will 
synthesize how effective coverage (and related concepts) of hypertension management has been 
historically defined and measured in low- and middle-income countries. Findings will be 
operationalized into a framework for measuring aspects of effective coverage relevant to 
hypertension management services in low- and middle-income countries. 
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Aim 2: Measure and describe key dimensions of effective coverage of services to manage 
hypertension in rural Bihar, India. Applying the framework proposed in aim 1, steps along the 
expanded cascade of care will be measured to describe the supply- and demand-side features of 
hypertension management, identify barriers to effective hypertension management, and propose 
strategies for improving hypertension management in rural Bihar, India.  
 
Aim 3: Assess the level of effective coverage of hypertension management services in rural 
Bihar, India. Findings from aims 1 and 2 will inform the construction of an index measure of 
effective coverage of hypertension management services. The coverage of key services will be 
measured and aspects of structural and process quality of primary care providers will be 
combined into an overall quality index. The two components (coverage and quality) will be 
combined to determine the effective coverage of hypertension management services in rural 
Bihar and will inform the global monitoring of effective coverage of hypertension-related 
services in the context achieving UHC. 
 
Conceptual Framework 
The following conceptual framework has been developed to describe how expanding effective 
coverage of hypertension management services leads to health improvements. The goal of this 
framework is to describe the factors (especially the health system-related factors) that contribute 
to improvements in health among those with hypertension. The framework adopts a patient-
centric approach and incorporates factors at several different levels. Influential works that 
informed the framework’s development include Shengelia’s effective coverage definition, 
Tanahashi’s model for bottleneck analysis, Andersen’s behavioral model of health services use, 
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Donabedian’s categorization of quality, the chronic care model, and the CDC’s policy 
framework for cardiovascular risk (Shengelia et al. 2005; Tanahashi 1978; R. M. Andersen 1995; 
Donabedian 1988; Homer et al. 2008). The original description of effective coverage is essential 
to understanding how the use of quality services translates to health improvements among those 
who are in need. Andersen’s behavioral model informs the interconnected roles of environments, 
population characteristics, and individual health behaviors with outcomes, and further links 
various types of access to health outcomes. Tanahashi’s framework is useful for identifying 
bottlenecks along the pathway from access to services to health gains for patients. The chronic 
care model applies many of the concepts previously described in general terms of providing 
health services to treat long-term diseases. Importantly, this model recognizes the relationship 
between health systems, specifically service providers, individuals, and communities and their 
importance in managing chronic diseases. Donabedian’s framework for quality helps describe 
the features that contribute to service quality, namely structures, processes, and outcomes. 
Finally, the CDC policy framework helps to further frame these factors in terms of improving 
cardiovascular health. Additionally, country-specific conceptual frameworks developed for 
controlling hypertension were considered to ensure that the framework under development was 
flexible enough to incorporate key aspects in various contexts (Huang et al. 2016; 
Chimberengwa and Naidoo 2019; Chukwuma et al. 2019).  
 
The final conceptual framework acts as a flowchart of factors that interact at multiple levels to 
contribute to or inhibit health benefits among those in need of hypertension management services 
(Figure 1.3). It starts with individual- and macro-level contextual factors that influence an 
individual’s predisposition to needing hypertension management services. The individual risk 
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factors for hypertension have been previously described and include biological factors (such as 
sex, age, genetic predisposition to hypertension, and factors during growth and development), 
behavioral factors (such as diet, level of physical activity, smoking and tobacco use, alcohol use, 
and level of stress), and individual socio-demographic factors (such as wealth, education, 
religion, and other racial or ethnic factors). Additionally, macro-contextual factors, such as 
policies (e.g. sodium-reduction policies), governance (e.g. ability to provide public goods like 
clean air), programmatic interventions (e.g. intensity of chronic disease programming), and other 
cultural and societal norms and values may contribute to an individual being more or less likely 
to have a need for hypertension management services. These macro-contextual factors also 
influence the health system and individual management of hypertension. 
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After describing the factors that place individuals at high risk for hypertension, the framework 
incorporates factors related to an individual’s hypertension management, starting with the 
individual’s need for services. The services required by an individual may vary based on their 
risk of hypertension and their current blood pressure level. For example, normotensive 
individuals are generally in need of interventions to educate and raise awareness, and require 
regular blood pressure measurement, whereas hypertensive individuals require behavioral 
changes and pharmacotherapy. The need for services can be based on several different 
typologies, but this framework adopts a normative need for services (based on International 
Society of Hypertension Guidelines), as it is the most comparable across contexts (Unger et al. 
2020). Next, an individual must be aware of their hypertension status in order to purposively 
utilize any services which may lead to an improvement in health. These services may include 
educating patients, providing lifestyle advice, or writing prescriptions and making follow up 
appointments. These services generally constitute the “process” component of Donabedian’s 
conceptualization of quality of care, which also influence the extent to which health 
improvements are realized. Adherence to the services (in terms of both patient 
compliance/adherence and continued provider follow-up) is a necessary condition to achieving 
sustained health gains over time. These health gains represent the “outcome” component of 
Donabedian’s quality framework and can either be narrowly defined (e.g. normal blood pressure 
levels) or represent broader conceptualizations of health (e.g. self-rated health). 
 
An individual’s hypertension management is occurring within the larger health system. Both 
demand- and supply-side factors influence the health system’s performance and the individual’s 
ability to manage hypertension. On the demand side, the community’s need for hypertension 
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management services (as determined by levels of hypertension awareness and prevalence) may 
influence the kinds of services available at the primary care level. Additionally, the kinds of 
services that are acceptable, and accessible to the community may influence the choices an 
individual makes in terms of managing their blood pressure. Examples include whether an 
individual is more likely to be aware of their hypertension status (e.g. if community awareness is 
high, an individual may be likely to request blood pressure screening services) and also how they 
choose to receive services (e.g. from a pharmacist or from a formally trained doctor). These 
demand-side factors are influenced by and also influence the supply of services that are available 
in many LMIC markets. Public and private health systems have variable levels of “structural” 
quality, including levels of staffing, medicines and supplies, and levels of training. These supply-
side factors primarily influence the provision of health services by dictating the service delivery 
platform (e.g. in-home visits from community health workers) and the overall quality of services 
received. 
 
Previous research has described the individual biological, behavioral, and sociodemographic 
factors associated with hypertension prevalence and control (James et al. 2014). There is some 
evidence about the systemic policy options that reduce the prevalence of hypertension and 
improve control in high-income settings, but there is far less research on hypertension 
management in LMICs (Institute of Medicine (US) 2010). While several studies have examined 
the specific individual factors associated with hypertension prevalence, treatment and control in 
specific countries, there is little work that comprehensively assesses health system performance 
in hypertension management and control in LMICs. Some studies have examined drivers of 
patient decision-making and have combined this information with aspects of service quality, but 
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these studies are limited in scope and do not provide much insight about the quality of 
hypertension management services provided by the health system (Kujawski et al. 2018; Gabert 
et al. 2017; Wollum et al. 2018; Galson et al. 2017). There is a need to further describe the 
interactions between the quality of hypertension management services, the use of these services, 
and the impact on community health to inform the organization of future-facing health systems 
that optimize population health outcomes. This thesis generates insights to fill this information 
gap in our understanding of health systems and hypertension management in LMICs.  
 
The Assessment of Primary Health Care in Bihar Study 
 
The thesis leverages the data collection activities from a larger study to assess the primary health 
care delivery systems in rural Bihar, India. Whereas comprehensive primary health care systems 
include a wide scope of activities, including interventions delivered by community health 
workers and primary prevention services, this study focuses on the facility-based service delivery 
component of primary care. The parent study was designed specifically to understand reasons for 
the low utilization of PHCs for curative and chronic care services in rural Bihar. Previous studies 
have pointed to factors including distance to provider, low structural and clinical quality of care, 
the costs of seeking care, and the functionality of outreach services as important determinants of 
patient care seeking (Rao and Sheffel 2018). However, little is known about the quality of care 
provided by public and private (both qualified and unqualified) providers in rural Bihar, or the 




1) To identify the type of primary care providers first contacted by patients (i.e. women, 
adult men, children, and the elderly) seeking ambulatory care in rural Bihar. 
2) To estimate the level of structural and clinical (i.e. process) quality of care among public 
and private (formal and informal providers of allopathic care) primary care providers in 
rural Bihar. 
3) To understand the drivers of patient choice of primary care provider (e.g. structural and 
clinical quality of care, distance, cost). In particular, how these factors determine patient 
decisions to use – or bypass – public sector primary care facilities.  
 
To achieve these objectives, a series of cross-sectional surveys was conducted to collect 
information from a sample of households as well as public and private primary care providers. 
The Assessment of Primary Health Care in Bihar Study is a component of the research arm of 
the BTSP, through which Oxford Policy Management (OPM) is funded by the Gates Foundation. 
Johns Hopkins University was subcontracted by OPM to design the study, OPM implemented 
the data collection with in-country staff, and CARE India was a key stakeholder in the project as 
the primary provider of technical support to the Government of Bihar. The following describes 
the design and methodology for the two phases of data collection which consisted of a household 
survey, and provider assessments.  
 
Phase I: Household Survey 
Study Design 
The first phase of data collection is a multi-stage cluster sampling household survey designed to 
provide state-representative estimates of individual care-seeking behaviors in rural Bihar. The 
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multi-stage cluster sample methodology has the advantage of increased feasibility, but yields a 
larger variance than a simple random sample, and is utilized by many surveys in developing 
countries including the Demographic and Health Surveys (DHS) and Multiple Indicator Cluster 
Survey (MICS) (International Institute for Population Sciences (IIPS) and ICF 2017; UNICEF 
n.d.). Sample size calculations for the household survey were motivated to detect differences in 
care-seeking patterns based on the quality of PHC providers. One study from another state 
reported that use of the local PHC improved with better quality clinical care, but only up to a 
point (Rao and Sheffel 2018). In this study, the quality of clinical care was conceptualized as 
provider competency, which was determined through the use of clinical vignettes to assess 
provider ability to treat a range of health conditions. The study found that an averagely equipped 
PHC with the least competent provider (competency score of 15 out of 100) who is regularly 
present is expected to be visited by 8% of local individuals that are sick and seek care outside 
home. The study also reported that if the same PHC had an averagely competent provider 
(competence score of 47 out of 100) it would be visited by 46% of local patients. Based on this 
study, we assume that averagely equipped PHCs in Bihar with an averagely competent clinician 
(i.e. score of 50 out of 100) receive 50% of the visits by local residents who are sick. Thus, to 
detect a 10% difference in the proportion of local patient visiting PHCs with and without 
competent clinicians with 80% power and =0.05, a total sample of 776 individuals who are sick 
and seek care is required (Annex 1). Estimates from the 2014 National Sample Survey (NSS) 
indicate that 6% of the population of rural Bihar was sick in the two weeks prior to the survey 
and 66% of those sick individuals sought treatment outside home (Ministry of Statistics and 
Programme Implementation 2014). Adjusting for a design effect of 2 (based on NFHS 4) and 
accounting for care seeking patterns, the required sample size is 2,352 sick individuals who 
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sought care (International Institute for Population Sciences (IIPS) and ICF 2017). Considering 
estimates of illness episodes prior to the survey, in order to include 2,352 patients who sought 
care outside the home, we require a sample of approximately 39,192 individuals. Assuming an 
average household size of 5, and accounting for a 20% non-response rate, the survey needed to 
sample at least 9,797 households. From sample size calculations for the provider assessments, we 
required 70 PHCs. Within the 70 PHC catchment areas, we selected 5 villages per PHC and 30 
households per village to arrive at a target sample size of 52,500 individuals and 10,500 
households for the survey. 
 
The primary sampling unit for the household survey was public primary health centers. Out of 
the 455 fully functional PHCs in Bihar (defined as all PHCs providing 24/7 child delivery 
services), 70 PHCs were randomly selected using stratified random sampling proportional to 
number of PHCs in Bihar’s nine divisions. The sampling frame was a census of all PHCs, 
provided by CARE India. The secondary sampling unit was villages within the primary health 
center’s catchment area. From the 2011 Census, each PHC has a complete list of all villages that 
fall within its catchment area (the geographic area that PHC is designed to serve). The average 
PHC catchment area contains 12 villages, and from the census of all villages in the catchment 
area, 5 villages were systematically randomly sampled by probability proportional to size. Size 
represents the estimated population within the total catchment area of each PHC as estimated by 
the National Census (2011). A total of 350 villages were selected for data collection. A listing of 
all households within each sampled village was carried out by the Public Health Foundation of 
India (PHFI) between September and December, 2019. The listing team ascertained the name of 
the household head, the religion and caste of the household, and the number of members in the 
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household for entire villages or for a randomly selected segment of a village if there were more 
than 350 households in a village. In this manner, we determined that the average sampled village 
had about 1,200 households and a population of approximately 6,500 people.  From each village 
listing of households, 30 households were randomly selected for inclusion in the study, for a 
target sample of 10,500 households. Every member of a selected household was included for 
interview in the survey, although different modules were applicable for different subgroups (e.g. 
only adults over the age of 30 were asked specific questions about chronic diseases, mothers 
were asked questions about the health of children under the age of 18).  
 
Study Tool 
The tool used to collect data in the household survey was a structured questionnaire with five 
sections. The first section collected information on the location of the household, demographic 
information about all household members including sex, age, marital status, and highest 
completed schooling. The second section was related to care-seeking during illness, in which 
each household member was asked about their primary occupation, monthly income, self-rated 
health, and whether they had experienced a health problem in the last 30 days. Individuals who 
responded that they had experienced a health problem were asked about the health problem, how 
long they have had it, how serious the condition was, whether they sought care outside the home 
to treat the condition, and reasons for seeking care (or not seeking care) from that particular 
provider. Information about the provider was also collected, including the type of provider (e.g. 
medical shop, private clinic, or PHC), the name of the provider, the provider’s location, reasons 
for choosing the particular provider, time and distance to reach the provider, trust and 
satisfaction with the provider, and cost of treatment. Further questions were asked about how the 
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illness affected the individual’s ability to work, and whether the individual was hospitalized in 
the last year. This section was asked to each adult (over the age of 18) in the household when 
possible, with the next closest family member (generally the female head of household) 
answering for adults who were not present or for children. The third section asked questions 
about five common chronic conditions (hypertension, diabetes, heart disease, asthma, and lung 
disease) to all adults over the age of 30. This section asked whether individuals had ever been 
diagnosed with one of these chronic diseases by a health worker, whether they were currently 
receiving treatment, and about characteristics of their usual source of care to manage the chronic 
condition (structured similarly to the care-seeking module in section 2). The fourth section asked 
women aged 15-49 years old about if they had ever given birth and whether they had given birth 
in the last year. If so, the mother was asked questions from a module about the child’s health 
(including issues related to child diarrhea and immunization) and care-seeking during pregnancy 
(structured similarly to the module in section 2). The fifth and final section collected information 
from the head of the household about the local PHC (including whether anyone has visited the 
PHC in the past year, travel distance to PHC, interactions with community health workers, and 
participation in community groups), and about the household’s socioeconomic status (including 
religion, caste, main household occupation, household assets, and total household expenditure).  
 
The household survey tool was developed by a team of researchers from Johns Hopkins with 
inputs from team members from OPM and CARE India. Wherever possible, the tool used 
validated questions from established household surveys implemented in the same context to 
ensure comparability (especially the NFHS and NSS). The survey tool was translated to Hindi by 
local researchers and pilot tested in Bihari communities that were not included in the household 
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survey sample. Two rounds of pilot testing (in August and September 2019) were conducted, 
during which cognitive probing was conducted with community members to ensure that 
questions were easy to understand and were addressing the intended constructs (Bowden et al. 
2002; G. B. Willis 1999). Questions were then revised as necessary and the final tool was 
entered into computer-assisted personal interviewing (CAPI) software. A manual was also 
developed by the study team to assist in the implementation of the tool based on experiences and 
lessons learned during pilot testing and development. Specific questions from the household 




Table 1.5: Key questions from household survey tool 
Concept Question in Household Survey Response Options Reference 
Survey 
Need  Have you ever had your blood pressure 





Same wording as 
NFHS 4 
Have you ever been told by a doctor or 
other health worker that you currently 




Same wording as 
NFHS 4 





Have you been taking any medications 
or other treatment for hypertension 




Same wording as 
NFHS 4 
In the past 12 months, have you sought 
care from any provider outside your 




Same wording as 
NSS 
How many visits to a doctor or health 
worker have you had in the last year to 




From which type of provider do you 




Village Health Sanitation 








On average, every month, how much do 
you spend on managing your 
hypertension? Please consider 
medicines, doctor consultation, 














Have you ever been hospitalized 





Overall, how satisfied are you with your 









Fieldwork and data collection for the household survey was led by OPM. A team of 35 local 
enumerators with previous experience conducting household surveys and at least a graduate 
degree in the social sciences was hired to conduct the fieldwork. Teams were trained over the 
course of seven days on the purpose of the study and how to correctly use the survey tool on 
electronic tablets using the CAPI software. The training also involved three days of field practice 
with the tool before the start of data collection. Written or oral consent to participate in the 
survey was obtained from the head of each household and participants were informed that they 
could stop answering questions at any time. One supervisor was assigned to each field team of 
seven enumerators. The supervisor observed surveys and conducted spot checks on the collected 
data to validate answers to key questions with 20% of the households. Central supervisors 
overseeing the entire data collection process also visited field sites with teams to provide 
oversight twice weekly. Daily debriefing sessions were conducted across the field survey teams 
and errors or difficulties were reported to the central supervisors. Twice a week, all of the 
supervisors had a call with the Johns Hopkins team to discuss any issues. At the end of each day, 
data was automatically uploaded to a central server from all of the tablets. This data was 
automatically run through a logic-checking do-file in Stata, and any outliers, unusual data, or 
missing data were flagged and checked with supervisors and enumerators to ensure accuracy of 
collected data (StataCorp 2014). The study also required collection of GPS data to inform the 
second phase of data collection.  
 
The names and locations of all public facilities and private providers/facilities where household 
members sought care in the past month, or where care was usually received for chronic disease 
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management, were recorded. Following the household survey, a second team used the location 
information provided in this list to locate providers in the sampled villages from whom 
respondents reported receiving care. The team recorded the GPS location and contact 
information of every sampled PHC and all private providers (formal and informally trained) 
mentioned in the household survey that were reported to be within 15 minutes driving distance or 
5 km of the respondent’s household. This list of providers constituted the sampling frame for the 
second phase of provider assessments.  
 
Fieldwork for the household survey was scheduled to begin in September 2019, however 
monsoons and severe flooding in Patna forced the team to reschedule. Ultimately, fieldwork for 
the household survey took place from November 2019 to March 2020. Due to the spread of 
COVID-19 in India, data collection was stopped on March 13, 2020. At this point, the first round 
of the household survey was completed, however the scheduled follow-up visits were not 
conducted, thus efforts to minimize bias from non-response due to migration or unavailability 
were not implemented. The household survey yielded a sample of 39,486 individuals from 8,365 
households from 343 villages across 70 blocks in 37 districts (Figure 1.4). Major reasons for 
non-response included the fact that households had migrated seasonally (n= 1,007 households), 
households were scheduled for re-visits but the follow-up visits were not completed due to the 
COVID-19 outbreak (n=660 households), and refusal among Muslim households due to 
suspicions over the Citizenship Amendment Act and the National Register of Citizens (n=404 
households). Since we were not able to do follow-up surveys, the sample from our household 
survey may have some systematic bias because it excludes migrant populations and Muslim 
households. The final sample covered 80.2% of the envisioned sample of households in rural 
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Bihar (the non-response rate was 19.8%) and contained slightly more than our required sample 
size of 39,192 individuals.  
 






Information collected from the household survey in CAPI was exported into a Stata dataset by 
the OPM team. The Johns Hopkins team created an automated analysis to check for outliers, 
missing values, and unusual estimates and these observations were discussed with the data 
collection team, and the datasets were cleaned accordingly. The multi-strata survey design has 
implications for the calculation of state-wide estimates for population health indicators. Sample 
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weights to account for the survey design and non-response are applied to all descriptive statistic 
calculations to obtain state-wide representative estimates for rural Bihar.  
 
Phase II: Provider Assessments 
Study Design 
The second phase of data collection relied on provider-based data collection techniques to assess 
clinical quality of care. Clinical quality of care is an elusive concept to measure and methods 
employed to assess different domains of quality (i.e. structure, process, and outcomes) deserve 
additional attention. Measuring structural quality is primarily done at the facility level, through 
the use of health facility assessments. There are a number of data collection methods that can be 
used depending on the purpose of the study, but these tools generally seek to quantify the 
availability and quantity of inputs (e.g. human capital, infrastructure, and supplies of drugs and 
equipment) which impact health service delivery (Edward et al. 2009; Nickerson et al. 2015). 
While they provide important information about available infrastructure, a common critique of 
these facility-based assessments is that they are poorly correlated with the actual provision of 
quality care and do not capture key elements of process quality (Macarayan et al. 2018; Hannah 
H Leslie, Sun, and Kruk 2017).  
 
Four methods are primarily used to measure quality of care related to processes in health systems 
research: chart reviews, standardized patients, clinical vignettes, and direct observations of 
provider-patient interactions. Chart reviews can be used to assess performance on clinical 
effectiveness measures, and are regularly used in high income countries to retrospectively assess 
performance of clinical management (Vassar and Matthew 2013; vonKoss Krowchuk, Moore, 
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and Richardson 1995). Due to a lack of systematic record keeping in many LMIC contexts, 
including Bihar, this methodology is infeasible. The use of standardized patients entails training 
actors to seek care while presenting with a pre-determined set of clinical symptoms and 
documenting what advice clinicians provide in response (Kwan et al. 2019; King et al. 2019; 
Wiseman et al. 2019). These studies have been used extensively in India and other LMICs to 
assess healthcare providers’ knowledge and practice in diagnosing and treating a number of 
common diseases (Das et al. 2012, 2015; Miller, Das, and Pai 2018; Das and Gertler 2007; Das 
and Hammer 2007; Das et al. 2016). Since standardized patients require patient-actors to have 
some clinical training, this is a resource-intensive method. Clinical vignettes are similar to 
standardized patients because providers are presented with a standardized case, but in this 
method, one interviewer poses as a hypothetical patient (and answers the provider’s questions) 
and the other interviewer records the processes that the provider performs in order to diagnose 
and treat the case. A substantial body of evidence has demonstrated that provider knowledge, as 
assessed by clinical vignettes, is a valid measure of the process of care provided in actual clinical 
practice (Peabody et al. 2000; Dresselhaus et al. 2000; Peabody, Luck, et al. 2004; Peabody, 
Tozija, et al. 2004; Dresselhaus et al. 2004; Peabody and Liu 2007). Unlike standardized 
patients, since providers are aware they are being evaluated, the Hawthorne effect may influence 
provider performance in clinical vignettes. 2 As such, vignettes can be interpreted as an upper 
bound on the quality of care of which a provider is capable (Das and Hammer 2014). A final 
method for assessing the process quality of care is by directly observing patient-provider 
interactions. These so-called patient observations, or direct observations, have the benefit of 
 
2 This effect was originally documented by (Mayo 1933), and is well-described by (Benson 2000).  The 
methodology of the original experiment and the description of the Hawthorne effect have since been debated (Jones 
1992; Wickström and Bendix 2000), but the original understanding of this effect is still widely recognized today. 
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observing what providers actually do during a consultation (Aujla et al. 2020). Several 
researchers have documented a difference between what providers say they will do for patients 
(in clinical vignettes) and what they actually do (in direct observations), coining the phrase the 
“know-do gap” to demonstrate this principle (Leonard and Masatu 2005; Mohanan et al. 2015; 
Leonard and Masatu 2010). However, the quality of data collected through direct observations is 
also impacted by the Hawthorne effect, and is extremely time-intensive, as it requires a large 
number of observations to achieve reasonable sample sizes for specific, less common diseases. 
Linkages between the process of health services provision and health outcomes are essential to 
understanding how the quality of care can result in improved health (Mant 2001). 
 
While process measures are direct measurements of the quality of care provided, outcome 
indicators reflect all aspects of care and are generally of greater intrinsic interest because they 
directly represent improvements in health. Outcome measures can be assessed by reviewing 
hospital records, however these records are generally not available in LMICs. Instead, 
population-level outcomes are generally measured through household surveys that are 
representative of a broader population. Phase I of the Assessment of Primary Health Care System 
in Bihar study collected several indicators of outcome quality related to hypertension 
management, including self-rated health, hospitalization outcomes, and patient satisfaction 
(Table 1.5). The provider assessment employed several of the aforementioned methodologies to 




Three data collection activities were implemented to understand the quality of services provided 
in the public and private primary health care system, namely (i) a facility-based assessment to 
measure structural quality of facilities/practices; (ii) clinical vignettes with the primary (or 
available) provider at a health facility/practice to measure provider knowledge (process quality); 
and (iii) direct observations of new3 provider-patient consultations to measure provider practice 
(process quality). Taken together, these tools were designed to provide a comprehensive 
understanding of the structural- and process-related quality of care among public and private 
(both formal and informal) primary care providers in Bihar. The tools also provide a detailed 
overview of several aspects of quality of care related to hypertension management (Figure 1.5).  
Figure 1.5: Provider assessment tools related to hypertension quality of care 
 
 
3 Only new provider-patient consultations were considered in order to standardize the history-taking and 
investigations portions of the direction observation 
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The sample size calculation for the provider assessment was motivated to detect a difference in 
the quality of care between public and private primary health care providers. The unit of analysis 
is a health care facility, and the main provider (or medical officer in charge, if there are multiple 
clinicians on duty) answered the tool. For public providers, this included PHC clinicians, and 
private providers included formal and informal providers practicing allopathic and AYUSH 
systems of medicine. One study from another Indian state estimated that clinicians at PHCs had a 
mean knowledge score of 57 on a scale ranging from 0-100 (Rao and Sheffel 2018). The sample 
size calculation suggests that to detect a 5-point difference in score between public and private 
providers with 80% power and =0.05, a sample of 34 clinicians in each group (total of 68 
clinicians) is required (Annex 1). Adjusting for a 20% non-response rate and DEFT of 1.5, and 
assuming that one clinician would be sampled from each facility, the total number of facilities 
required was 132, or 66 public facilities and 66 private facilities. A previous study found that the 
average Indian village has 3.2 primary healthcare providers, the majority of which operate in the 
private sector (Das et al. 2020). Our sample therefore needed to include providers from at least 
66 PHCs and private providers from at least 20 villages to detect a 5-point difference in quality 
score between public and private clinicians. We rounded this upwards to include 70 PHCs and 
private providers from 70 villages in our study. Our study’s sample represented about 15% 
(70/455) of the functional block level PHCs in Bihar. 
 
All three provider assessment activities were carried out at each of the 70 PHCs sampled in 
Phase I. One of the five villages from each PHC catchment area was selected through simple 
random sample and all three provider assessment data collection activities were conducted with 
all providers/facilities utilized by respondents and identified in Phase I that were within close 
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proximity (5 kilometers) of that village. This included all public, private, and informal providers 
from which care was sought. Even though they are an important source of care, medical shops 
and pharmacies were excluded from the Phase II data collection activities because 
pharmacists/chemists were unable to answer most of the modules of the provider assessment 
during pilot tests. The final sample size was estimated to be 70 PHCs and 224 private providers 
for the facility assessment and clinical vignettes. For the patient observation tool, it was 
envisioned that 5 patient interactions would be observed per facility, for a total sample size of 
350 patient observations at public clinics and 1,120 patient observations at private facilities.  
 
Study Tools 
Development of the three study tools for the provider assessment followed a similar pattern. 
First, a review of similar tools (ideally previously validated in India) was conducted to ensure 
that question items had been tested and could be comparable over time. Next, the Johns Hopkins 
team developed the tool, with inputs from clinicians, colleagues at OPM, and partners at CARE 
India. Third, the tool was translated into the local language and entered into a CAPI software. 
Finally, the tool was pilot tested and adjusted based on experiences and lessons learned during 
pilot testing. The tools were pilot tested in January 2020 and again in early February 2020. The 
following section describes each of the three tools in detail. 
 
The first tool, the facility assessment, is comprised of seven sections. The first section collected 
background information on the facility, including the GPS location, the type of facility, 
information about the opening hours, and about the facility’s infrastructure (e.g. is there a 
pharmacy, is there a power supply, and is there a running water supply). The second short 
 65 
section recorded information about the levels of staffing in the facility. In the third section, 
providers indicated the volume of patients that the facility treated in the last three months, and 
also described the kinds of services the facility provides. Next, enumerators were trained to 
determine the availability and test the functionality of several basic pieces of equipment (e.g. a 
weighing scale, a thermometer, and a sphygmomanometer). Another section collected 
information on the infection and waste management processes employed at the facility. The sixth 
section, on immunization services, determined whether relevant supplies to support vaccination 
were present (e.g. sharps container, immunization cards, and a refrigerator). The final section 
collected information about the availability of general drugs, key drugs for maternal and child 
health, and vaccines. This list of drugs was informed by Bihar’s List of Essential Medicines for 
use at PHCs (Government of Bihar 2018). Other questions and the structure of the tool were 
informed by the Service Provision Assessment (SPA) and the Service Availability and Readiness 
Assessments (SARA) tools (The DHS Program n.d.; World Health Organization 2014).  
 
Clinical vignettes were the second tool employed to assess process quality via the knowledge of 
providers in rural Bihar. Four vignettes were developed to assess provider skills: one on 
diagnosing a new case of hypertension and initiating first-line treatment, one on diagnosing a 
simple case of childhood diarrhea and prescribing oral rehydration salts (ORS), one on 
diagnosing childhood pneumonia and prescribing antibiotics, and a final vignette on recognizing 
a case of angina and starting treatment with nitrates and immediately referring to a higher level 
of hospital. Each vignette employed one enumerator who pretended to be the patient (or the 
patient’s mother) presenting to the clinic and answering questions about the condition, and 
another enumerator who recorded the provider’s stated actions in a structured data collection 
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form. The data collection tool first collected background information about the health worker, 
including the age, sex, religion, and caste of the provider. It also collected information about the 
provider’s medical training, current residence, involvement in practitioner groups, and whether 
they had treated anyone with chronic conditions (and later COVID-19) in the last 6 months. The 
tool followed a standard format for each of the four vignettes: first the case was presented to the 
provider. Next the provider was prompted to ask all of the questions they would normally ask to 
take the patient’s history. During this section, the enumerator pretending to be a patient was 
trained to respond to provider questions in a standardized way. The following section on 
examinations recorded information on the tests that the provider would perform based on the 
previous answers from the history-taking section. The patient-enumerator also gave standardized 
responses to explain the results of each of the examinations. The provider was then asked to 
make a diagnosis based on the previous information. Based on this diagnosis, the provider was 
prompted to make a judgement about whether referral or a follow-up appointment were 
necessary. The provider was also asked which medicines she would prescribe (the name, dose, 
frequency, and duration of the prescription were recorded) and what additional advice the 
provider would give the patient, including any danger signs the patient should watch out for. The 
development of each of the four vignettes was informed by previously designed and validated 
tools with the input of local and specialist physicians. Specifically, the pneumonia and diarrhea 
vignettes had been previously validated and used in the Indian context, while the hypertension 
and angina vignettes were developed with substantial input from cardiologists to address India’s 
shifting burden of disease. (Das and Hammer 2005). 
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The third component of the provider assessment, the patient observation tool, was designed to 
test the existence of a know-do gap in clinicians under study. Thus, its design closely mirrored 
the structure of the clinical vignettes. After receiving a patient’s consent to participate in the 
study, the tool took information on the patient’s age, sex, and primary and secondary complaints. 
If the age and complaint matched the characteristics of the clinical vignettes (i.e. an adult with 
high blood pressure or angina or a child with diarrhea or cough) then the tool was modeled after 
the clinical vignette form, and enumerators recorded all history taking questions asked by the 
provider, examinations conducted, and diagnoses made. For other patient types, a standard 
patient observation form was used to record questions asked by the provider about duration and 
severity of illness and additional symptoms, as well as generic tests performed such as blood 
pressure measurement and checking temperature. For all patient observations, the enumerator 
recorded whether the provider told the patient the name of their illness, explained the cause of 
the illness, precautions to take at home, potential danger signs, and whether a prescription was 
made. After patients left the office, enumerators reviewed the patient’s prescription script and 
recorded information about the diagnosis, and the name, dose, frequency, and duration of the 
drug(s) prescribed. The duration of the consultation was also recorded.   
 
Data Collection 
Fieldwork for the second phase of data collection was led by OPM and conducted by ten 
enumerators, three supervisors, and one central supervisor. Five of the enumerators were 
qualified nurses with clinical and research experience, and five of the enumerators were 
graduates in the social sciences with previous experience conducting facility surveys. Nurse 
enumerators and non-nurse enumerators paired up to implement the data collection. Nurse 
 68 
enumerators were the moderators during the clinical vignettes and led the data collection during 
the facility assessment and patient observations. The non-nurse enumerators pretended to be the 
patient during the clinical vignettes and played a supporting role during the facility assessment 
and patient observations (e.g. finding sphygmomanometers and other equipment, copying patient 
prescription scripts, and providing other general assistance). Three to four pairs of enumerators 
were supervised by a more experienced OPM employee, who assisted in the overall coordination 
of data collection by finding providers based on GPS locations recorded during Phase I, fixing 
appointments with providers, and answering questions and allaying concerns about the study 
(usually from informal providers). The supervisors also observed surveys and conducted spot 
checks on the collected data to validate answers to key questions with 20% of the providers. 
Central supervisors overseeing the entire data collection process also visited field sites with 
teams to provide oversight twice weekly. 
 
Teams were trained over the course of ten days in February 2020 and a seven-day refresher 
training was conducted in February 2021. The training consisted of sessions on the purpose of 
the study, how to correctly use the survey tool on electronic tablets using the CAPI software, and 
four days of field practice before the start of data collection. Written consent to participate in the 
survey was obtained from all providers and from patients who were observed during patient-
provider interactions. Daily debriefing sessions were conducted across the field survey teams and 
errors or difficulties were reported to the central supervisors. Twice a week, all of the supervisors 
had a call with the Johns Hopkins team to discuss any issues. At the end of each day, data was 
automatically uploaded to a central server from all of the tablets. This data was automatically run 
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through a logic-checking do-file in Stata, and any outliers, unusual data, or missing data were 
flagged and checked with supervisors and enumerators to ensure accuracy of collected data. 
 
There were no issues with use of the facility assessment tool or the clinical vignettes. Supervisors 
proactively reached out to providers to schedule interviews to minimize disruption during patient 
consultation hours and maximize provider response rates. Although the study was designed to 
observe five patient interactions during each facility visit, this became a major bottleneck for 
survey implementation. Many of the providers that were visited did not receive five patients 
throughout the course of an entire day, which left enumerators idle for hours after completing the 
facility assessment and the clinical vignettes. To solve this problem, we adjusted the survey 
protocol to apply the patient observation tool to all patient interactions that occurred over the 
course of three hours at the clinic. This ensured that enumerators could complete all tools for at 
least two providers per day. 
 
Data collection started on February 18, 2020 and was halted on March 13, 2020 due to the 
COVID-19 outbreak. During the first phase of data collection, providers from 28 out of the 70 
selected villages were sampled (40% of envisioned sample). Data collection was completed in 
the remaining villages between February 22, 2021 and March 15, 2021, however the patient 
observations were not conducted when data collection resumed in 2021 due to concerns over 
enumerator safety during the ongoing COVID-19 pandemic. In total, facility assessments and 
clinical vignettes were administered to providers in the 70 villages that were selected for data 
collection and patient observations were conducted with providers in 28 of these villages.  
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There were 502 unique providers utilized by individuals from the 70 selected villages in the 
household survey and located by the GPS team. Of these providers, 390 were reached for the 
provider assessment (76.4%). This compares favorably with the provider response rate from a 
previous study in India with similar study design, which reported a response rate of 41.9% 
among local providers (Das et al. 2020). Vignettes and facility assessments were conducted for 
all 390 providers, but there was variation in the number of patient observations across providers. 
In total, 377 patient interactions were observed across 110 providers in 28 villages. Among the 
168 providers included in the 2020 data collection, the average number of patient observations 
was 2.2 per provider and ranged from 0 to 6 observations per provider. There were fewer patient 
observations at private providers than public providers. Even though 17.2% of the sampled 
providers were public facilities in the 2020 data collection, 34.2% of patient observations were 
recorded in public facilities.   
 
The final sample included 390 providers for whom the facility assessment and clinical vignettes 
were conducted. The sample included 47 PHCs, 23 CHCs (that functioned as a PHC), 1 District 
hospital, 314 private clinics, and 5 private hospitals. The primary reason for non-response was 
that providers were not available when enumerators were at the village for data collection. This 
was mostly because providers maintained seasonal or limited hours during certain days of the 
week. Whenever possible, appointments were made to ensure provider availability and to ensure 




All data was collected via tablets and automatically uploaded to a central server through the 
CAPI application. As data was uploaded to a central server, OPM staff translated the data into a 
Stata dataset, on which several quality checks were routinely conducted to flag outliers and 
questionable values for supervisors to check with enumerators. The methodology to obtain state-
representative estimates of provider quality differed by provider type. Sample weights were 
applied to obtain state-representative estimates for PHC-related quality of care but since there 
was no census of private providers, it is impossible to determine state-representative estimates 
for quality domains in the private sector.  
 
Ethics and Author’s Contributions 
The project was a collaboration between Johns Hopkins University, CARE India, and Oxford 
Policy Management, and was funded by the Bill and Melinda Gates Foundation under the BTSP. 
The Assessment of Primary Health Care System in Bihar study was approved for human subjects 
research by the Johns Hopkins University Institutional Review Board (IRB00009563). It was 
also approved by the Sigma Institutional Review Board in India (Doc#'s 1910787106 / 
1910789424). The principle investigator was Dr. Krishna Rao and other JHSPH faculty members 
on the project team included Dr. Henry Perry, Dr. David Bishai, Japneet Kaur, and Niketa 
Pawar. Contributing JHSPH graduate students included Caitlin Noonan (2020 MSPH graduate, 
Health Systems program), Onaopemipo Abiodun (PhD candidate, Health Systems Program), 
Hunied Kautsar (2021 MSPH graduate, Health Systems Program), and Joseph Millward (2020 
MHS graduate, Health Systems Program). Additional members of the project team included 
Navneet Kumar (Oxford Policy Management), Bhavna Seth (Johns Hopkins School of 
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Medicine), and Satbir Kaur (Indian Institute of Health Management Research/ Johns Hopkins 
Bloomberg School of Public Health). All study investigators completed training in human 
subjects research and have declared no conflicts of interest. 
 
The author of this dissertation joined the Assessment of Primary Health Care System in Bihar 
Study as a research assistant in September 2019. The author was closely involved all phases of 
the project, and played a lead role in designing and planning the household survey, developing 
tools (especially the chronic disease module in the Phase I study and the hypertension vignette in 
the Phase II study), translating tools to CAPI software, conducting pilot tests, participating in 
enumerator trainings, supervising data collection, cleaning data, performing analysis, and 
disseminating results. This has included three field visits to Bihar in September 2019, November 
2019, and January through February 2020.  
 
During the onset of the COVID-19 outbreak, the author participated in a research effort to 
leverage the network of providers identified in the Assessment of Primary Health Care System in 
Bihar Study to support the Government of Bihar’s COVID-19 response. A rapid telephonic 
survey was conducted to assess provider knowledge, attitudes, and practices towards COVID-19 
treatment and the results were shared with the government and published (Rao et al. 2021). The 
author has also continued to support local Bihari researchers in publishing their work and to 
support CARE India with technical assistance in designing evaluations and conducting relevant 
research as needed to support the larger BTSP (e.g. on non-communicable diseases and on urban 
health in Bihar).  
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Outline for Subsequent Sections 
The remaining chapters of this thesis describe how the findings from this study are applied to 
improve the measurement of effective coverage for services to manage hypertension. Chapters 
two through four can be read as standalone publications and may repeat key definitions, 
assumptions, and findings that appear elsewhere. The second chapter reviews the existing 
evidence on measuring effective coverage of hypertension management services through a 
scoping review and proposes a framework to address current gaps in the conceptualization of 
effective coverage and assist in future measurement efforts. The third chapter applies the 
framework to rural Bihar, India to demonstrate key barriers to achieving effective hypertension 
management. Chapter four proposes and calculates a single metric for measuring effective 
coverage of hypertension management services, drawing on lessons from the previously 
designed framework and its application. The final chapter presents the policy relevance, future 
areas for research, and concluding thoughts generated by this dissertation.  
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Chapter 2: The Expanded Hypertension Care Cascade 
 
A scoping review to improve effective coverage of hypertension management 
services in low- and middle-income countries 
 
Abstract 
Background: With the steadily rising burden of hypertension in low- and middle-income 
countries (LMICs), there is an urgent need to measure the coverage of health services that 
effectively manage blood pressure. However, there is little agreement on how to define effective 
coverage and the existing hypertension care cascade (hypertension prevalence, percent aware, 
percent treated, and percent controlled) does not account for the quality of services provided.  
Methods: A systematic scoping review of published literature was used to identify studies that 
defined effective coverage of hypertension management services or incorporated dimensions of 
service quality into population coverage measures. These findings were used to inform an 
expanded hypertension care cascade from which quality-adjusted coverage can be calculated. 
Results: The review identified 20 relevant studies, including 8 which defined effective coverage 
for hypertension management services and 12 that reported a measure of service quality in a 
population-based study. Based on commonly reported barriers to hypertension management, new 
steps on the proposed expanded care cascade include (i) percent screened, (ii) percent linked to 
quality care, and (iii) percent adhering to quality treatment. 
Conclusions: There is little consensus on the definition of effective coverage of hypertension 
management services, and most studies do not describe the quality of hypertension management 
services provided to populations. Incorporating key aspects of service quality to the hypertension 
cascade of care allows for the calculation of quality-adjusted coverage of relevant services, 




Optimally organized health systems provide people with access to needed health services without 
causing financial hardships, but unless these services are of a certain level of quality, they may 
not improve population health. It is widely accepted that expanding the coverage of health 
services alone is not sufficient to improve population health for maternal and child health 
interventions (Tanahashi 1978; Hannah H Leslie et al. 2017). Without considering service 
quality, measurements of service coverage, also known as “crude coverage”, are only weakly 
associated with the health benefits received by a population (Amouzou et al. 2019). Effective 
coverage is a promising metric for evaluating program and health system performance because it 
captures whether individuals are receiving health services of sufficient quality to achieve the 
health improvements that are possible from medical and behavioral interventions (Ng et al. 
2014). Effective coverage of key health services has been adopted by the World Health 
Organization (WHO) and the World Bank as a metric for monitoring progress towards universal 
health coverage, and therefore for measuring health system performance globally. 
 
Despite the promise of effective coverage, there is not yet consensus on how to operationalize its 
measurement. An initial paper described six methods for calculating effective coverage and a 
recent scoping review found that at least four of these approaches have been adopted to measure 
intervention quality and calculate effective coverage, ranging from tracking changes in 
biomarkers to using statistical (Table 2.1) (Ng et al. 2014; Jannati et al. 2018).  
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Table 2.1: Approaches to calculate effective coverage 





Focuses on the health care 
process 
Involves indicators that 
target the resource and 





















Offers information from 
both demand- and 
supply-side factors 
 
Resource and activity 
outputs can serve as 
objective indicators 
Subjectivity in patient 
assessments of quality 
 
High outputs or content 
of care may not directly 
translate into health 
gains 
Biomarkers 
Focuses on the health 






(Pebody et al. 





Provides an objective 
measure of actual health 
gains or impact 
Collection of biomarker 
data can be costly and 








Focuses on changes in 
individual health outcomes 








(Sterne et al. 




Provides measurement of 
treatment effectiveness 
for chronic conditions 
over time 
Limited to interventions 
that involve close 
patient monitoring and 










Compares health outcomes 
of individuals who had 
intervention exposure to 
those who did not have 
exposure to an intervention 
Assessment of 
health impact of 
IPTp and ITNs  
 




Allows for the 
quantification of the 
health gains associated 
with intervention 
exposure by calculating 
odds ratios or relative 
risks with existing data 
Household surveys are 




need to be accounted for 
due to the observational 
nature of analysis 
Statistical 
methods 
Uses statistical and 
econometric techniques, 
such as instrumental 
variables and matching, to 
estimate health outcomes 












Offers a convenient 








and a health outcome 





Estimates health outcomes 
while accounting for the 
patient characteristics and 
risks of death that can vary 










Provides an indicator for 
quality of care that 
reflects both procedural 
outputs and the health 
impact of received care 
Limited to interventions 
that are delivered at 
health facilities- Certain 
risks may not be easily 
adjusted for if they are 
challenging to quantify 




Previous studies have calculated effective coverage by adjusting intervention coverage levels 
according to a level of intervention quality, such as service readiness, quality of care provided, or 
health outcomes achieved (Nguhiu, Barasa, and Chuma 2017; Marsh et al. 2020; Colson et al. 
2015; Hannah H Leslie et al. 2017). The Institute for Health Metrics and Evaluation (IHME) has 
approximated effective coverage by modeling outcome-based measures across populations and 
the WHO is developing new weighting methods to further advance coverage estimates based on 
modelled health outcomes (World Health Organization 2020; Lozano and GBD 2019 Universal 
Health Coverage Collaborators 2020). Working within these global measurement frameworks, 
national and sub-national efforts to calculate effective coverage of services primarily focus on 
health outcomes as a measure of intervention quality. While this approach has the benefit of 
providing an estimate of the health gains directly experienced by populations, many factors 
beyond the reach of the health system can influence health outcomes. These factors, or social 
determinants of health, are interrelated issues which influence health including social status, 
early life exposures, employment, social support and/or exclusion, and stress (Marmot 2005). 
Measures of effective coverage that only incorporate health outcomes capture the impact of these 
social determinants and therefore may not reflect the direct contributions of health system 
performance to improving population health. Methods for calculating effective coverage that 
consider the quality of services provided by the health system address this shortcoming.   
 
Incorporating appropriate measures of service quality4 into effective coverage calculations is 
challenging. Quality in healthcare has been conceptualized as consisting of three parts: structure, 
related to the settings in which care occurs; process, what is actually done to provide care; and 
outcomes, the effects of care on the health status of patients and populations (Donabedian 1966, 
 
4 In this study, service quality primarily refers to structure and process quality 
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1988). All three of these quality components influence the effective coverage of interventions to 
some extent (Box 2.1) (Amouzou et al. 2019). While structural quality is conceptualized as a 
necessary precondition to good quality care, studies have demonstrated that it is poorly 
correlated with provision of evidence-based care in low- and middle-income countries (Hannah 
H Leslie, Sun, and Kruk 2017; Hodgins and D’Agostino 2014). As previously mentioned, 
outcome measures of quality may not adequately capture health system performance due to the 
substantial impact of social determinants on health outcomes. Increasingly, measuring the 
processes of care provided and their impact is being recognized as vital for assessing health 
systems performance (Bilimoria 2015; Akachi and Kruk 2017; Kruk et al. 2018).  
 
Box 2.1: Quality components that inhibit effective coverage of health services 
 
For some interventions, it is relatively easy to measure aspects of process quality that will result 
in improved health [e.g., determining whether a child received three doses of diphtheria, tetanus, 
and pertussis (DTP) vaccine according to an immunization schedule]. In these cases, there are 
obvious solutions for adjusting contact coverage measures to arrive at estimates of effective 
coverage (e.g., measuring the percent of population covered by one dose of DTP versus the 
percent of population covered by three doses of DTP). For other health services, such as those to 
Structure 
• Lack of service availability 
• Insufficient equipment and medicines 
 
Process 
• Providers do not follow standards of clinical care 
• Patients do not adhere to recommended treatment 
 
Outcomes 
• Low patient satisfaction 
• Sub-optimal intervention efficacy 
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diagnose and manage hypertension, the processes that should be included in effective coverage 
measurements are less clearly defined.  
 
Hypertension, or raised blood pressure5, is a leading cause of global cardiovascular mortality and 
morbidity, which causes a third of all deaths globally (Zhou et al. 2017). Between 2000 and 
2010, the age-standardized prevalence of hypertension fell by 2.6% in high-income countries, 
but rose by 7.7% in low- and middle-income countries, demonstrating the need for increased 
attention to hypertension management in these settings (Mills et al. 2016). Hypertension can be 
controlled at the primary care level with a combination of sustained lifestyle changes and 
relatively affordable pharmaceutical options, however successful treatment requires continuous 
monitoring and interaction with the health system. Successful management of hypertension at the 
population level is indicative of strong health system provision of preventive and curative 
services. Therefore, measuring the coverage of hypertension management services6 that result in 
sustained non-elevated blood pressure levels, or the effective coverage of hypertension 
management services, can indicate health system performance.  
 
Population-level progress towards controlled blood pressure has been measured in a more or less 
standard way in the US and internationally since at least the 1980s using a cascade of care 
framework (Cummings et al. 1982; National Heart Blood and Lung Institute 1985; Chadha et al. 
 
5 Specifically, hypertension is defined as a systolic blood pressure of 140 mm Hg or more and/or diastolic blood 
pressure of 90 mm Hg or more and/or taking antihypertensive medication 
 
6 Hypertension management services include all of the services that result in sustained non-elevated blood pressure 
levels, including screening and early detection/diagnosis, counseling on lifestyle modifications, prescribing 
antihypertensive medications, monitoring effectiveness of treatment, and continuing interactions between providers 
and patients. 
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1990). The cascade of care usually involves measuring blood pressure levels of individuals 
sampled in a population-based survey and recording: 
(i) the prevalence of blood pressure (based on elevated blood pressure readings on the 
day of the survey or reported use of antihypertensive medicine),  
(ii) the awareness of hypertension (the percent of those classified as hypertensive who 
had been previously diagnosed by a health worker),  
(iii) the treatment of hypertension (the percent of hypertensives who report recently taking 
antihypertensive medicines), and 
(iv) the control of hypertension (the percent of those who report taking antihypertensive 
medication and have non-elevated pressure on the day of the survey).  
 
This standard hypertension cascade of care, measured at the population level, has enabled several 
powerful systematic reviews and meta-analyses on hypertension management in countries, 
regions, and globally (Bosu 2010; Mills et al. 2016; Zhou et al. 2017; Geldsetzer et al. 2019; Akl 
et al. 2020). However, the hypertension cascade of care does not account for the quality of health 
services that contribute to improved health. For other, mostly maternal and child health 
interventions, cascades of care have been expanded to account for process quality, which are 
used in turn to measure effective coverage (Amouzou et al. 2019; Marsh et al. 2020). The 
absence of process quality-related indicators in the hypertension cascade of care prohibits its 
ability to adequately measure health system performance related to hypertension care. 
 
While the existing hypertension cascade of care framework does incorporate a key measure of 
outcome quality (the percent of those who report taking antihypertensive medication and have 
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non-elevated pressure on the day of the survey), process quality measures are needed to fully 
understand the role of the health system in achieving population blood pressure control. Without 
understanding the coverage of quality-adjusted services and examining relevant inputs and 
processes, health services research may not reveal the drivers of and barriers to successful 
hypertension management and improved health. Thus, supply-side factors should be considered 
and incorporated within the hypertension cascade of care. This scoping review study seeks to 
review definitions of effective coverage for hypertension management services, including how 
non-outcome quality measures have been incorporated into studies that examine the hypertension 
cascade of care in low- and middle-income countries. Based on these findings, improvements to 
the cascade of care framework will be proposed to inform improved measures of effective 
coverage of hypertension management services. A scoping study methodology is the correct 
approach for this research question, as it is a broader topic where many different study designs 
might be applicable (Arksey and O’Malley 2005; Munn et al. 2018). 
 
Methods  
The study followed Arksey and O’Malley’s process for conducting a scoping review, 
incorporating subsequent methodological advancements (Arksey and O’Malley 2005; Levac, 
Colquhoun, and O’Brien 2010). One overarching research question was identified, specifically 
“how have measures of coverage of hypertension management services in low- and middle-
income countries considered aspects of service quality?” To find relevant studies, we performed 
a search of electronic journals and databases including Scopus, EMBASE, PubMed, 
ScienceDirect, ProQuest, and Web of Science using keywords “hypertension” and “effective 
coverage” or “cascade of care” and its variants. An additional search was conducted in a subset 
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of databases to include published studies that included aspects of hypertension management (e.g. 
prevalence, treatment, and control) but did not mention the care cascade by name (see Annex 2 
for search strategy). The search strategy was calibrated to ensure that three pre-identified “tracer” 
articles which discussed effective coverage of hypertension management services were included 
in results (Lozano et al. 2006; Liu et al. 2008; Charoendee et al. 2018). These searches were 
conducted on 12 and 26 October 2020 and were supplemented by periodic searches of grey 
literature databases and suggestions from experts to include additional information. Titles and 
abstracts of articles were collated, duplicates were removed, and titles and abstracts were 
screened for relevance in the Cochrane Community’s screening and data extraction tool, 
Covidence (Veritas Health Innovation, n.d.). Relevant studies identified through title and abstract 
screening included those that (i) mentioned hypertension in the title, (ii) were conducted in a 
low- or middle-income country according to 2018 World Bank classifications, (iii) reported data 
collected since 2000, (iv) were associated with a full text manuscript in English (conference 
abstracts and commentaries were excluded but corresponding authors were contacted when 
possible), (v) used a population-representative study design (which is necessary to calculate 
coverage of a service in the general population), and (vi) reported sufficient information to 
calculate coverage. Any relevant study that mentioned “effective coverage” in the title or abstract 
was automatically included in the full text review. Studies were excluded during the full-text 
review if they (i) did not report any measure of service quality, (ii) reported on quality of care for 
pregnancy-related hypertension, (iii) reported on specific populations (not age-related) that 
preclude generalization to entire populations, or (iv) included the words “effective coverage” but 
did not define the concept specifically for hypertension management services. The full text of 
selected studies was reviewed and relevant information (on study type, data sources, definition of 
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effective coverage, incorporation of service quality, among others) was extracted in an online 
survey platform, Qualtrics (“Qualtrics” 2005). At the title and abstract screening and full-text 
review stages, two reviewers examined each article, and conflicts were discussed and resolved 
by the study leader. Findings were summarized in tables that demonstrated (i) how “effective 
coverage” of hypertension management has been defined, and (ii) how dimensions of service 
quality have been incorporated into studies reporting population-level coverage of hypertension 
management services. The quality of included articles was assessed using the Appraisal tool for 
Cross-Sectional Studies (Annex 3) (Downes et al. 2016). Findings were used to propose 
additional steps on the hypertension care cascade, including methods to improve the 
measurement of effective coverage for health systems performance evaluation. Finally, the 
revised framework was shared with experts on effective coverage and hypertension management 
experts and feedback was incorporated to improve the overall framework.   
 
Results 
Across the databases, 5,045 records were identified, including 3,670 unique records which were 
screened for relevance. After title and abstract screening, 585 relevant records were assessed for 
eligibility for full-text review. Of these, 264 full-text records were reviewed and 20 records were 
included that defined effective coverage of hypertension services (n=8) or incorporated measures 










There were eight reviewed records which defined effective coverage of services related to 
hypertension management (Table  2.2).  
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Definition of Effective 
Coverage 




















20 years old  
The ratio of actual reduction 
in systolic blood pressure to 
the difference between 
pretreatment systolic blood 
pressure and the target blood 
pressure for all individuals 
with hypertension (i.e., the 
proportion of the population 
reduction in blood pressure 
that can potentially be 
delivered through treatment 
that is actually delivered). 
Outcome quality 
 
Reduction in systolic blood 
pressure compared with 













only 23%  
 
 


















Percentage of hypertensive 
people who reported having 
taken control measures and 
whose blood pressure was 




Normal blood pressure 
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receives appropriate 
hypertension screening and/or 
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Effective universal coverage 
is the proportion of patients 
that effectively received care 
after demanding services to 
the health system for the 
control of hypertension  
Outcome quality 
 






























Number with effective control 




Percentage who show 
therapeutic effects (reduced 
blood pressure) among those 




























Proportion of individuals in 
need who experience 
potential health gains 
 
 
Outcome quality  
 
Blood pressure tests<140/90 





Patients with hypertension 
without hypertension-related 




















The fraction of blood pressure 
reduction that is delivered to 
the population who take the 
anti-hypertensive medication  
Outcome quality 
 
Actual reduction in systolic 
blood pressure and/or 
diastolic blood pressure 
through taking 
antihypertensive medication 
from 2011 to 2013 as 

















Definition of Effective 
Coverage 
Quality Measure Reported Effective vs 
Crude 
Coverage 






















Ratio of actual reductions in 
biomarkers to potential 
reductions that could be 
delivered for individuals 
receiving treatment.  
 
Denominator is treated 
individuals instead of all 
individuals in need 
Outcome quality 
 
Averaged the differences 
between observed and 
counterfactual blood 
pressure levels among 
treated participants to 
estimate average treatment 















These studies took place in Mexico, China, Japan, and Thailand and were published between 
2006 and 2020. Among the six studies that reported crude and effective coverage, the average 
difference in coverage estimate was 18.9% (Figure 2.2). All eight of the studies reported some 
measure of outcome quality in their definition of effective coverage, however there were 
differences in the way effective coverage was operationalized. Definitions of effective coverage 
included the ratio of actual reduction in blood pressure over target reduction (Lozano et al. 
2006), the percent of the hypertensive population achieving blood pressure control (Hashiguchi 
et al. 2019), and the percent of the hypertensive population experiencing potential health gains 
(hypertension-related hospitalization) (H H Leslie, Doubova, and Pérez-Cuevas 2019). Three of 
the studies defined effective coverage for hypertension management services among other health 
services within the context of evaluating health systems performance (Lozano et al. 2006; Liu et 
al. 2008; H H Leslie, Doubova, and Pérez-Cuevas 2019). Two studies defined effective coverage 
for hypertension management alongside other chronic diseases, namely diabetes and 
dyslipidemia (Hashiguchi et al. 2019; Ikeda et al. 2020). One study considered a package of 
hypertension screening-related interventions and defined effective coverage for individual 
aspects of a national hypertension screening program (Charoendee et al. 2018). Cross-sectional 
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data sources were used in the majority of studies (7 out of 8), and longitudinal data sources were 
used in one study (Y Zhao et al. 2020). Out of the eight studies, only one study reported any 
quality measure other than outcome quality, and reported process quality indicators on what 
kinds of screening-related services were received by certain population segments in need 
(Charoendee et al. 2018).  
 
 




In addition to the records that defined effective coverage for hypertension management services, 
there were 12 studies that considered coverage of these services adjusted for aspects of service 
quality (Table 2.3). These studies were published between 2007 and 2020 and took place across 
9 countries: Bangladesh, Brazil, Cuba, India, Kenya, South Africa, Tajikistan, Tanzania, and 
Uganda. Only one study was representative at the national level (Macinko, Leventhal, and Lima-
Costa 2018). Eight studies incorporated measures of process quality and seven studies 
incorporated measures of structural quality (some studies described measures of both process and 
structural quality). 
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Table 2.3: Studies that incorporate service quality into measures of coverage 
Author, year Study Type/Data 
source 
Study population Cascade of 
Care 
Quality Measure Reported Notes 
(Thorogood 





















Availability of drugs in clinics 
(stock outs) 
 
Clinics either had to deny treatment 
to patients or switch treatment to 
another drug- both were likely to 
reduce adherence 
 
Lack of appropriate equipment 
(none were in satisfactory condition)  
Hypertension management 
was studied in the context 

















Diagnosis by a qualified doctor 
 
Adherence to treatment 
Only about half of people 
with self-reported 
hypertension were 
diagnosed by qualified 
doctors. 
 
26.2% of hypertensives 









India: Urban slum 
dwellers in Kolkata 
 
Hypertensive 













Structural quality:  
Availability of medications 
 
Process quality:  
Adherence to medication in the past 
week 
 
Adherence to lifestyle modification 





All quality measures are 
based on self-report 
 
Patients adherent to 
prescribed medications 
were 2 times more likely 
to achieve blood pressure 
control than those who 
were not 

























Accessing health professional for 
follow up 
 
Adherence to medication 
All quality measures are 
based on self-report 
 































Perceived lack of diagnostic 
equipment and testing capabilities 
(demand side) 
 
Patients were referred to private 
institutions or higher levels of care, 
stockouts were frequent, not enough 
time to counsel patients (supply 
side) 
 
Gaps in availability of diagnostic 
equipment and pharmaceutical 
supplies 
Used a linked survey study 
design 
 
Poor description of results 
(text does not match the 
tables) 
















Long wait times, understaffing, lack 
of experience, and medication costs 
 
Outcome quality: 
Perceived quality of biomedical 
healthcare delivery 
 
A cascade of care was not 
explicitly defined, but the 
study accounted for the 
type of treatment received 
by hypertensives 
(biomedicine or traditional 
medicine) 
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Author, year Study Type/Data 
source 
Study population Cascade of 
Care 
















Adults 18 or older 





















Continuous, high-quality care was 
defined as reporting no financial or 
organizational barriers to accessing 
hypertension-related healthcare, 
reporting that laboratory/diagnostic 
examinations were requested, that 
the provider knew about results of 
any diagnostics or lab-oratory exams 
(if requested), and receipt of all 
health advice 
 
All quality measures are 















South Africa: 2 
Districts 
(Umgungundlovu 
and Pixley ka 
Seme) 
 
















Limited availability of testing 
equipment 
 
Perceived prevalence of stockouts 
 
Long wait times which reduced care-
seeking and patient interest in 
returning for care 













regions (Sughd and 
Khatlon) 
 












Insufficient supply of equipment and 
human resources. 
 
Sphygmomanometers are not 
replaced and calibrated regularly 
 
Process quality: 
Current protocols lack clear 
guidance for each level of the health 
system 
Also conducted a literature 
review on the range of 
clinical and non-clinical 




These solutions included 
mobilizing faith-based 
organizations, scaling up 
screening through May 
Measurement Month and 
health caravans, leveraging 
service user interactions 
with pharmacy care, 
introducing job aids for 
providers, and task-
shifting to increase 




















Type of pharmacological treatment 
 
Measured adherence with treatment 
among those taking drugs using 
Morisky’s Medication Adherence 
Questionnaire 
Used a linked survey study 
design 
 
Receiving drugs and 
adherence were not 
associated with higher 












India: one urban 









Facility readiness, human resources, 
availability of drugs 
 
Process quality: 
Patient adherence to medicines 
Used a linked survey study 
design to interview 
hypertensives identified in 
the first phase 
 91 
Author, year Study Type/Data 
source 
Study population Cascade of 
Care 
Quality Measure Reported Notes 






facility records  





















and referred to 
care 
 
Linked to care 
within 2 years 
 
Patients retained 
after first visit 
 
Blood pressure 




normal at last 
visit 
Process quality: 
Implementation fidelity of providers 
(e.g. asked history of HTN, blood 
pressure checked twice, appropriate 
linkage to care, appropriate 
prescription based on examination) 
 
Retention in care (follow-up 










The most common study designs were mixed-methods designs that paired quantitative 
population-based survey data with qualitative information collected from patients and/or 
providers. Mixed-methods studies that incorporated qualitative data from patients described 
structural quality issues such long wait times, lack of drugs, and poor adherence, and outcome 
quality issues related to patient satisfaction (e.g. poor perceived quality of services) (Wollum et 
al. 2018; Chukwuma et al. 2019; Galson et al. 2017). Providers described a lack of appropriate 
equipment, stockouts of medicines, and insufficient time to counsel patients on lifestyle advice 
(Thorogood et al. 2007; Gabert et al. 2017). Studies that used linked population-based survey 
study designs with information collected in facilities were able to provide quantitative estimates 
about these structural quality constraints. Cross-sectional household surveys were also frequently 
used to understand additional information about hypertension treatment, primarily focusing on 
availability of health services (including screening and diagnosis), the specific types of 
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medication taken, adherence to treatment, and patient satisfaction. Five studies did not explicitly 
define a care cascade and four studies used the traditional hypertension care cascade, however 
three recently published studies proposed alternative hypertension care cascades. One study 
separated the treatment step into service initiation and continued treatment (Chukwuma et al. 
2019). Another included supply-side considerations, namely contact with the health system 
(service availability), and the receipt of continuous, high-quality treatment (quality-adjusted 
treatment) (Macinko, Leventhal, and Lima-Costa 2018).  The third study, which linked detailed 
information from a hypertension screening and management intervention with a household 
survey, included multiple steps related to screening, referral to care, linkage to care within two 
years, retainment in care, and then characteristics about the care provided during provider 
interactions (Heller et al. 2020). Of note, a series of World Bank reports on cascades of care for 
hypertension which identified supply- and demand-side bottlenecks to achieving hypertension 
control were identified through grey literature searches, which are presented as a supplementary 
table (Annex 4) 
 
The structure- and process-related quality features identified in the articles fall into three main 
categories: facility readiness (including equipment, medicines, human resources), content of care 
(including adherence to treatment protocols, type of pharmacological treatment prescribed, and 
health advice given), and patient adherence to treatment (including adherence to medicines, and 
retention in care). An expanded cascade of hypertension care is proposed that builds on previous 
standardized steps, incorporating steps to indicate the effectiveness of screening and treatment 
services provided by the health system (Figure 2.3). Three new steps are proposed in the 
expanded proposed hypertension care cascade: the percent of hypertensives that have ever had 
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their blood pressure measured (to indicate frequency of blood pressure screening and early 
diagnosis), the percent of hypertensives linked to quality care (to indicate the quality of care that 
follows treatment protocols), and adherence to evidence-based treatment regimens (to indicate 
the quality of services to increase adherence). Additionally, population-level prevention is 
acknowledged within the expanded care cascade to include key preventative measures that 
influence the prevalence of high blood pressure and the likelihood of achieving blood pressure 
control. On the AXIS scale for rating the quality of observational studies, the 20 studies that 
informed the expanded hypertension care cascade were of high quality, scoring an average of 
15.9 out of 20 (ranging from scores of 9 to 20).  
 







Despite major gaps demonstrated between crude and effective coverage, there is no consensus 
among researchers on what constitutes effective coverage of hypertension management services. 
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the massive variability introduced when effective coverage for hypertension management 
services is calculated using non-standardized methods. The hypertension care cascade is a more 
commonly used approach to identify bottlenecks in achieving hypertension control, however 
studies that provide insight into structural and process quality for hypertension management 
services received by populations are limited. The standardization of this cascade has allowed for 
many powerful meta-analyses, but gaps remain, as the cascade measures the coverage of 
hypertension control, without accounting for the effect of health system-related services that 
contribute to effective management. Various studies have increasingly tried to fill these gaps by 
expanding the traditional cascade of hypertension care to include information on process quality 
such as linkage to services, the content of treatment, and adherence to treatment. Studies have 
also separated screening for hypertension from the treatment of hypertension, acknowledging 
that the quality of screening services will influence the number of individuals who are linked to 
treatment in general. Expanding the hypertension cascade of care framework to incorporate 
measures of both screening- and treatment-related process quality will help directly identify 
service bottlenecks across the continuum of hypertension management services. This expanded 
framework would also bridge the gap between the often-reported cascade of care and the 
emerging conceptualization of effective coverage by providing an indication of quality-adjusted 
coverage of hypertension management services.  
 
Previous efforts have characterized steps in care cascades where health benefits can be lost on 
the pathway to effective coverage, however these have not been applied to hypertension care 
cascades (Tanahashi 1978; Amouzou et al. 2019; Marsh et al. 2020). The proposed new steps 
enable the quantification of missed opportunities for hypertension management based on access 
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to care, and the calculation of quality-adjusted coverage and user-adherence-adjusted coverage of 
hypertension management services. They also allow for a more comprehensive approach to 
studying effective coverage of these services beyond health outcomes alone. 
 
While the proposed framework does not yet include standardized metrics for measuring quality 
of care or patient adherence, some potential measurement methods are proposed based on the 
results of this review (Table 2.4). Linkage to quality care may refer to the availability of drugs 
and testing equipment (structural quality), provider fidelity to standard treatment guidelines 
including prescribing practices and patient adherence (process quality), and/or patient 
satisfaction (outcome quality other than blood pressure control) among others. These can be 
measured by including additional questions to population-based surveys or through studies that 
link findings from household surveys (which provide information on service utilization and 
health outcomes) and facility-based surveys (which provide information on service quality). 
Patient adherence can include retention in care over time, adherence to lifestyle modification 
advice, and/or adherence to medication. These can easily be incorporated as additional questions 
to household surveys or through more complex methods like pill counts or treatment diaries. 
Even without standardized measurements of quality of care and patient adherence, it is hoped 
that the proposed framework can promote the consideration of intermediate outcomes such as 
fidelity to treatment protocols and regimens when examining population coverage of 
hypertension services. This consideration will also help to advance the conceptualization of 
process quality within effective coverage of hypertension management services, contributing to a 
standardized metric which will help improve health systems performance measurement. 
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Table 2.4: Proposed expanded hypertension care cascade description 






step in the 
care cascade 
Notes and Considerations 
True Population 











based surveys with 
biometric measurements 




A high blood pressure 
reading at one point in time 
is not sufficient to diagnose 
hypertension. Cross-
sectional studies that 
classify hypertensives 
based on one high blood 
pressure reading may be 
over-estimating the size of 



















records to determine 
how often providers 
measure patient blood 
pressure 




Population beyond those in 
need (A) should be 
screened for high blood 
pressure, however for the 
cascade framework, it is 
important to understand 
how many of those in need 
of services were previously 
screened. 
 
Individuals may also need 
to be screened more or less 
frequently based on other 









diagnosed by a 
health worker  
Cross-sectional and 
longitudinal population-
based surveys based on 
self-report 
 
Linked facility records 
to determine number of 
hypertensive patients 




Often referred to as the 
population “aware” of their 
condition. 
 
If providers are diagnosing 
non-hypertensive patients 
(false positives), the 
population diagnosed and 
true population in need (A 
and C) could be over-
estimated 
Population 





pressure who are 




based surveys based on 
self-report 




Previously referred to as 
the population “treated” or 
receiving any treatment for 
hypertension. 
 
Discrepancies can arise 
from differences in 
definitions of contact 
coverage (e.g. taking any 
medication vs interactions 
with health providers) 
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2018; Heller et 
al. 2020) 
This estimate requires some 
incorporation of a 
definition of “quality” of 
hypertension treatment. For 
standardization purposes, 
fidelity to national/global 
treatment guidelines would 
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based surveys with 
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Health gain can be defined 
in multiple ways (e.g. 
controlled blood pressure 




There are some potential drawbacks to the expanded hypertension cascade of care. One of the 
major bottlenecks described in the reviewed studies was a lack of facility readiness and structural 
quality. The percent of population ever screened (step B) is envisioned to be an indicator of 
facility readiness (to provide blood pressure screening services), however there are shortcomings 
in this step’s ability to fully describe facility readiness. For example, the proposed step does not 
indicate how recently the individual has been screened for high blood pressure, which has 
implications for timely diagnosis of hypertension. Further, it does not indicate the quality of the 
screening services provided (e.g., whether correct cuff size is used, whether blood pressure 
measured twice) which has a large influence on whether or not a correct diagnosis is made. Other 
drawbacks include the fact that certain steps are linked to locally relevant factors. Specifically, 
step E relies on hypertension management services being provided according to standards, which 
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may vary locally, and step G may rely on a context-specific definition of non-elevated blood 
pressure (e.g., 140/90 mmHg vs 130/80 mmHg based on locally accepted guidelines). The 
proposed expanded cascade of care should be further discussed by global and local teams of 
researchers to reach consensus on how to operationalize this framework in future research. 
 
This study should be considered within its limitations. First, the search strategy excluded studies 
that did not provide population-representative estimates of hypertension management service 
coverage. Qualitative studies that examined the extent of provider knowledge relevant to 
hypertension treatment were therefore excluded (Neupane et al. 2015; Vedanthan et al. 2014). 
Several representative facility-based studies examined aspects of quality hypertension care, but 
without linking to a population-level survey, the percent of the population receiving these 
services, and thus the effective coverage of those services, was unknown (Mbui et al. 2017; Gala 
et al. 2020).  Such linked study designs are common in the maternal and child health literature 
and should be increasingly used to determine quality-adjusted coverage for non-communicable 
disease management (Kanyangarara, Munos, and Walker 2017; Marchant et al. 2015; Nguhiu, 
Barasa, and Chuma 2017; Munos et al. 2018). Second, the final results did not include studies 
published in a language other than English. At least one study was found in Spanish that 
included the effective coverage of hypertension but was excluded (Ríos-Blancas et al. 2017). 
Due to commonalities in authorships and study area with another included article, it is likely that 
the findings from this article are reflected in the results (Lozano et al. 2006). Third, this study is 
a review of the quality of hypertension management services, and is not intended to be a 
comprehensive review of all issues related to measuring effective coverage. While the expanded 
cascade of care acknowledges the importance of community-level preventive measures, these are 
not emphasized. Further, with new guidelines suggesting that the ideal threshold blood pressure 
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is under 130/80 mmHg, the population in need of hypertension series and the hypertensive 
population with controlled blood pressure will drastically change (Whelton et al. 2018). Studies 
that have examined the effects of applying these guidelines report increases in hypertension 
prevalence ranging from 17.6% to 23.8% (Abariga, Al Kibria, and Albrecht 2020; Kibria et al. 
2018; Mahdavi et al. 2020).  Future studies on effective coverage should consider the impacts of 
these various guidelines on effective coverage calculations. 
 
Research agendas for infectious diseases that use care cascades to ascertain effective coverage 
are advancing from simply measuring the cascade steps to conducting quality improvement and 
implementation research studies to understand how to prevent losses between steps 
(Subbaraman, Jhaveri, and Nathavitharana 2020; Tun, Go, and Yansaneh 2020; Agins et al. 
2019). There are several recently published studies that signal a similar evolution in the 
hypertension management literature (Limbani et al. 2019; Gimbel et al. 2020; Djasri, Laras, and 
Utarini 2019). This study contributes to this broader shift in the field by describing measures of 
non-outcome quality related to hypertension management that can be used to calculate effective 
coverage. It also proposes an approach to unify previous cascade of care research with the 
emerging need to account for quality of health services in effective coverage calculations. Within 
this proposed framework, several additional studies are proposed to deepen understanding of 




Table 2.5: Proposed areas for gap analysis 
Gap Analysis 
and Areas for 
Further Study 
Description Proposed studies (and examples 
where applicable) 
Prevention Community-based prevention measures 
influence the number of people in need of 
hypertension services and may also improve 
blood pressure control (e.g. if high sodium 
foods become less available) 
Effect of salt-reduction 
interventions on hypertension 




Those who truly have high blood pressure 
but either do not get their blood pressure 
measured because they do not have access to 
health services or because screening services 
are not performed when health services are 
utilized 
Cohort studies with routine blood 
pressure measurements or 
population-based cross-sectional 
studies that ask about the last time 
blood pressure was measured  
Diagnosis Gap 
(B→C) 
Those who are screened but are not 
diagnosed as hypertensive due to faulty 
equipment, insufficient provider knowledge, 
or lack of access to health services to receive 
a formal diagnosis. 
Clinical vignettes or standard 
patients to determine provider 
knowledge/ ability to diagnose true 






Those who are diagnosed as hypertensive 
but are not linked to any care either because 
they do not have access to providers or they 
choose to seek additional care.  
Longitudinal studies that follow 
newly diagnosed hypertensives and 
determine barriers and facilitators 





Those who are linked to care but the care 
provided does not follow treatment standards 
Clinical vignettes or standard 
patients to determine provider 
knowledge/ ability to provide 
treatment according to standards 
Adherence Gap 
(E→F) 
Those who are receiving quality 
management services but are not adhering to 
the prescribed treatment for a variety of 
reasons (e.g. too expensive, medicines 
unavailable, low health literacy)  
Longitudinal studies that track 





Those who are adhering to prescribed, 
quality treatment but are still unable to 
achieve controlled blood pressure or other 
health gains. Could be due to resistant 
hypertension or other reasons.  
Longitudinal studies that track 
treatment and adherence over time 






This study reviewed the evidence on effective coverage for hypertension management, and more 
broadly, quality within the hypertension care cascade. Although there is no universally 
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recognized definition of effective coverage or service quality, there are some common 
approaches to describing barriers on the pathway to effective coverage of hypertension 
management services. These approaches have been incorporated into an expanded cascade of 
care framework that considers aspects of structural and process quality. The proposed framework 
should encourage future studies to consider and incorporate aspects of service quality in 
population measures of coverage and to improve the understanding of how interventions result in 
better intermediate outcomes (e.g. expansion of screening services, fidelity to treatment 
guidelines, and medication adherence). These studies are essential for understanding how to best 
align interventions and health systems to combat the rising burden of hypertension in low- and 
middle-income countries. With the rising global burden of non-communicable diseases, this 
approach of studying effective coverage and quality-adjusted cascades of care can help to 
advance measurement of health systems performance, ultimately improving the quality of life for 




Chapter 3: Barriers on the Pathway to Effective Hypertension 




Background: Identifying gaps in the continuum of chronic care at the primary care level can 
inform program design and save lives. This study applies an expanded cascade of care 
framework to examine supply- and demand-side barriers to achieving effective hypertension 
management in rural Bihar, India.   
Methods: Information from two state-representative household surveys conducted between 2019 
and 2020 was used to calculate the population of hypertensive individuals that (i) need services, 
(ii) have ever had their blood pressure measured, (iii) have received a diagnosis, (iv) are linked to 
any care, (v) are linked to quality care, (vi) that adhere to prescribed treatment, and (vii) that 
achieve health gains in rural Bihar. Facility assessments, clinical vignettes, and direct patient 
observations conducted in 2020 and 2021 provided insights into health systems-related barriers 
preventing individuals from achieving effective hypertension control. 
Results: Care seeking information from 14,386 individuals and blood pressure readings from 
45,459 individuals was obtained. Quality of care of 390 providers was assessed. There are an 
estimated 6.6 million undiagnosed hypertensive individuals in rural Bihar, 2.1 million of which 
have never had their blood pressure measured before. Providers only measured blood pressure in 
30.1% of patients over the age of 30 who visited a clinic. While 95.8% of diagnosed individuals 
are linked to some care, between 18.8% and 69.4% of those individuals are linked to providers 
who have demonstrated the knowledge required to diagnose and treat hypertension. From 
vignettes, 74.2% of providers who treated hypertension were able to correctly diagnose a new 
case of hypertension. Of these providers who correctly diagnosed hypertension, 59.3% were able 
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to write an appropriate prescription that would safely reduce the patient’s blood pressure, 10.5% 
advised the patient that they would need to regularly monitor their high blood pressure and 3.4% 
explained that hypertension is a lifelong condition requiring daily treatment. 
Conclusions: The largest barrier to achieving effective hypertension control in rural Bihar is the 
lack of timely diagnosis, suggesting a need for increased population blood pressure screening 
services. While the coverage of services for diagnosed individuals is high, the quality of these 






Globally, the epidemiologic transition is well underway, with non-communicable disease 
(NCD)-related deaths rising from 42.2% to 60.6% of mortality in low- and middle-income 
countries (LMICs) from 2000 to 2016 (World Health Organization 2018). Local, state, and 
national health systems are confronted with the challenge of adapting care models to address 
these chronic, often lifelong conditions, while also maintaining services that have effectively 
reduced the impact of infectious diseases and maternal and childhood conditions over time. 
Reorganizing and expanding comprehensive primary health care systems to provide effective 
management services for NCDs is a key strategy for achieving universal health coverage in 
LMICs (The Lancet 2018; Hone, Macinko, and Millett 2018; Beaglehole et al. 2008). 
Understanding barriers to achieving effective coverage of chronic care services at the primary 
care level can inform future program design and save lives.  
 
Bihar, India’s third most populous state, is facing a double burden of persistently high prevalence 
of infectious diseases and rapidly increasing incidence of chronic illnesses. Hypertension, or high 
blood pressure7, is the leading metabolic risk factor for death in the State, and its prevalence is 
steadily increasing (Indian Council of Medical Research, Public Health Foundation of India, and 
Institute for Health Metrics and Evaluation 2017; Vital Statistics Division 2012; International 
Institute for Population Sciences (IIPS) and ICF 2017). Hypertension can be prevented through 
community- and individual-level interventions and can be managed with cost-effective tools 
delivered by primary health care systems (Saif-Ur-Rahman et al. 2019; Gaziano, Opie, and 
Weinstein 2006). However, only 17.3% of adults (age 18-49) with elevated blood pressure in 
 
7Hypertension is defined as a systolic blood pressure of 140 mm Hg or more and/or diastolic blood pressure of 90 
mm Hg or more and/or taking antihypertensive medication 
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Bihar are currently taking any medication for blood pressure control (Prenissl et al. 2019). This 
low level of treatment coverage suggests a lack of access to primary health services in the state. 
 
Bihar’s public primary health care system is comprised of community health workers, a limited 
number of health and wellness centers, sub-centers, primary health centers (PHCs), and 
community health centers (CHCs). PHCs are supposed to be staffed by formally trained doctors, 
serve between 20,000 and 30,000 people, and provide curative and preventive services at 
nominal fees. In Bihar, where 88.7% of people reside in rural areas, PHCs should be a focal 
point for facility-based service delivery, however in reality, only a minority of people seek care 
from public health providers (Vital Statistics Division 2012; Office of the Registrar General & 
Census Commissioner 2011). Instead, people overwhelmingly seek care from local private 
providers who are either fully qualified doctors (providers with a Bachelor of Medicine, 
Bachelor of Surgery, or MBBS degree), trained in Indian systems of medicine (providers with a 
degree in Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homeopathy, or AYUSH 
providers), or informally trained (or untrained) providers.  
 
While studies have examined the quality of care provided by India’s pluralistic health systems, 
little is known about how effective public and private primary care providers are in the context of 
diagnosing and treating non-communicable diseases (Das and Hammer 2005; Das et al. 2020). In 
Bihar, major information gaps exist relative to hypertension management services, especially in 
rural areas where informal providers are more prevalent (Rajeev Gupta 2004; Anchala et al. 
2014; Rajeev Gupta, Gaur, and S. Ram 2019). This gap is significant in light of the fact that the 
quality of care is a major driver of provider choice among households with hypertensive 
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individuals (Kujawski et al. 2018). In order to effectively advocate for increased NCD 
programming, policymakers must be aware of the gaps existing between the demand for a 
service and the current supply (and quality8 of) of that service.  
 
A recent study presented aspects of hypertension care in India among individuals aged 15 to 49 
and reported that the crude prevalence of hypertension in Bihar is 12.8% (95% CI 12.0 – 13.7) 
(Prenissl et al. 2019). Of those individuals, 46.8% (43.3 – 50.4) were previously aware of their 
high blood pressure status, 17.3% (15.4-19.3) were receiving treatment (currently taking BP-
lowering medication), and 12.3% (10.8-14.1) had their hypertension under control (blood 
pressure <140/90 mm Hg during the time of the survey) (Prenissl et al. 2019). By describing a 
cascade of hypertension care, this study, like others before it, provides important contributions to 
describing the hypertension management landscape in India (Devi et al. 2013; Anchala et al. 
2014; Rajeev Gupta 2004; R Gupta et al. 2018). However, several key gaps limit this analysis 
from providing sufficient information to address the burden of hypertension and related diseases 
in India and other LMICs. Primarily, this analysis does not include individuals over the age of 
49, a major shortcoming considering that the odds of hypertension increase significantly with 
every 5 years over the age of 50 in India (Lloyd-Sherlock et al. 2014). Second, while 
policymakers can understand the points in the hypertension care cascade where the most patients 
are lost in Bihar (53.2% have hypertension but are not aware, 29.5% who are aware were not 
receiving treatment), the current framework does not explore how health systems can close these 
gaps. Finally, the cascading framework of hypertension care (percent screened, percent aware, 
 
8 Quality of care is conceptualized as having three parts: structure (the inputs and resources needed to provide care), 
process (the activities and services actually provided during care) and outcomes (the changes in health realized by a 
patient) (Donabedian 1966, 1988). 
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percent treated, and percent controlled) does not consider the effects of adequate input and 
process quality on health, and therefore presents an incomplete picture of how the Bihari health 
system is addressing hypertension care. To address the burden of hypertension and related 
diseases in Bihar and similar LMIC settings, there is an urgent need for research to understand 
the factors that prevent the achievement of effective hypertension management.  
 
The effective coverage framework is a useful tool for understanding whether populations are 
receiving the interventions they need at sufficient quality to improve health. Dimensions of need 
for, use, and quality of hypertension management services can be organized in a stepwise fashion 
in a cascade of care to indicate levels of care received by populations, progressing from the 
population in need of services along a cascade of necessary treatment conditions, ultimately 
ending with the percent of individuals who achieve a specific health gain (Tanahashi 1978; 
Amouzou et al. 2019). Existing efforts to measure care cascades traditionally focus on the 
services and health benefits received at the population level, however they do not collect 
information on the structure- or process-quality related features of services provided by health 
systems. For health conditions, especially hypertension, there are many factors beyond the health 
services received by an individual that contribute to a differential risk of disease and subsequent 
control. These factors, sometimes referred to as social determinants of health, have been 
documented in several settings and include socioeconomic factors (age, sex, education, and 
wealth), geography (urban versus rural), health behaviors (smoking, physical activity, diet), and 
other psychosocial factors (stress, social cohesion, lack of social support) (Basu and Millett 
2013; Tapela et al. 2020; Commodore-Mensah et al. 2021; Peltzer and Pengpid 2018). As a 
result, cascades of care that rely on outcome measures of quality reflect the influence of these 
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social determinants of health and do not directly reflect health system performance. An expanded 
cascade of care has been proposed to measure barriers on the pathway to effective coverage of 
hypertension management interventions based on a scoping review of quality-adjusted services 
(Chapter 2). Understanding and quantifying supply- and demand-side factors that contribute to 
drop-off along the cascade of care for hypertension management within the general population 
can inform future policy for improving hypertension management in primary health care settings 
in Bihar and other LMIC settings. This study applies the expanded cascade of care as a 
measurement model to understand aspects of effective coverage of hypertension management 
services in Bihar, India. By highlighting the health system-related factors that contribute to the 
largest gaps along the pathway to effective coverage, this analysis will help policymakers to 
address the most significant bottlenecks to effective blood pressure management, resulting in 




This analysis operationalizes the expanded cascade of care as a measurement framework to 
understand gaps in effective coverage of hypertension management services (Figure 3.1).  
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The expanded cascade of care was developed based on a scoping review on effective coverage 
and quality-adjusted coverage of hypertension management services in LMICs (Chapter 2). The 
cascade’s conceptual model is arranged to address the largest reported gaps in hypertension care, 
namely a lack of structural quality (e.g., lack of preparedness to screen for hypertension and 
initiate treatment) and a lack of process quality (i.e., treatment that did not follow protocols and 
inadequate adherence to treatment). The conceptual model also reports on steps that have 
previously been included in traditional cascades of care, including the percent of hypertensives 
who are aware of their diagnosis (step C), the percent of hypertensives taking any treatment (step 
D), and the percent of hypertensives achieving a health gain (step G, when health gain is equated 
to normal blood pressure levels). The number of individuals at each step will be quantified and 
health systems-related factors that contribute to gaps between the steps will be examined using 
the findings from the Assessment of Primary Health Care in Bihar study. The ideal 
measurements along the steps of the expanded cascade of care, along with the measurements 
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your blood pressure 
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or other health 
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Patient Observations: 
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patient interactions 
where blood pressure is 
measured by provider* 
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providers have first line 
antihypertensive 
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providers treat 
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hypertension in the last 6 
months? What percent of 
private providers would 
refer a newly diagnosed 
patient to a PHC? *+ 
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with biomarkers: 
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pressure of individuals 
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Legend: *Indicates method used in the current study; +Indicates a proxy for the measurement of the respective 
step on the expanded care cascade 
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The methods of the Assessment of Primary Health Care in Bihar study have been explained in 
detail elsewhere (Chapter 1). Briefly, the study collected both demand- and supply-side data 
about the primary health care system in rural Bihar using a cross-sectional household survey and 
a provider assessment respectively. The demand-side data collection consisted of a household 
survey which employed a three-stage sampling design, with rural PHCs as the primary sampling 
unit, villages within the PHC catchment area as the secondary sampling unit, and households 
within the village as the tertiary sampling unit. PHCs were selected from a census of functional 
PHCs using stratified random sampling proportional to the number of PHCs in Bihar’s nine 
divisions. Villages were sampled by probability proportional to population size from a census of 
villages within each selected PHC’s catchment area, and 30 households were randomly sampled 
from each selected village using a complete listing of households. All consenting members of 
selected households were included in the study and administered a standard questionnaire in the 
local language by trained enumerators. The questionnaire included sections on demographic 
information, whether the respondent was sick in the last 30 days, and if so, where they sought 
care and characteristics about their care-seeking experiences. Individuals age 30 and older were 
asked about care-seeking related to major chronic diseases (hypertension, diabetes, chronic heart 
disease, asthma, and chronic obstructive pulmonary disease). Data was collected between 
November 2019 and March 2020. Responses from the household survey informed sampling for 
the provider assessments.  
 
Local public and private care providers (including MBBS, AYUSH, and informal providers) 
within 5 km of selected villages that were utilized by respondents from the household survey 
were found in the community and included in the supply-side provider assessment. The provider 
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assessment was administered by enumerators with nursing degrees and consisted of three parts: a 
facility readiness assessment, clinical vignettes, and direct patient observations. The facility 
readiness assessment was designed to understand the medicines, equipment, human resources, 
and processes available to providers while giving care. In the clinical vignettes, hypothetical 
patients were described to providers to assess provider knowledge on how to treat certain 
conditions (hypertension diagnosis, child diarrhea, child pneumonia, and angina). Providers were 
prompted to ask questions about the patient’s history, list the tests they would conduct on the 
patient, make a diagnosis, describe the advice they would give the patient, and if necessary write 
a prescription for the patient. To understand provider practice, nurse enumerators observed 
patient-provider interactions and recorded provider actions using a standardized form. 
Enumerators stayed with the provider for up to three hours and observed up to five consultations 
where the patient presented to the clinic with a new health complaint, collecting information on 
the same processes observed for the clinical vignettes (i.e., patient history, tests conducted, 
diagnosis, advice given, and prescription). Data collection for the provider assessment took place 
between January and March 2020, was halted due to the coronavirus (COVID-19) outbreak, and 
then completed between February and March 2021. Due to the continuing spread of COVID-19, 
when data collection resumed in 2021, the patient observation component of the provider 
assessment was dropped to ensure safety of enumerators and patients.  
 
All tools were pilot tested in rural Bihar to ensure that questions captured intended constructs. 
Data for the household survey and provider assessment was collected on tablets using 
SurveySolutions, a free Computer Assisted Personal Interviewing (CAPI) software developed by 
the World Bank (World Bank, n.d.). Enumerators all had previous experience in data collection 
 114 
and participated in a week-long training to familiarize themselves with the tool, the CAPI 
platform, and to resolve any lingering questions. Direct supervision and random response 
reliability checks were conducted in the field to ensure quality of collected data. All data was 
passed through logic checks and unusual responses were discussed and resolved between 
supervisors and enumerators. All cleaning and analysis took place in in Stata (StataCorp 2014).  
Normalized weights were calculated for each individual in the household survey to account for 
probability of selection through the study’s design and to account for non-response rates. All 
descriptive statistics for estimates from the household survey incorporated these weights, while 
estimates from the providers surveys were unweighted due to the lack of a complete sampling 
frame of private providers. Multiple clinicians who have practiced primary care medicine in 
India and similar low- and middle-income settings reviewed the prescriptions written by 
providers in the clinical vignettes, and rated the quality of prescriptions on a scale including (i) 
inappropriate and harmful, (ii) inappropriate but not harmful, and (iii) appropriate for safely 
lowering blood pressure using a standardized protocol (Annex 5). To account for the variability 
in private provider qualifications, supply-side results from the private sector are presented 
disaggregated by provider training. Two-sample t tests and analysis of variance tests were 
conducted as appropriate with  = 0.05 to determine whether differences between provider 
groups (private MBBS, private AYUSH, private informal provider, and public providers) were 
statistically significant. Additional analysis was conducted on the individual and community 
factors associated with receipt of services (i.e. screening and diagnosis). Since these studies are 
commonly described in India, this analysis is provided as a supplementary material in Annex 6 
(Moser et al. 2014; Rajeev Gupta et al. 2017; Chow and Yusuf 2010; Busingye et al. 2017; Jonas 
et al. 2010; Kusuma, Gupta, and Pandav 2009; Sathish et al. 2012; Kaur et al. 2012). 
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Data from the household survey and the provider assessment was linked through a direct 
matching process to determine the percent of individuals linked to quality care (step E).  
Hypertensive individuals were matched with the providers from whom they sought care. 
Individuals were not linked to their providers if they (i) sought care more than 5 kilometers away 
from their village (because providers were not eligible for the provider assessment), (ii) sought 
care from medical shops who did also provide some care (because these providers were unable to 
complete the provider assessment during pretesting), or (iii) sought care from a provider within 5 
kilometers of the village but the provider was not able to be located by the study team. Providers 
were deemed to be of good quality if during the hypertension vignette they both correctly 
diagnosed the patient as hypertensive, and wrote a prescription that was judged by clinician 
reviewers to safely lower the patient’s blood pressure.  
 
The Assessment of Primary Health Care in Bihar study is approved for human subjects research 
by the Johns Hopkins University Institutional Review Board (IRB00009563) and by the Sigma 
Institutional Review Board in India (Doc#'s 1910787106 / 1910789424). All study investigators 
completed training in human subjects research and declared no conflicts of interest.  
 
Since the Assessment of Primary Health Care in Bihar study did not collect biomarkers on 
individual blood pressure levels, preliminary results from the fifth National Family Health 
Survey (NFHS-5) (conducted in 2019) and population data from the most recent national Census 
(conducted in 2011) were used to estimate the number of people living with hypertension in 
Bihar (Ministry of Health and Family Welfare, Government of India, and International Institute 
for Population Sciences 2021; Office of the Registrar General & Census Commissioner 2011). 
 116 
The NFHS-5, like all previous NFHS surveys, employs a stratified two-stage random sampling 
design with villages as the primary sampling units and households as secondary sampling units. 
Responses were representative at the district level and included three measurements of blood 
pressure for people age 15-49 (women) and 15-54 (men). More information about the sampling 
procedure and survey can be found online. Estimates collected from the NFHS-5 and the 
Assessment of Primary Health Care in Bihar study were age-standardized using the rural age-






In total, 39,486 individuals were included in the household survey, including 14,386 individuals 
who were 30 years or older and answered the chronic disease module and 950 individuals who 
reported previously being diagnosed as hypertensive (Table 3.2).  
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Table 3.2: Household survey respondent characteristics 
 All respondents (N 
= 39,486) 
Respondents over 30 
(N=14,386) 
Respondents aware of 
hypertension diagnosis (N 
= 950) 
Sex 
Male 18,719 (47.4%) 6,644 (46.1%) 339 (42.0%) 
Female 20,767 (52.6%) 7,742 (53.8%) 551 (58.0%) 
Missing 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Age 
Average (SD) 25.8 (20.2) 48.6 (13.9) 58.0 (13.4) 
Religion 
Hindu 35,541 (90.0%) 13,066 (90.8%) 839 (88.3%) 
Muslim 3,909 (9.9%) 1,307 (9.1%) 110 (11.6%) 
Other (Christian, 
Buddhist Jain) 
26 (0.1%) 8 (0.1%) 0 (0.0%) 
Missing 10 (<0.1%) 5 (<0.1%) 1 (<0.1%) 
Caste 
Scheduled Caste 10,252 (26.0%) 3,453 (24.0%) 139 (14.7%) 
Scheduled Tribe 544 (1.4%) 180 (1.3%) 10 (1.0%) 
Other Backwards Caste 24,901 (63.1%) 9,094 (63.2%) 596 (62.8%) 
General 3,779 (9.6%) 1.654 (11.5%) 204 (21.5%) 
Missing 12 (<0.1%) 12 (<0.1%) 0 (0.0%) 
    
Highest level of Education Achieved 
No schooling 13,115 (33.2%) 8,072 (56.1%) 504 (53.1%%) 
Some schooling  18,708 (4749%) 5,034 (35.0%) 349 (36.7%) 
Higher secondary 
schooling or above 
4,039 (10.2%) 1,279 (8.9%) 97 (10.2%) 
Missing+  3,624 (9.2%) 1 (<0.1%) 0 
Occupation 
Not employed 30,225 (76.6%) 7,350 (51.1%) 609 (64.1%) 
Agriculture 3,111 (7.9%) 2,727 (18.9%) 176 (18.5%) 
Labor 3,346 (8.5%) 2,282 (15.9%) 45 (4.7%) 
Self-employed 1,920 (4.9%) 1,453 (10.1%) 81 (8.5%) 
Service/salaried 875 (2.2%) 572 (4.0%) 39 (4.1%) 
Missing 9 (<0.1%) 2 (<0.1%) 0 (0.0%) 
Illness in last 30 days 
Yes 15,824 (40.1%) 8,362 (58.1%) 871 (91.7%) 
No 23,642 (60.0%) 6,020 (41.9%) 79 (8.3%) 
Don’t know 11 (<0.1%) 2 (<0.1%) 0 (0.0%) 
Missing 9 (<0.1%) 2 (<0.1%) 0 (0.0%) 
Hospitalized in last year 
Yes 1,259 (3.2%) 704 (4.9%) 95 (10.0%) 
No 33,672 (85.3%) 13,674 (95.1%) 854 (89.9%) 
Don’t know 12 (<0.1%) 5 (<0.1%) 1 (0.1%) 
Missing+ 4,543 (11.5%) 3 (<0.1%) 0 (0.0%) 
Self-Rated Health* 
Average (SD)  3.9 (0.8) 3.7 (0.9) 3.3 (0.9) 
Legend: +Question not asked to children under the age of 5; *Self-rated health is assessed on a scale from 1 
(very poor) to 5 (excellent) 
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The NFHS-5 survey included blood pressure measurements for 45,459 individuals in Bihar. The 
provider assessment included 390 providers from 70 villages, 368 of whom (94.4%) said they 
would treat the hypothetical case who presented to the clinic in the vignette. (Table 3.3). 
 
Table 3.3: Provider assessment respondent characteristics 
 Private Providers (N = 319) Public providers (N = 71) 
Sex of Provider 
Male 311 (97.5%) 62 (87.3%) 
Female 7 (2.2%) 9 (12.7%) 
Missing 1 (0.3%) 0 (0.0%) 
Age of Provider 
Average (SD) 45 (14) 48 (11) 
Caste of Provider 
Scheduled Caste 31 (9.7%) 7 (9.9%) 
Scheduled Tribe 11 (3.5%) 4 (5.6%) 
Other Backwards Caste 165 (51.7%) 31 (43.7%) 
General 110 (34.5%) 28 (39.4%) 
Other 2 (0.6%) 1 (1.4%) 
Place of Residence 
Same Town/Village as clinic 238 (74.6%) 47 (66.2%) 
Other town/village 81 (25.4%) 24 (33.8%) 
Provider Training 
MBBS 15 (4.7%) 47 (66.2%) 
AYUSH 54 (16.9%) 18 (25.4%) 
Informal training 250 (78.4%) 0 (0.0%) 
Other allopathic medicine 0 (0.0%) 6 (8.5%) 
Years worked at facility 
Average (SD) 15 (13) 6 (6) 
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In the 70 villages where the provider assessment was conducted, 192 individuals self-reported a 
previous hypertension diagnosis. Of these 192 individuals, 85 were linked to the provider from 
whom they sought care (Figure 3.2). Twelve individuals were not linked to local providers 
because the provider was not found. Reasons for not finding these providers included (i) the 
provider was not able to be located based on information provided by the individual (n=7), (ii) 
the individual did not remember the name of their provider (n=3), and (iii) the provider was out 
of town for an extended period during the provider assessment (n=2). In total, our study 
administered the provider assessment to 83% of the providers from whom care was sought in the 
household survey. This compares favorably with the provider response rate from a previous 
study in India with similar study design, which reported a response rate of 41.9% among local 
providers (Das et al. 2020). Hypertension-related structural and process quality features were 
determined for public providers and MBBS-trained, AYUSH, and informal providers (Table 










Table 3.4: Supply-side quality characteristics 
Domain Operational Indicator Private- 
MBBS  
(n = 15) 
Private-
AYUSH 
(n = 54) 
Private-
Informal 
(n = 250) 
Public 
 





Percent of providers with a functioning blood 
pressure measurement device* 





Percent of patients over age 30 screened for high 














Percent of providers who checked blood pressure 
once during vignette 





Percent of providers who checked blood pressure 
twice during vignette 





Percent of providers who are able to correctly 
diagnose hypertension during vignette * 





Percent of providers who have amlodipine in stock 
on day of survey* 





Percent of providers who have hydrochlorothiazide 
in stock on day of survey* 





Percent of providers who have atenolol in stock on 
day of survey* 






Percent of providers who refer a newly diagnosed 
hypertensive patient to a PHC  





Percent of providers who write a newly diagnosed 
hypertensive patient an appropriate prescription 





Percent of providers who write a newly diagnosed 
hypertensive patient a harmful prescription 





Percent of providers who explain to a newly 
diagnosed patient that hypertension is a lifelong 
condition requiring daily monitoring and treatment 
during vignette 
0.0% 0.0% 4.3% 9.8% 
Legend: *Indicates a significant difference between provider types at the alpha = .05 level 
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Table 3.5: Expanded cascade of hypertension care in Bihar, India 




True Population in 
Need (A) 
Percent of population 
with blood pressure 




Hypertension prevalence is 
17.0% in adults age 15-49 




Percent of population 
with high blood 
pressure who have had 
previously had blood 
pressure measured 
according to standards 
77.5% of adults age 30 and 
older had ever had their 
blood pressure measured 
by a health worker 
30.1% of adults over the 
age of 30 presenting to 
clinics during direct 
observations had their 
blood pressure measured 
by a provider 
Population 
Diagnosed (C) 
Percent of population 
with high blood 
pressure who were 
previously diagnosed 
by a health worker  
8.1% of adults ever 
screened before reported a 
previous diagnosis of 
hypertension from a health 
worker 
74.2% of providers were 
able to correctly diagnose 
a new case of 
hypertension 
Population linked 
to any care (D) 
Percent of population 
with high blood 
pressure who are 
linked to any treatment 
95.8% of adults with a 
previous hypertension 
diagnosis visited a health 
worker to manage 
hypertension in the last 
year  




82.3% of providers 
treated a case of 







to standards (E) 
Percent of population 
with high blood 
pressure who are 
linked to quality 
treatment 
4.7% of hypertensive 
individuals received their 
usual care from providers 
who are known to provide 
quality care 
59.3% of providers who 
accurately diagnosed 
hypertension wrote 
prescriptions that were 





treatment (F)  
Percent of population 
receiving quality 
treatment and adhering 
to treatment as 
prescribed 
45.9% of those who sought 
care saw providers at least 
4 times a year  
4.8% of providers would 
advise newly diagnosed 
patients that hypertension 
is a lifelong condition 




Percent of population 
with controlled blood 
pressure 
9.5% of adults with a 
previous hypertension 
diagnosis have ever been 
hospitalized because of 
their hypertension (4.6% in 
the past year) 
NA 





True Population in Need 
The NHFS-5 estimates that the state-wide prevalence of hypertension is about 17.0% among 
individuals over age 15 in rural Bihar. This equates to about 9.5 million individuals in rural Bihar 
who are somewhere on the hypertension management cascade and in need of health services 
(Annex 7).  
 
Population Screened 
Of the 14,386 individuals in the survey aged 30 or over, 77.5% had ever had their blood pressure 
measured by a health worker before the survey date (95% CI from 76.3% to 78.6%). For rural 
Bihar, this equates to an age- and sex-standardized 76.2% of adults who have ever been 
screened, meaning there are some 13.3 million adults aged 15 or older in Bihar who have never 
had their blood pressure measured. From the provider assessments, 90.9% of all providers had a 
functioning blood pressure measurement device at the time of the assessment. Across patient 
observations, 30.1% of patients over the age of 30 who presented to primary care providers had 
their blood pressure measured. Patients aged 30 or older presenting to private primary care 
providers were significantly more likely to have their blood pressure measured than those 
presenting to public providers (36.5% versus 19.7%). Among private providers, formally trained 
providers checked adult blood pressure more frequently than informal providers (MBBS 
providers checked blood pressure in 70.0% of visits, AYUSH providers checked blood pressure 






In the household survey, 6.3% of all adults over the age of 30 reported ever being diagnosed with 
hypertension by a health worker. The percent of adults over age 30 reporting a hypertension 
diagnosis increased to 8.1% among those who had been ever had their blood pressure measured 
before. Additionally, the prevalence of self-reported hypertension among those over the age of 
50 increased by age group from 7.2% of adults age 50-59 to 10.9% of adults age 60-69, rising to 
15.2% of those 70 and older. The age-standardized prevalence of hypertension in rural Bihar was 
estimated at 5.2%. On average, people with a hypertension diagnosis learned about their 
diagnosis 5.2 years ago, but 20.1% of diagnoses occurred within the last year. Of the providers 
surveyed who would treat the case, 74.2% were able to correctly diagnose a new case of 
hypertension in a clinical vignette. While 87.3% of public providers were able to correctly 
diagnose hypertension, private providers were less likely to correctly diagnose hypertension in a 
vignette (85.7% of private MBBS providers, 71.7% of private AYUSH providers, and 70.0% of 
private informal providers). Common incorrect diagnoses included headaches, migraines, or no 
diagnosis.  
 
Population Linked to Any Care 
Of the 950 individuals over age 30 with self-reported hypertension, 95.7% were taking any 
antihypertensive medication in the last 12 months and 95.8% visited a health worker in the last 
year to manage their hypertension. The majority availed services from the private sector (46.4% 
from private doctors and clinics, 18.9% from pharmacies or compounders, 14.5% from private 
hospitals, and 14.3% from traditional healers). Among the 5.6% of individuals who sought care 
from the public sector, the majority (58.8%) sought care from district hospitals. Of the 390 
 125 
providers included in the study, 94.6% report treating hypertension and 82.3% of providers 
treated a hypertensive patient in the last 6 months. From the clinical vignette, 91.2% of providers 
who correctly diagnosed a case of hypertension stated they would treat the individual at their 
clinic. The majority (55.7% of providers) would treat without further referral, but 35.5% of 
providers would refer the patient to another clinic while starting some treatment. The availability 
of three first-line antihypertensive therapeutics – a calcium channel blocker (amlodipine), a 
thiazide diuretic (hydrochlorothiazide), and a beta-blocker (atenolol) – was assessed. Across 
providers, 40.0% were unable to offer any antihypertensive medication and 12.0% had all three 
types of medication. The most commonly available antihypertensive therapy was amlodipine 
(available from 51.5% of providers) and the least commonly available medication was 
hydrochlorothiazide (available from 23.1% of providers). 
 
Population Linked to Quality Care 
The perceived quality of hypertension management services was an important consideration for 
individuals in their care-seeking decisions. Of the 933 individuals who sought hypertension 
management services from the private sector, 62.2% did not seek hypertension treatment from 
their local PHC due to the low perceived quality of care. This resulted in people traveling an 
average of 29.2 kilometers (95% confidence interval of 20.9 to 37.5 kilometers) to seek 
hypertension management services. Across providers, there were gaps in the process quality of 
hypertension treatment in the clinical vignettes. While 92.1% of all providers measured blood 
pressure once, only 16.9% of providers measured blood pressure a second time to confirm 
diagnosis in the vignette. A suite of lifestyle modifications was infrequently recommended as 
treatment: while 81.6% of all providers recommended reducing salt intake and/or having a 
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healthy diet, 39.2% advised regular exercise or physical activity, and only 3.0% advised the 
patient to stop smoking. Among the 325 providers that correctly identified the patient in the 
vignette as hypertensive, 59.3% of prescriptions were rated as appropriate for safely reducing 
blood pressure, 15.8% were rated as inappropriate, but not harmful, and 11.0% were rated as 
harmful to the patient. The safety of 2.9% of prescriptions could not be determined because they 
contained non-allopathic treatments.  
 
In villages where provider quality was known, of the 192 individuals previously diagnosed as 
hypertensive, nearly half (44.3%) traveled more than 5 kilometers away to receive care and the 
quality of these providers was unknown. Nearly a quarter of individuals (23.4%) sought care 
from local providers who did not demonstrate basic knowledge of hypertension diagnosis and 
treatment and a further 7.3% sought care from medical stores whose operators were unable to 
complete the provider assessment due to lack of medical knowledge. Of the 192 hypertensive 
individuals, 36 (18.8%) were receiving care from providers who were able to accurately 
diagnose an individual as hypertensive, and who wrote an appropriate prescription to safely 
lower blood pressure. In total, the quality-adjusted coverage of hypertension management 
services in rural Bihar is as low as 18.8% and as high as 69.4% if all of the unsampled providers 




Figure 3.3: Individual hypertension care-seeking in villages where provider quality assessments 
were conducted (n=192) 
 
Legend: *A provider is considered to be of sufficient quality if during a clinical vignette simulating care for a 
hypertensive patient, they (i) correctly diagnose a hypertensive patient, and (ii) write a prescription that is 
deemed appropriate for safely lowering the patient’s blood pressure.  
 
 
Population Adhering to Prescribed Treatment 
On average, people who sought care outside of the home to manage their hypertension had 4.8 
visits to a provider per year. The median monthly amount spent on hypertension management is 
250 rupees (US$3.35). From the provider assessment, providers did not generally provide 
feedback on the chronic nature of hypertension. In clinical vignettes, among providers who gave 
a new diagnosis of hypertension, 4.8% indicated that they would explain that hypertension is a 
lifelong condition requiring daily treatment and 14.1% advised that patients would need to 
regularly monitor their high blood pressure.  
 
Provider not found for 
interview
6.3%
Bypassed all local 
providers (>5 km away)
44.3%Went to low quality* 
providers
23.4%
Went to medical stores 
(assumed poor quality)
7.3%




Population Achieving Health Gain 
In general, self-rated health was significantly higher among adults age 30 and older who had not 
been diagnosed with hypertension than adults who had been previously diagnosed as 
hypertensive. Among respondents who were aware of their high blood pressure, 9.5% had ever 
been hospitalized due to their hypertension. This includes 4.6% of hypertensive aware patients 
who were hospitalized for chest pain, cardiovascular problems, or hypertension in the past year.  
 
Expanded Hypertension Care Cascade 
When the results are graphed along the expanded hypertension care cascade, the major barriers 
to achieving effective coverage of hypertension management services are revealed (Figure 3.4). 
There are some 6.6 million individuals over age 30 in rural Bihar with hypertension who have 
not been diagnosed (Steps A-C). The majority of these people (4.5 million) have had their blood 
pressure measured by a health worker at some point, but remain undiagnosed (Steps B-C). This 
represents the largest gap on Bihar’s expanded hypertension care cascade. However, an 
additional 2.1 million people with hypertension have never had their blood pressure measured by 
a health worker (Steps A-B). The second major gap is among diagnosed hypertensives who are 
linked to quality care (Steps E-F). Even though the majority (95.8%) of diagnosed hypertensive 
individuals are linked to some care, only between 18.8% and 69.4% are linked to providers who 
provide quality care. This means that between 0.8 and 2.2 million people in rural Bihar are 








Figure 3.4: Expanded hypertension care cascade for adults over age 30 in rural Bihar and 
confidence intervals 
 
Legend: *The point estimate for population with health benefit is hypertensive individuals who had not been 
hospitalized for their condition. The confidence intervals for population with health benefit are an estimation 





This study identifies gaps on the hypertension care cascade and suggests areas for intervention to 
improve the management of hypertension at the primary care level. The majority of individuals 
in need of hypertension services have either never been screened for high blood pressure or have 
been screened at some point but have not been diagnosed by a health worker. When compared 
with a similar population (rural adults aged 30-54) in the NFHS-49, these same steps are 
consistently where most people are lost along the hypertension care cascade (Figure 3.5). This 
 
9 NFHS-4 data are used for validation because access to the full NFHS-5 was not granted to the author before the 


















































study contributes the important additional finding that the quality of hypertension management 
services in rural Bihar is low, potentially preventing millions of people from achieving effective 
hypertension management. Results from the provider assessments provide insight on areas for 
health system-wide intervention. 
 






At least three distinct factors reduce successful hypertension management at the primary care 
level in Bihar: a lack of service readiness, missed opportunities, and inadequate process quality. 
Each of these bottlenecks negatively impacts services along several stages of the hypertension 
cascade. The first gap is caused by insufficient structural quality of providers, who are lacking 
the supplies needed to diagnose and treat high blood pressure. Over ten percent of private 
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measurement device, prohibiting any kind of blood pressure measurement or screening. Even if 
providers could successfully diagnose an individual with high blood pressure, 39.6% were not 
able to offer any front-line antihypertensive therapeutics, meaning that a substantial percent of 
providers are not prepared to initiate treatment upon diagnosis. There are a range of factors that 
contribute to a lack of available medicines, including logistics and supply chains, procurement 
preferences, and marketing of medicines. However, it is important that public and informal 
providers alike should be stocked with functioning blood-pressure measurement devices and a 
supply of antihypertensive medication to ensure that providers are able to screen patients for high 
blood pressure, diagnose new cases, and immediately initiate treatment.  
 
Beyond having an appropriate supply of equipment and medications, providers should take 
advantage of opportunistic screening to improve hypertension management. According to India’s 
national hypertension guidelines, all adults over the age of 18 are supposed to be screened during 
each interaction with the health system (Ministry of Health and Family Welfare 2016). Despite 
these recommendations, only 30.1% of adults over age 30 (and 29.7% of adults age 18 and older) 
who presented to clinics had their blood pressure measured. The guidelines also state that 
hypertension diagnoses should be made at primary health clinics (Ministry of Health and Family 
Welfare 2016). Some 47.4% of private providers said that they would not refer a newly 
diagnosed hypertensive patient to a PHC, therefore missing another opportunity to officially 
confirm the diagnosis according to national guidelines. Given the fact that the majority of all care 




Screening, diagnosis, and treatment capabilities of providers in rural Bihar are inadequate. Only 
16.9% of providers measured blood pressure twice during clinical vignettes, which may result in 
misclassification of hypertension diagnoses. Even if providers were able to identify a case of 
hypertension, only 59.3% were able to write an appropriate prescription which could safely 
lower a patient’s blood pressure. Additionally, less than 5% of providers informed newly 
diagnosed hypertensive patients of the chronic nature of their disease and the actions required to 
treat it. Among all providers included in the study, only 8.5% measured blood pressure twice, 
were able to diagnose a new case of hypertension, and wrote an appropriate prescription to lower 
blood pressure. As previously described in India, the quality of care is an important determinant 
of facility choice among households with hypertension (Kujawski et al. 2018). The likelihood of 
receiving high quality hypertension care from a provider in rural Bihar is astonishingly low. In 
summation, public and private providers alike require training on how to properly measure blood 
pressure, diagnose hypertension, and provide appropriate advice and pharmaceutical therapy.  
 
Findings from this study are subject to some important limitations. First, the household survey 
study design was cross-sectional and did not include biometric measurements of blood pressure. 
This means that neither elevated blood pressure nor blood pressure control could be measured in 
the household survey, adherence over time could not be tracked, and that all estimates are based 
on self-reported hypertension diagnosis. One implication is that this study’s estimate of step G, 
the population achieving health gain, is larger than previous steps, which is unusual for care 
cascades. The NFHS study’s large sample size and standard methodology provide reliable and 
valid estimates of hypertension and can be used as an estimate for the population achieving 
health gain - future studies should compare hypertension management in the state over time 
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using these data sources. Additionally, previous studies have demonstrated validity between self-
reported and true hypertension status, suggesting that this is an acceptable method for data 
collection (Najafi et al. 2019). Second, the clinical vignettes were not measurements of what 
providers did in practice and only four consultations to manage hypertension were directly 
observed. While studies have demonstrated correlations between provider competence and 
provider actions, there is typically a gap between the two (Das and Hammer 2014; Leonard and 
Masatu 2010). However, the knowledge of providers is generally regarded as the upper limit of 
what a provider can do, so our estimates of provider quality are likely to be conservative in 
nature. Third, the study design was limited to assessments of providers utilized in local rural 
markets (within 5 km of a sampled village). While the majority of individuals with hypertension 
sought care from providers within 5 kilometers of their home (55.6%), over a quarter of 
individuals (28.2%) traveled more than 20 km to receive treatment, indicating that people may 
have been traveling to urban centers to seek care where the perceived quality of care was higher. 
Fourth, due to a lack of standardized metrics and available data, it is difficult to measure the 
percent of population linked to quality care and the percent of the population adhering to 
prescribed treatment with confidence. Although this study attempts to describe the percent of 
individuals linked with quality care (Figure 3.3), the quality of care is unknown for 50.5% of 
providers utilized. Future studies should endeavor to advance the measurement of quality of care 
provided by the health system and individual adherence to treatment. The primary strength of 
this study is that it provides insight into both the supply- and demand-side characteristics of 
hypertension management in a setting undergoing epidemiological transition.  
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Our findings for rural Bihar reinforce the conclusions of Prenissl and others that the majority of 
individuals in India with high blood pressure have either never been screened or are not aware of 
their condition, (i.e., they have not been diagnosed as hypertensive) (Prenissl et al. 2019). 
Community-based screening efforts could help to fill this gap, as proactive screening and 
diagnosis could help to identify hypertension individuals and initiate treatment sooner, however 
the quality of care in Bihar must also be improved in order to achieve improved health outcomes 
for more people. This study adds insights about the health systems bottlenecks that are 
preventing individuals from achieving blood pressure control. Namely, a lack of provider 
knowledge on how to properly diagnose and treat patients, combined with a lack of provider 
action to opportunistically screen individuals are contributing to the large number of 
hypertensives that are either unscreened or undiagnosed. Interestingly, this study suggests that 
once individuals actually become aware of their high blood pressure status, the vast majority, 
including those in rural Bihar, are able to access care. However, the quality of care received by 
individuals in rural Bihar is generally quite low across provider types, which contributes to 
reduced rates of effective blood pressure management. Future efforts to measure the effective 
coverage of hypertension management services in LMICs should consider the coverage and 
quality of a range of services associated with blood pressure control, including screening, 




The expanded hypertension care cascade is a useful framework for understanding the state of 
hypertension management and should be considered for wider use in hypertension and other 
chronic disease research in LMICs. This framework goes beyond the traditional cascade of care 
and demonstrates that there are gaps both in the access to screening services and in the ability of 
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providers to correctly diagnose hypertensive patients. Although improving screening and 
diagnosis services would have the largest impact on retaining people in the care cascade, this 
study indicates that the quality of care provided in rural Bihar is low. With the rising burden of 
non-communicable diseases and hypertension in Bihar, increasing screening practices without 
first adequately preparing providers and clinics would be irresponsible. Without first improving 
quality of care, patients newly linked to care are not likely to experience health gains, and may 
even suffer from adverse effects from the large proportion of providers who are unable to 
effectively provide hypertension management services.  
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Chapter 4: An Index for Measuring Effective Coverage of Hypertension 




Background: Given the rising prevalence of high blood pressure in low- and middle-income 
countries, there is an urgent need to assess health system ability to manage hypertension in the 
population. We describe a comprehensive approach for measuring effective coverage of 
hypertension management services, and apply the method to rural Bihar, India.  
Methods: Information from two state-representative household surveys and a provider 
assessment (including a facility readiness survey and a clinical vignette) was used to calculate a 
“hypertension management service coverage index” (HMSCI). The HMSCI combines service 
coverage measures (percent of adult population screened, percent of hypertensives previously 
diagnosed, and percent of diagnosed hypertensives currently taking anti-hypertensive drugs) with 
structural and process quality measures (readiness, examinations, diagnosis, advice, and 
prescription– all rated on a scale from 0-1) to calculate effective coverage.  
Results: Coverage of key hypertension management services in rural Bihar is 69.5% but the 
effective coverage of these services is 31.3%. Quality of hypertension management services is 
uniformly low across Bihar. Providers are most proficient in diagnosing hypertension (0.69), but 
least proficient in providing lifestyle advice (0.41) and correctly examining patients for 
hypertension (0.42). Public providers (0.77) and privately trained allopathic doctors (0.75) 
provide significantly higher quality hypertension care than private providers practicing Indian 
systems of medicine (0.58) and informal providers (0.59).  
Conclusions: Effective coverage of hypertension management care is substantially lower than 
service coverage, limiting hypertension management in rural Bihar. Improvements in the quality 
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of hypertension care are necessary to address the rising burden of hypertension in rural Bihar and 






Over a decade has passed since the 2010 global burden of disease study determined that high 
blood pressure is the leading risk factor for loss of healthy life years globally, yet little has been 
done to measure and monitor health system capacity to properly manage hypertension at the 
population level. The scientific community has identified several evidence-based, cost-effective 
interventions for blood pressure management to prevent cardiovascular disease in low- and 
middle-income countries (LMICs), including reducing salt intake, increasing physical activity, 
stopping tobacco use, and prescribing (and adhering to) antihypertensive medication in high risk 
patients (Murray et al. 2003; Bertram et al. 2018; Kostova et al. 2020; World Health 
Organization 2010). These interventions can be implemented through primary health care 
systems and could potentially avert between 1.4 and 1.8 million deaths per year if delivered at 
scale and following clinical guidelines in LMICs (Lim et al. 2007; Bertram et al. 2018; Kontis et 
al. 2019). Despite the clear benefits of improving hypertension management, little progress has 
been made to assess the coverage of high-quality hypertension management services.  
 
The quality of health services provided in low- and middle-income countries is garnering 
increased attention in the global health literature (Kruk, Larson, and Twum-Danso 2016). This is 
an essential paradigm shift, as increases in coverage of health services do not result in better 
population health outcomes unless the services provided are of adequate quality (Boerma et al. 
2018; Larson et al. 2017; Kruk et al. 2018). Quality of care is a complex concept that has several 
components including structure (the physical and organizational features of healthcare settings), 
process (the delivery of health services), and outcomes (the health benefits received by 
individuals and populations as a result of care) (Donabedian 1988). Adequate structural quality is 
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necessary for high quality services, but does not guarantee that services will be delivered 
according to evidence-based standards. Measuring quality of care solely based on health 
outcomes has the benefit of being directly linked to population health, but does not indicate how 
to improve the process of delivering care. Additionally, health outcomes are influenced by social 
determinants of health, which exist beyond the health system and may reduce the direct link 
between services provided and health status. Quality of care has been incorporated into 
measurement of service coverage through the effective coverage metric.  
 
Effective coverage measures the fraction of potential health gain actually delivered through the 
health system to populations in need, and is estimated by multiplying the utilization (0 if not 
utilized and 1 if utilized) and quality of a service (scaled between 0, lowest quality, and 1, 
optimal quality), conditional on the need for the service (Shengelia et al. 2005). Since effective 
coverage can be calculated at the individual level, averaged across interventions, and aggregated 
to sub-national and other various units of analysis, it has been adopted as a metric for monitoring 
overall health systems performance, including progress towards Universal Health Coverage 
(UHC) (Ng et al. 2014). Key studies have calculated effective coverage scores within specific 
services (e.g. obstetric care), for multiple services at the national level (e.g. in Mexico), and 
across multiple services and countries (Larson et al. 2017; Lozano et al. 2006; Hannah H Leslie 
et al. 2017). Despite the growing interest in measuring effective coverage, little has been done to 
apply the concept specifically to hypertension management services. 
 
Basic services to manage hypertension can be provided at low cost at the primary care level, 
either at facilities or in communities. In Bihar’s pluralistic health system, a number of actors 
 140 
provide primary health care services, including public providers (who work in primary health 
centers or community health centers), private allopathic providers (clinicians with Bachelor of 
Medicine, Bachelor of Surgery degrees, or MBBS providers), private alternative medicine 
providers (practitioners with degrees in Ayurveda, Yoga and Naturopathy, Unani, Siddha and 
Homeopathy, or AYUSH providers), and private informally trained providers (called IPs). A 
range of services are involved in providing effective hypertension care. First, at-risk populations 
must have their blood pressure measured regularly and accurately. Next, a health worker must be 
able to correctly diagnose an individual as hypertensive and communicate the implications of a 
diagnosis to a patient. Third, the health worker must prescribe an appropriate regimen of 
appropriate lifestyle changes and pharmaceutical therapies, adapting the regimen as necessary 
based on the patient’s response to treatment until blood pressure is lowered to a non-elevated 
level.10 Finally, the patient must adhere to the recommended regimen and maintain a healthy 
level of blood pressure. Previous efforts to measure effective coverage for blood pressure 
management tend to either focus on select parts of these services (e.g. screening) or solely on 
outcome measures of normal blood pressure, however there is no consensus on a single metric 
(Charoendee et al. 2018; Yang Zhao et al. 2020). A scoping review found that effective coverage 
for hypertension management has been defined in at least eight different ways (Chapter 2). In 
part because there is no single indicator for tracking effective coverage of hypertension 
management services, hypertension has not been incorporated into overall indices for measuring 
health systems performance and progress towards UHC (Table 4.1). As a result, none of the 
indicators used to track UHC are currently measuring health system ability to provide effective 
 
10 The definition of elevated blood pressure varies based on the guidelines used. In accordance with national Indian 
guidelines, elevated blood pressure is defined as systolic blood pressure greater than 140 mm Hg or diastolic blood 
pressure greater than 90 mm Hg (Shah and Association of Physicians of India 2019) 
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services to manage hypertension. Whereas immunization, antenatal care, and HIV/AIDS services 
each regularly appear in these indices, hypertension management is neglected. Given the 
substantial global burden of hypertension, this is a major shortcoming in the UHC monitoring 
framework that requires urgent attention.   
 
Table 4.1: Universal health coverage monitoring indices and consideration of hypertension 
management 





World Bank service 
coverage index (2020) 
 
(Boerma, AbouZahr, et 
al. 2014; Wagstaff et al. 
2015; Boerma, Eozenou, 
et al. 2014) 
None “We excluded… hypertension treatment  and 
diabetes treatment mostly  on  the  grounds 
that  few household surveys collect the 
necessary data.” 
WHO UHC service 
coverage index (2019) 
 
(World Health 
Organization and World 
Bank 2019) 
Age-standardized  
prevalence of non-raised 
blood pressure (systolic  
blood  pressure  <  140  mm  
Hg  and  diastolic  blood  
pressure  <  90  mm  Hg)  
among adults aged 18 years 
and older 
 
(proxy for health promotion 
and medical services) 
Alternative indicator: “Measure of treatment 
coverage among people with hypertension” 
 
“Measuring  effective  treatment  coverage is 
also a priority, particularly since linked 
individual-level data on disease prevalence, 
treatment status, and clinical  control  are  
increasingly  available  for  people  with  
hypertension and diabetes” 
GBD 2019 - UHC 
effective coverage index  
 




None “Due to limited data quantity or quality (or 
both), we could not include several original 
candidates for effective coverage indicators 
including some expressly recommended by 
the GPW13 ERG, including effective 
management of hypertension and diabetes” 
GBD 2017 – UHC 
service coverage index 
for SDGs  
 
(Lozano et al. 2018) 
None Not acknowledged 
Health service coverage 
index 
 
(Leegwater, Wong, and 
Avila 2015) 




India, like many LMICs, is suffering from a steadily rising burden of hypertension (Devi et al. 
2013). In 2015, the national prevalence of hypertension was 18.1% among those under the age of 
50, with substantial gaps in screening, awareness, treatment, and hypertension control (Prenissl 
et al. 2019). Although the country has made a commitment to increasing access to primary care 
services to treat non-communicable diseases (NCDs), little is known about the quality of services 
actually provided by public and private providers to manage high blood pressure in India. 
Studies have demonstrated a wide variation in the quality of primary care more generally across 
the nation, with formally trained providers in impoverished states like Bihar performing 
significantly worse than informal providers in other states, but these studies did not focus on 
hypertension management or other NCDs (Das et al. 2020). Furthermore, the quality of 
hypertension management services, specifically process quality, seems to drive patient choice in 
provider for hypertension management in India (Kujawski et al. 2018). Gaps along the pathway 
to effective coverage of hypertension management services have been identified in rural Bihar, 
India, but effective coverage of the services associated with hypertension management has not 
been adequately measured in the state or the country (Chapter 3). Summary measures of 
effective coverage that can be calculated nationally, sub-nationally, and across various 
sociodemographic characteristics can promote equitable action and strengthen accountability for 
improving provision of services. There is currently no such summary measure for monitoring the 
effective coverage of hypertension management services. This study describes a comprehensive 
approach for measuring effective coverage of hypertension management services, and illustrates 
the application of this approach to estimate effective coverage of hypertension management 






Bihar is amongst the poorest states in India with a population of about 100 million, making it 
more populous than all but 14 countries in the world. The state is located in northeast India, 
covers a total area of about 95,000 square kilometers (about the same size as Portugal), and is 
geographically dominated by the Ganges River and its floodplains. Despite its immense 
population in a relatively small geographic area, 88.7% of the population is considered to live in 
rural areas (Office of the Registrar General & Census Commissioner 2011). Bihar is comprised 
of 38 districts split into 9 divisions. Although the population is relatively young, Bihar is 
currently experiencing epidemiologic transition and is suffering from a double burden of acute 
and chronic conditions (42.6% of disease burden is due to communicable disease, 47.6% is due 
to noncommunicable disease) (Indian Council of Medical Research, Public Health Foundation of 
India, and Institute for Health Metrics and Evaluation 2017). As in many other states in India, 
Bihar has a pluralistic health system in which both allopathic and homeopathic systems of 
medicine are practiced. 
 
Data Sources 
A hypertension management services coverage index (HMSCI) is proposed to estimate effective 
coverage of hypertension services. Calculation of the HMSCI is primarily based on a linked 
household survey and provider assessment in rural Bihar, from the Assessment of Primary 
Health Care in Bihar (APHCB) study. The sample size motivations and details of this study have 
been previously described (Chapter 1). Briefly, the household survey was a multi-stage cluster 
sampling survey designed to provide division-representative estimates of individual care-seeking 
behaviors in rural Bihar. The survey did not include biometric data, however adults aged 30 and 
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older indicated whether they had ever had their blood pressure measured by a health worker, 
whether they had been previously diagnosed with hypertension by a health worker, and if so, 
characteristics of the care they receive to manage their hypertension. All members of sampled 
households indicated the facilities/providers from which they sought any health care services, 
including those to manage hypertension, in the last 30 days. Local private providers (those within 
5 km of the sampled village) identified in the household survey and providers at the nearest 
Primary Health Clinic (PHC) comprised the sampling frame for the provider assessment.   
 
In one fifth of sampled villages from the household survey, provider assessments were 
administered to all identified sources of health care services, including public providers, private 
providers with formal training, practitioners of Indian systems of medicine, and informally 
trained providers. The provider assessment included a facility readiness assessment, used to 
determine structural quality of the caregiving setting, and clinical vignettes to indicate a measure 
of process quality. In a clinical vignette, a provider is presented with a hypothetical case and 
indicates the process of history-taking questions, examinations, diagnosis, and treatment she 
would perform for that patient. Although some researchers have noted a gap between what 
clinicians say they will do in vignettes and what they actually do in practice, an emerging body 
of evidence suggests that provider knowledge, as assessed by clinical vignettes, is a valid 
measure of the process of care provided in actual clinical practice (Leonard and Masatu 2005; 
Peabody et al. 2000; Dresselhaus et al. 2004). The vignette methodology has been used 
extensively to assess an upper bound of a provider’s ability to provide quality care in India and 
other LMICs (Das et al. 2020; Das and Hammer 2014, 2005, 2007). The vignette used to assess 
provider quality of care for hypertension management was based on a hypothetical 55-year-old 
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female patient who presents to a clinic with a headache and a previous high blood pressure 
reading (Annex 8). The vignette was designed in consultation with doctors and pilot tested with 
local primary care providers in Bihar for psychometric validation. Interviewers were trained on 
how to provide standard responses throughout the vignette administration.  
 
This study also employs data from Bihar’s portion of the 2014-2015 National Family Health 
Survey (NFHS-4). The NFHS-4 is a national survey conducted on a sample of women aged 15-
49 and men aged 15-54 that is representative at the district level (International Institute for 
Population Sciences (IIPS) and ICF 2017). NFHS-4 includes biometric information, including 
blood pressure measurements, from a sample of women and men.  
 
Index Development 
The HMSCI was developed based on a conceptual model of how hypertension management 
services contribute to improved health among individuals with raised blood pressure (Figure 
1.3). This conceptual model demonstrates that the effect of the use of hypertension management 
services on health gains is influenced by the quality of these services, necessitating a 
representation of quality-adjusted coverage. The HMSCI also relies on the framework used to 
calculate effective coverage, where the coverage of services is adjusted by service quality 
(Shengelia et al. 2005). The index was constructed following an internationally recognized 
methodology for constructing a composite indicator (Nardo et al. 2005; Saltelli 2007) (Table 
4.2). The HMSCI was calculated for Bihar, India, and consists of a composite measure of 
hypertension management service coverage, adjusted by a composite quality of service score.  
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Table 4.2: Steps for the construction of the hypertension management services coverage index 
Step Description Application to study 
Theoretical 
framework 
A theoretical framework should be 
developed to provide the basis for the 
selection and combination of single 
indicators into a meaningful composite 
indicator under a fitness-for-purpose 
principle. 
Two theoretical frameworks are used- the 
expanded care cascade for hypertension 
management for the concepts related to 
hypertension management and the effective 
coverage framework for constructing a 
composite indicator of effective coverage 
Data selection Indicators should be selected on the basis 
of their analytical soundness, 
measurability, country coverage, relevance 
to the phenomenon being measured and 
relationship to each other. The use of proxy 
variables should be considered when data 
are scarce.  
Indicators for service coverage were selected 
based on their ability to be measured at the 
population level. 
 
Indicators for quality were selected based on 
their relevance as assessed by clinical experts 




An exploratory analysis should investigate 
the overall structure of the indicators, 
assess the suitability of the data set and 
explain the methodological choices, e.g., 
weighting, aggregation. 
Exploratory analyses found that certain 
individual characteristics were associated with 
likelihood of blood pressure measurement and 




Consideration should be given to different 
approaches for imputing missing values. 
Extreme values should be examined as they 
can become unintended benchmarks.  
Missing blood pressure measurements were 
addressed by referencing a survey (NFHS-4) 
that took blood pressure measurements. 
Normalization Indicators should be normalized to render 
them comparable. 
All coverage indicators are normalized on a 
scale of 0-100% coverage of quality services 
Weighting and 
aggregation 
Indicators should be aggregated and 
weighted according to the underlying 
theoretical framework. 
Individual coverage indicators were calculated 
using weights to account for survey design. 
Coverage of services was equally weighted 
using the geometric average, and the final 
coverage index was multiplied by quality (rather 




Analysis should be undertaken to assess the 
robustness of the composite indicator in 
terms of e.g., the mechanism for including 
or excluding single indicators, the 
normalization scheme, the imputation of 
missing data and the choice of weights. 
Multiple measures of coverage (including 
contact with any provider in the last year vs 
taking any antihypertensive medication) and 
quality were assessed to determine stability of 
the effective coverage index.   
Links to other 
variables 
Attempts should be made to correlate the 
composite indicator with other published 
indicators as well as to identify linkages 
through regressions. 
In an assessment of validity, the HMSCI was 
compared with other potential measures of 
effective coverage 
Visualization Composite indicators can be visualized or 
presented in a number of different ways, 
which can influence their interpretation. 
The HMSCI was mapped to demonstrate 
variation in service coverage and effective 
coverage across the state 
Back to the real 
data 
Composite indicators should be transparent 
and be able to be decomposed into their 
underlying indicators or values.  
The methods section describes in detail the 
calculation of the individual coverage indicators 





The HMSCI is composed of coverage indicators for three services related to hypertension 
management and is adjusted by a composite quality score (incorporating dimensions of structural 
and process quality) for providers. The three coverage indicators are: (i) screening of the general 
population, (ii) hypertension diagnosis, and (iii) linkage to care (Table 4.3). These three 
indicators are selected based on the conceptual framework and represent the coverage of 
preventive services in the general population, the coverage of diagnostic services in the 
hypertensive population (both measures of secondary prevention), and the coverage of tertiary 
prevention services (hypertension treatment). While an indicator for the coverage of primary 
preventive services is missing, these indicators represent a more complete understanding of the 
services provided to an individual throughout the life-course, an essential component of 
measuring UHC  (Lozano and GBD 2019 Universal Health Coverage Collaborators 2020; 
Fullman and Lozano 2020). Appropriate survey weights were utilized to account for the design 
of each of the surveys and calculate division-wide estimates of the percent of individuals in need 
of each service who receives it. Overall coverage of the three services is calculated using the 
geometric average of the three individual service coverage scores. The geometric mean is used 
because it takes account of positive synergies and negative externalities that are not accounted 




Table 4.3: Calculation of coverage components of the hypertension management services 
coverage index  
Service Numerator (use) Denominator (need) Data source 
General population 
screening 
Number of adults over 
30 who have ever had 
their blood pressure 
measured 







Percent of adults over 




Percent of adults over 
30 who are considered 
to have high blood 








Linkage to care Number of adults over 
30 who have taken a 
medication to lower 
blood pressure in the 
last 12 months 
Number of adults over 





Legend: *An individual is considered to have high blood pressure if (i) the average of the second two systolic 
blood pressure measurements was 140, (ii) the average of the second two diastolic blood pressure 




The quality score for individual providers is calculated using items from the facility assessment 
and from the examination, diagnosis, advice, and treatment sections of the hypertension vignette 
for a total of five quality domains (Table 4.4). Previous studies analyzing results from clinical 
vignettes have combined scores on individual items into an index using weights generated 
through item-response theory, weights based on relative importance of items based on guidance 
from clinicians, and through simple averages of included items (Das and Hammer 2005; Peabody 
et al. 2000; Leonard and Masatu 2005). To enhance transparency, this study utilizes the simple 
average calculation method, though four alternative index aggregations were calculated and 
compared (Annex 9). Items in the final index are included based on three clinicians’ 
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assessments11 of the most important aspects of hypertension management. Across a quality 
domain, the number of goods available (in the facility assessment) or actions taken (in the 
vignette) are summed and then divided by the total number of relevant items in each domain. To 
assess the appropriateness of treatment, a standard protocol was employed by two clinicians to 
judge whether prescriptions written by sampled providers would likely result in a healthy 
reduction in blood pressure over time using a standard protocol (Annex 5). For each provider, the 
average domain-wise score was summed and then divided by 5 to obtain a final quality score, 
which is bounded between 0 (worst quality) and 1 (highest quality). The quality score is 
averaged across all providers within a geographic district to receive an aggregate quality 
adjustment score in a region. Additionally, the quality of hypertension management services is 




11 The clinicians involved in the assessment included a primary care physician currently practicing in rural Bihar, a 
primary care physician trained in an LMIC setting in Southeast Asia, and an emergency room physician from Johns 
Hopkins. The clinicians weighted the relevant “importance” of various items within the hypertension vignette and 
the most “important” items were kept in the quality index. 
 150 

























































    
 
Mirroring the calculation of effective coverage first described by Shengelia and colleagues, the 
HMSCI is calculated by multiplying the service coverage index by the provider quality index, or 
in other words, the product of utilization of services (conditional on need) and quality (Shengelia 
et al. 2005). To demonstrate the ability to aggregate the HMSCI at various geographic units, 




All analysis was done in Stata SE version 14.1 (College Station, TX). Wald tests and Bartlett’s 
test of equal variance were calculated to determine whether there were significant differences 
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across divisions in input indicators and the final index. For providers that responded they would 
not give treatment to a patient after making a diagnosis, no further information was collected 
about advice given or prescriptions, and the provider received a “0” for quality on that section. 
With the exception of one provider who opted out of the facility assessment, there was no 




The APHCB study included 14,386 individuals aged 30 years or older and 950 individuals who 
were previously diagnosed as hypertensive in rural Bihar. The NFHS-4 study included biometric 
information on 51,684 individuals in Bihar, including 44,480 who lived in rural areas. The 
provider survey collected data on 390 providers, including 71 public providers, 15 MBBS-
trained private providers, 54 AYUSH private providers, and 250 informal providers. Among 
adults in rural Bihar, the overall coverage of hypertension management services is relatively high 
(Table 4.5). The coverage of blood pressure measurement services among adults over the age of 
30 was 77.47% state-wide, varied significantly (p<0.01) across the divisions, and ranged 
between 70.09% of the population (Bhagalpur division) and 83.03% of the population (Purnia). 
Awareness of hypertension diagnosis varied significantly across the divisions (p<0.01). 
Relatedly, the percent of expected hypertensives aware of their diagnosis was 45.24% across the 
state and showed the greatest amount of variation of any hypertension management service, 
ranging from 32.06% (Bhagalpur division) to 93.53% (Patna division). Finally, the vast majority 
of individuals (95.78% state-wide) who were aware of their hypertension diagnosis were taking 
antihypertensive medication, ranging from 91.26% (Patna division) to 100% of sampled 
individuals in the Purnia division, and significant variance was observed between the divisions 
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(p<0.01). In all, the service coverage index ranged from 59.54% (Bhagalpur division) to 86.52% 
(Patna division) with a state-wide average of 69.5%. 
 
 




































(G = E * F) 
Bhagalpur 70.09% 32.06% 93.93% 59.54% 0.38 22.63% 
Darbhanga 78.06% 51.16% 98.24% 73.20% 0.54 39.53% 
Kosi 75.97% 33.20% 96.70% 62.48% 0.56 34.99% 
Magadh 73.16% 54.75% 96.23% 72.78% 0.46 33.48% 
Munger 77.92% 32.14% 94.00% 61.74% 0.29 17.90% 
Patna 75.87% 93.53% 91.26% 86.52% 0.40 34.61% 
Purnia 83.03% 29.98% 100.00% 62.90% 0.52 32.71% 
Saran 80.54% 38.74% 95.66% 66.83% 0.41 27.40% 
Tirhut 77.76% 50.58% 97.11% 72.55% 0.46 33.37% 
Bihar  77.47% 45.24% 95.78% 69.50% 0.45 31.28% 
 
The simplified quality score for management of hypertension (including structural quality) 
yielded the highest average quality score, and the ranking of division by quality was relatively 
stable across calculation methods (Annex 9). The overall quality of hypertension management 
services did not vary significantly across the divisions (p=0.41) (Table 4.6). Providers were 
weakest in their ability to give lifestyle advice about hypertension: across divisions, 81.60% of 
providers gave advice to keep a healthy diet, however less than half (39.17%) of providers 
advised patients to increase exercise, and only 13.06% of providers advised the patient that they 
would need to monitor their blood pressure over time. Across quality categories, providers were 
best at making a diagnosis, with 69.47% of all sampled providers able to correctly make a 
hypertension diagnosis. Common misdiagnoses included headaches, migraines, or no diagnosis.   
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Examination Diagnosis Advice Prescription Quality 
Score 
Bhagalpur 0.49 0.42 0.44 0.39 0.38 0.38 
Darbhang
a 0.47 0.44 0.70 0.45 0.54 0.54 
Kosi 0.48 0.39 0.60 0.42 0.56 0.56 
Magadh 0.47 0.38 0.75 0.39 0.46 0.46 
Munger 0.38 0.48 0.62 0.36 0.29 0.29 
Patna 0.44 0.42 0.69 0.43 0.40 0.40 
Purnia 0.47 0.40 0.81 0.32 0.52 0.52 
Saran 0.34 0.43 0.66 0.43 0.41 0.41 
Tirhut 0.43 0.45 0.69 0.41 0.46 0.46 
Bihar 0.44 0.42 0.69 0.41 0.45 0.45 
 
 
The quality of hypertension management services was assessed by provider type in rural Bihar 
(Figure 4.1). Public providers performed significantly better than IPs in all 5 quality categories. 
Additionally, public providers performed significantly better than AYUSH providers in terms of 
service readiness, diagnosis, prescription, and overall quality. IPs had significantly better service 
readiness than AYUSH providers, but both were significantly worse than private MBBS and 
public providers. Despite the small sample of private MBBS doctors, both private MBBS doctors 
and public doctors demonstrated significantly better knowledge of hypertension management 









When accounting for quality, the coverage of hypertension management services drops from 
69.5% in crude coverage to 31.28% in effective coverage statewide. Effective coverage of 




To our knowledge, this study is the first attempt to combine indicators of structure and process 
quality into a measure of effective coverage for non-communicable disease management 
services. While services such as contact coverage for blood pressure measurement in adults and 
linkage to care among hypertensives are generally high in rural Bihar, the quality of hypertension 
management services among primary care providers is low, drastically reducing the effective 
coverage of these services (Figure 4.2). Only 16.78% of providers measured blood pressure more 
than one time, and among the providers who were able to accurately diagnose a hypertensive 
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patient, only 59.34% were able to write an appropriate prescription to safely lower blood 
pressure. Even more troubling is that 10.99% of providers wrote a prescription that would result 
in harm to the patient. Given that perceived quality is a key driver of care-seeking for 
hypertensive individuals in India, measures to improve the clinical quality of care provided by 
the public sector may improve utilization of these services (Kujawski et al. 2018; Chapter 3). 
This study reveals the lack of access to quality services for non-communicable diseases for the 
majority of the population in a large Indian state and suggests areas for improvement.  
 





Our findings add to the expanding body of literature that uses process quality to measure 
effective coverage of health services. Previous studies have demonstrated a quality gap in the 
effective coverage of antenatal care, family planning, and sick child care across eight LMICs 
(Hannah H Leslie et al. 2017). Our results suggest that the quality gap is not limited to services 
for reproductive, maternal, and child health, but also extend into services to manage non-
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communicable diseases. Previous studies have reported no difference in the likelihood of giving 
a correct diagnosis or appropriate treatment between IPs and qualified primary providers for a 
few common conditions such as child pneumonia and asthma (Das et al. 2012). Our study 
demonstrates that public (formally trained) and private MBBS providers give significantly higher 
quality hypertension care than both IPs and private AYUSH providers in rural Bihar. This is 
problematic, as IPs and private providers are overwhelmingly the providers of choice in rural 
areas. IPs have demonstrated their ability to treat other common conditions such as diarrhea and 
childhood pneumonia at levels similar to formally trained providers, however there is a major 
quality gap in their ability to manage hypertension. As the burden of disease in LMICs continues 
to shift towards non-communicable diseases, the quality of services to diagnose and manage 
conditions such as hypertension must be better studied and improved. Future efforts to study 
service quality through vignettes, standardized patients, and direct observation should include 
modules on hypertension management and services to manage other high-priority non-
communicable diseases.  
 
This study also improves the measurement of effective coverage for services to manage non-
communicable diseases. Previous efforts have either focused on controlling blood pressure 
among specific populations such as the elderly (Y Zhao et al. 2020) or have focused on one 
aspect of hypertension management such as screening services (Charoendee et al. 2018). The 
HMSCI can be constructed at subnational levels and within subgroups, and also focuses on a 
range of hypertension management services spanning several target populations (e.g. screening 
for all adult populations and pharmaceutical treatment and lifestyle advice for diagnosed 
hypertensives). All previous efforts to measure effective coverage of hypertension management 
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services have suffered due to a lack of consensus on a single metric, despite the importance that 
is placed on measuring coverage of hypertension management services (Agyepong and Murray 
2018). Several indices for monitoring progress towards UHC exclude hypertension management, 
citing reasons such as “insufficient data”. As household surveys become more robust and begin 
to include biometric data and other indicators of hypertension management coverage, now is the 
perfect time to reach consensus on a measurement of effective coverage for hypertension 
management services.  
  
There are several limitations to this study. First, the HMSCI does not account for population-
level preventive interventions, like salt reduction in processed foods or air quality improvement, 
which may have significant impacts on population-level hypertension prevalence and blood 
pressure control. It also does not account for population adherence to prescribed lifestyle advice 
treatment, which is a necessary condition for achieving blood pressure control. However, by 
incorporating the quality of the services provided by the public and private health sectors in 
India, the HMSCI indicates the level of health gain that can be achieved from services delivered 
specifically by the health system. The rapidly changing body of evidence related to hypertension 
management means that certain indicators and sub-items, such as measuring blood pressure 
twice during a clinical visit, may have reduced importance within the overall index (Lu et al. 
2021). It will be important to further refine the HMSCI based on inputs from global and local 
experts to ensure that it reflects the most important aspects of hypertension management. A 
second limitation has to do with the measurement strategies used in this study. The APHCB 
study did not include the measurement of biometric data (such as blood pressure), necessitating 
the use of additional data sources to estimate the percent of individuals with raised blood 
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pressure who were aware of their diagnosis. Future attempts to replicate the HMSCI can use data 
from a single household survey and directly measure the percent of the population who is aware 
of their hypertension diagnosis. Although there is a 5-year time lag between the NFHS-4 and the 
APHCB, preliminary results released from the NFHS-5 study have demonstrated that 
hypertension prevalence is increasing in rural Bihar, suggesting that our calculations for 
awareness of hypertension diagnosis are likely an underestimate of the current situation. Third, 
the APHCB found that hypertensive individuals traveled an average of 18.1 kilometers for 
hypertension care, and that 36.3% of all individuals linked to care bypassed local options to 
manage their hypertension. Geographically linking individuals to providers at a local level may 
be inappropriate as individuals may not receive care from these providers, however by using 
division-wide averages of quality, we believe we are using a sufficiently broad geographic area 
to link these individuals to quality estimates representative of their true source of care (M. A. 




This is the first attempt to describe an overall indicator of effective coverage for a range of best-
practice services associated with hypertension management in a low- or middle-income country. 
The need for such an indicator is dire, as hypertension continues to add to the burden of disease 
across the world and its successful management is an integral component of health systems that 
achieve UHC. The HMSCI is designed to address shortcomings in the current measurement of 
effective coverage for hypertension management services. It’s application to rural Bihar suggests 
areas to improve the quality of hypertension diagnosis and treatment services at the primary care 
level. More broadly, the HMSCI is a starting point towards reaching consensus on a single 
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indicator for measuring a health system’s ability to provide the range of effective hypertension 
management services that improve population health.   
  
 160 
Chapter 5: Conclusion 
 
 
As the mantra, “what gets measured gets managed” suggests, the first step to improving 
hypertension management services in LMICs is to agree on the measurement methods used to 
evaluate health systems performance. This thesis contributes to the improvement of population 
health by developing and applying methods to evaluate the coverage of quality hypertension 
management services in low-resource settings. The following chapter highlights main findings 
from each of the three studies, describes strengths and limitations of the overall dissertation, 





Despite the steadily rising burden of NCDs, including hypertension, in LMICs, there have been 
few efforts to prepare health systems to address these health risks. While methods of measuring 
health system performance are increasingly being developed to monitor the effective coverage of 
interventions to improve maternal and child health and reduce the impact of communicable 
diseases, NCDs are being neglected. The basis for this dissertation is the conceptual framework 
through which contextual, individual, and health system factors modify an individual’s 
hypertension management experience and ultimately influence the extent to which an individual 
can experience improved health (Figure 1.3). This work focuses on the health system’s role in 
improving health, and advances methods of evaluating health system provision of quality 
hypertension management services. The thesis develops a framework for measuring gaps along 
the hypertension care continuum, applies the framework to rural Bihar, India to identify key 
bottlenecks to providing quality hypertension care, and proposes an improved method for 
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measuring effective coverage of hypertension management services based on the observed 
bottlenecks.  
 
The first aim of this research develops a measurement framework for tracking effective coverage 
of hypertension management based on a review of how effective coverage and quality-adjusted 
measures of hypertension management services have been previously described. Although there 
are at least eight studies that have reported effective coverage of hypertension-related services, 
there is no consensus on how effective coverage is defined, making comparison between and 
within countries difficult. Studies that calculate effective coverage of hypertension management 
within the same country show a wide variation in effective coverage estimates, indicating that 
methodological differences have a substantial impact on these assessments. Further, these studies 
primarily focus on outcome measures of quality which are often heavily influenced by social 
determinants of health. This dependence on outcome quality neglects important structural and 
process-related factors that determine the quality of care received by individuals. The only study 
that incorporates process quality in the definition of effective coverage focuses on one aspect of 
hypertension management (i.e. blood pressure measurement), suggesting that more work is 
needed to develop comprehensive effective coverage metrics (Charoendee et al. 2018). While 
there are several studies that measure the quality of hypertension management services received 
at the population level, none attempts to calculate a quality-adjusted coverage score for 
hypertension management services. As a result, the coverage of high-quality hypertension 
management services in LMICs is largely unknown. Those studies that did report on process 
quality demonstrate major gaps in provider fidelity to protocols (both in terms of blood pressure 
measurement and treatment) and patient adherence to medicines. Therefore, an expanded 
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hypertension care cascade is proposed with additional steps to formalize the inclusion of 
screening among the general population, to include linkage to quality care (i.e., care that follows 
treatment protocols), and to include patient adherence to medicines. The final expanded 
hypertension cascade of care is based on the findings of the scoping review and can be used to 
identify barriers to achieving effective hypertension management in LMICs. 
 
Chapter two’s results suggest that while many studies quantify the prevalence of hypertension 
and coverage of screening and treatment services in LMICs, few examine the content of services 
provided during these visits. The second aim of this research is to apply the expanded 
hypertension cascade of care framework to a low-resource setting: rural Bihar, India. Applying 
the expanded hypertension cascade of care to data collected from households confirms the 
findings of previous studies: that the majority of hypertensive individuals in rural Bihar have 
either never had their blood pressure measured (~22% of hypertensive individuals) or had been 
previously screened but remained undiagnosed (~47% of hypertensive individuals). Of those 
hypertensive individuals linked to any care, as few as 19% were linked to providers who were 
able to accurately diagnose hypertension and prescribe appropriate treatment. This suggests that 
the additional steps (linkage to quality care and adherence to treatment) are essential for 
understanding barriers to effective hypertension management in rural Bihar. Further, the study’s 
analysis of hypertension management services suggests that the quality of hypertension care in 
rural Bihar is substandard in multiple regards. In terms of structural quality, 40% of all providers 
are not able to offer a single front-line antihypertensive medication. Direct observations of 
patient visits reveal that only 30% of all adults are being opportunistically screened for high 
blood pressure during routine primary care visits. Further, in terms of provider knowledge, only 
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a fifth of providers know to check blood pressure twice during a patient visit and among the 
providers who correctly diagnose hypertension, 40% of prescriptions written to treat 
hypertension are inappropriate for lowering blood pressure (including 11% of prescriptions that 
could cause harm to the patient), and less than 5% of providers are explaining the lifelong nature 
and treatment needs of hypertension to newly diagnosed patients. This supply-side information 
supplements the traditional demand-side cascade of care analysis and provides important insights 
as to why individuals are lost along the hypertension cascade of care, namely because providers 
do not have the structural capacity or demonstrate the knowledge to be able to administer the 
quality care that will result in early diagnosis and successful treatment of high blood pressure.  
 
While the second research aim provides key and novel insights as to why individuals are not able 
to receive the potential health benefits from hypertension management services in rural Bihar, it 
does not provide a method for reporting the effective coverage of these services. The third 
research aim addresses the shortcomings of previous effective coverage metrics and proposes an 
index measure of effective coverage that captures the major gaps identified in rural Bihar’s 
expanded hypertension cascade of care. The new metric incorporates the coverage of multiple 
services associated with effective hypertension management (i.e. screening, diagnosis, and 
treatment). The metric also incorporates dimensions of service quality which were found to be 
inadequate in the first and second research aims (i.e. facility readiness, examinations, diagnosis, 
prescription, and advice). When applied to rural Bihar, the index suggests that while the 
coverage of various hypertension management services is generally high, the quality of these 
services is low, reducing the potential health gains that can be experienced by the population. A 
further examination of hypertension service quality demonstrates that public providers and 
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private MBBS doctors provide significantly better-quality hypertension care than private 
AYUSH providers and informal providers. This index can be used by policymakers to improve 
hypertension services (e.g. by helping to prioritize expansion of coverage or improvement of 
service quality) and fills the need for an effective coverage metric for hypertension services, 
which is currently absent within the UHC tracking framework.  
 
Taken together, this dissertation suggests that the process quality of hypertension management 
services is substandard and requires more attention in Bihar and other low-resource contexts. 
This work has implications at several levels. For individuals, it is important to note that public 
providers give superior hypertension care in rural Bihar. Although individual preference for 
hypertension management in rural Bihar is skewed towards private providers due to a perceived 
lack of quality in public facilities, our results suggest that most patients can receive higher 
quality hypertension care for free (and usually closer to home) if they attend their local PHCs. 
Community awareness of hypertension should be expanded, to generate demand for higher 
quality services, which may in turn force informal providers and other providers to improve their 
hypertension-related knowledge. Local policymakers in Bihar should recognize the importance 
of improving the quality of hypertension management services (rather than prioritizing the 
expansion of service coverage alone). Finally, the broader public health audience should 
recognize the benefits of using the expanded cascade of care and of further developing the 
proposed effective coverage index to study hypertension management and improve efforts to 
monitor progress towards UHC. These findings should be interpreted within the strengths and 
limitations of the research effort. 
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Strengths and Limitations 
 
While the strengths and limitations of individual studies have been previously described, it is 
also important to consider the relative strengths and limitations of the overall thesis. 
 
This thesis employs a mixed method, exploratory sequential study design with a focus on 
quantitative methods (Creswell and Plano Clark 2006). The sequential study design means that 
the insights gained from the scoping literature review are incorporated in the measurement 
framework, which in turn informs the key dimensions to be included in the final index of 
effective coverage. This comprehensive approach to metric development results in an evidence-
based, high quality measure of effective coverage for hypertension management services. 
Another key strength of the study is the linked household and provider survey design. The 
provider survey’s sampling frame is sourced from responses given to the household survey. This 
study design enables analysis on both the supply- and demand-side characteristics of 
hypertension management, and further enables direct linking of individuals to the providers from 
whom they receive care, a powerful tool for measuring effective coverage of health services (Do 
et al. 2016). Additionally, the study collects information on private providers, including 
informally trained providers, which are an important source of primary care in Bihar and other 
LMICs but are often excluded from health services research. The findings of this thesis are 
representative of the rural population and primary health care providers for the entire state of 
Bihar - a population of nearly 92 million people. The immediate external validity of this study 
therefore applies to a large population, suggesting that the findings are generalizable to a broad 
population of similar characteristics.  
 
 166 
Several innovations also contribute to the strength of the thesis. To our knowledge, this is the 
first study to use a clinical vignette to study provider knowledge of hypertension case 
management in LMICs. Although frequently used to study provider knowledge, vignettes have 
historically focused on treating maternal and child health conditions or communicable diseases. 
This study is also the first attempt to design an index of effective coverage for multiple services 
associated with treating single health condition. While several indices exist to measure the 
effective coverage of services across a health system, such a composite measure has not been 
developed to capture the numerous services associated with managing a single health condition. 
Furthermore, this is one of only a few studies that has attempted to incorporate structural and 
process service quality into a measure of effective coverage or quality-adjusted coverage of 
services more broadly (Hannah H Leslie et al. 2017). This thesis, therefore, adds to the growing 
body of research on high quality health systems in LMICs, and is distinguished as one of the 
early NCD-focused contributions to the field. There are also some important limitations to the 
study that must be considered.  
 
The first group of limitations is shaped by the design of the broader Assessment of Primary 
Health Care in Bihar study. Since the study did not collect information on the quality of 
providers that were visited by patients but were located beyond 5 kilometers from the home, the 
quality of care given by these providers is unknown. As a result, the true effective coverage of 
the entire health system (including urban providers) cannot be calculated. More broadly, the 
results of both the household survey and the provider survey are not generalizable to the urban 
population in Bihar. Bihar’s population is 89% rural, so this is not a major issue for 
generalizability within the state, but it does hinder the generalizability of findings to urban 
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contexts, which may experience different levels of prevalence of high blood pressure and of 
coverage and/or quality of hypertension management services. Next, there was additional data 
that could have further benefitted the dissertation but were not within the scope of the parent 
study’s household survey. These data include (i) multiple biometric blood pressure 
measurements taken during the household survey, (ii) detailed information on when patients last 
had their blood pressure measured and by whom, (iii) detailed information on when and how 
patients were diagnosed as hypertensive (e.g. upon admission to hospital or by a community 
health worker), (iv) detailed information on patient adherence to medicine and treatment, and (v) 
information on patient knowledge, attitudes, and practices about hypertension and relevant 
lifestyle modifications. Another notable limitation is the fact that the thesis only focuses on 
hypertension management services, and does not consider preventive interventions. While these 
preventive measures are essential for hypertension management and control, there was no scope 
to collect additional information in the household or provider surveys on interventions. Finally, 
the study was designed to be able to compare the knowledge of providers (through clinical 
vignettes) with the practice of providers (through direct observation), however the number of 
patients who presented to clinics for hypertension care while observations were ongoing (four 
visits) was insufficient to conduct this analysis. This number was influenced in part by the 
changes to data collection procedures after the COVID-19 pandemic.  
 
Additional limitations were related to external factors that may have influenced the data that was 
collected. First, data collection for both the household survey and the provider quality 
assessment was interrupted by the COVID-19 pandemic. For the household survey, the only 
COVID-19 related interruption was to the “follow-up” phase of data collection, where 
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subsequent visits were scheduled with households that were selected to respond to the household 
survey but were not present during the first round of data collection. Conducting the “follow-up” 
phase would have improved response rates among households which were not present during the 
first visit and would have reduced non-response bias. The provider survey was paused after 28 of 
the 70 sampled villages were visited, and data collection was resumed nearly one calendar year 
later. During this time, we noted that several providers identified in the household survey one 
year prior had either stopped practicing medicine, permanently moved from the village in which 
they formerly practiced, or died. If COVID-19 changed provider practices, then there may be 
systematic differences between the data collected pre- and post-COVID-19 interruption. 
However, to protect enumerators and patients, the direct observation component of the provider 
assessment was abandoned after data collection was resumed, and it is less likely that COVID-19 
changed provider knowledge (which would be reflected in the clinical vignettes) than provider 
practices. Another important contextual factor that might have impacted data collection was the 
Citizenship Amendment Act, which discriminated against Muslim Indians, causing distrust 
among predominantly Muslim communities, which reduced their participation in our household 
survey.  Our household survey may therefore underrepresent Muslim populations, which would 
be problematic if those not included in our study have different characteristics than the 
populations included in our study.  
 
Recommendations for Future Research 
 
This dissertation lays the foundation for several important research activities which fall into three 
broad categories: replicating the research processes of this thesis, studying the expanded 
hypertension cascade of care in greater depth, and further advancing measures of effective 
coverage. The first broad category involves replicating the research processes described in this 
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thesis for other disease conditions and/or for hypertension in other contexts. By following the 
research process employed in this dissertation (i.e. conducting a scoping review to develop an 
evidence-based cascade of care, applying the cascade to identify major gaps, and developing an 
effective coverage index that measures the coverage and process quality of key services), the 
measurement of effective coverage can be improved for other understudied NCDs. Additionally, 
the process of applying the expanded cascade of care, followed by calculating the effective 
coverage index in other contexts can be useful to identify patterns in gaps and evaluate the 
effective coverage of hypertension management services across multiple contexts. This would 
add to the growing knowledge base on areas where governments need to intervene to improve 
coverage of effective hypertension management services.  
 
The second potential area for future research involves studying the entire expanded cascade of 
care in depth. This dissertation provides great insight into the quality of hypertension 
management services, but it does not indicate the kinds of patient or provider characteristics that 
are associated with better adherence to treatment. Protocols have already been designed to 
describe the factors associated with medication adherence among hypertensive patients in 
LMICs (Agbor, Takah, and Aminde 2018). Future studies, ideally longitudinal in nature, would 
help to understand the kinds of care that improve patient adherence and ultimately blood pressure 
control. Longitudinal studies that follow a cohort of pre-hypertensive individuals over time could 
collect data on what kinds of care individuals receive, who develops hypertension (and who 
among the hypertensives eventually achieves blood pressure control), and where along the 
cascade of care most of these people are lost. Such longitudinal studies are essential for 
understanding the service delivery strategies that are necessary for achieving ideal health 
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outcomes, especially normal blood pressure levels. These studies would also help to understand 
how frequently individuals with high blood pressure fluctuate between normo- and hypertension 
over time, which would provide important evidence either in favor of or against the use of using 
cross-sectional surveys to determine outcome measures for measuring effective coverage of 
hypertension management services.  
 
Finally, future studies can help to further advance the hypertension management service 
coverage index. It is essential to gain consensus from stakeholders (including public health 
experts, physicians, and patients) about the specific components that should contribute to the 
final index. A Delphi study on the essential services and quality metrics that should be included 
in the index could be conducted to reach such a consensus in a systematic way. Other studies can 
continue to advance the methodology of the index, by (i) testing and validating new, more exact 
techniques to link patients with providers, (ii) weighting the service quality components by 
relative importance to health outcomes, (iii) calculating the effective coverage of services for 
population subgroups (e.g. by caste, by religion, and/or by sex), and (iv) validating the index 
with other measures that indicate effective coverage of service. Finally, future studies on 
tracking effective coverage within health systems should incorporate the hypertension 
management service coverage index to ensure that services to measure hypertension are 




This research has several important policy implications that exist at multiple levels of 
implementation. At the local level in Bihar, while the quality of hypertension management care 
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given by public providers is significantly better than informal providers or private AYUSH 
providers, there is still much room for improvement. The government should institute trainings 
to address knowledge gaps of these providers and should work to ensure that supply chains are 
strengthened so that all PHCs have a steady supply of first line antihypertensive medications. 
Although some government officials are reluctant to engage the private sector (especially 
informal providers), these findings suggest that key opportunities to screen and diagnose 
individuals are being missed. If private sector providers can be trained to regularly measure 
patient blood pressure, and referral pathways are formalized with government providers so that 
suspected cases are referred to the local PHC, hypertension can be detected much earlier, and 
treatment can be initiated sooner, resulting in improved health for individuals and greater savings 
for health systems (due to reduced strokes or severe events associated with advanced 
hypertension). Additionally, awareness of hypertension among community members should be 
increased so that there is a greater demand for high quality services and so that the community 
becomes knowledgeable about the lifestyle modifications that can reduce the risk of developing 
hypertension and improve non-pharmaceutical blood pressure treatment. 
 
At the state-level, this study has important implications, especially within the context of the 
Ayushman Bharat (AB) comprehensive health reform scheme. The first component under the 
AB scheme is to create 150,000 health and wellness centers (HWC) across the country to deliver 
comprehensive primary health care. These HWCs are envisioned to deliver an expanded range of 
services with particular emphasis on addressing non-communicable diseases (Ministry of Health 
& Family Welfare 2019). The results of this study demonstrate that the government does not 
necessarily need to expand services in rural Bihar, but rather should focus on improving the 
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quality of services already in existence. If these HWC are staffed by individuals who provide 
lower quality care, they will not be improving upon the services currently available in rural 
Bihar, since the coverage of services is already generally high. Hence, special efforts must be 
made to ensure that the quality of care provided at HWCs is sufficiently high and that HWCs are 
promoted as additional, high quality options to ensure that there is demand in the community for 
these services. 
 
Finally, at the national and global level, this study suggests that the process quality of 
hypertension management services may be low in many contexts. The measurement of blood 
pressure levels alone may be hiding substandard service quality, as individuals who are 
predisposed to achieving blood pressure control may do so with relatively little intervention from 
the health system. Given the rapidly increasing burden of disease, there must be a global 
commitment to study and improve hypertension management services in LMICs. As the global 
population of individuals in need of blood pressure management services increases, it is 
imperative that health systems and individual providers are knowledgeable and prepared to 
provide these essential services. An important step to demonstrating this commitment at the 
global level is to ensure that services to manage hypertension are included in all future UHC 




This dissertation contributes to the management and measurement of health systems performance 
related to providing hypertension management services. The process quality of hypertension 
management services is not well studied, but deserves attention in health systems research, as it 
reflects the impact of services provided rather than outcomes which can be heavily influenced by 
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social determinants of health. Even in rural Bihar, access to hypertension services (once 
diagnosed) is high, however people are not screened for high blood pressure frequently enough, 
resulting in delayed diagnosis. The quality of hypertension care provided in Bihar is substandard. 
While most primary care providers have the ability to diagnose hypertension, there are 
significant gaps in their ability to measure blood pressure in patients according to internationally 
recognized standards, give lifestyle advice, and write appropriate prescriptions for safely 
lowering blood pressure.    
 
The dissertation develops a generic, evidence-based measurement framework for quantifying 
gaps along the hypertension care cascade, applies the framework to a low-resource setting (rural 
Bihar, India) to describe the health system-related factors that contribute to these gaps, and 
finally proposes a single index measure for tracking and improving effective coverage of 
hypertension management services over time. Without appropriate measures of health system 
performance, there is no way of knowing whether the interventions that can improve quality of 
life are being delivered to those in need. This research can help to bridge the gap between health 
systems metrics and ensuring freedom from avoidable ill health due to hypertension for millions 








Annex 1: Assessment of Primary Health Care in Bihar Sample Size Calculations 
 
 
Sample size calculation to detect differences in care seeking preferences among households 
 
Stata code: power twoprop .5, diff(.05 .1) 
 
Estimated sample sizes for a two-sample proportions test 
Pearson's chi-squared test  
Ho: p2 = p1  versus  Ha: p2 != p1 
 
 
Alpha Power N N1 N2 Delta P1 P2 Difference 
.05 .8 3130 1565 1565 .05 .5 .55 .05 
.05 .8 776 388 388 .1 .5. 6 .1 
 
776 * 2 (design effect) = 1,552  
1,552 / 0.66 (percent of sick patients who sought care) = 2,351.5 
2,352 / 0.06 (percent of individuals who were sick in last two weeks) =  39,191.6 individuals 
39,191.6 / 5 (average household size) = 7,838.3 households  
7,838.3 / 0.8 (20% non-response rate) = 9,797.9 households 
 
 
Sample size calculation to detect differences in quality across public and private providers 
 
Stata code: power twomeans 57, sd(7.25) diff(5(5)15)  
 
Estimated sample sizes for a two-sample means test 
t test assuming sd1 = sd2 = sd 
Ho: m2 = m1  versus  Ha: m2 != m1 
 
 
Alpha Power N N1 N2 Delta M1 M2 Difference Standard 
Deviation 
.05 .8 68 34 34 5 57 62 5 7.25 
.05 .8 20 10 10 10 57 67 10 7.25 
.05 .8 10 5 5 15 57 72 15 7.25 
 
34 public facilities and 34 private facilities required 
35 * 1.5 (DEFT) = 52.5 





Annex 2: Scoping Review Search Strategy 
 
Search conducted on 12 October, 2020 
Database Effective Coverage N Care Cascade N Combined N 
SCOPUS TITLE-ABS-
KEY ( “effective 
coverage”  AND  “hypertens




KEY ( “effective 
coverage”  AND  




KEY ( hypertension )  AND
  ( TITLE-ABS-
KEY ( "effective 
coverage" )  OR  ( TITLE-
ABS-
KEY ( cascade  AND  care )










121 hypertension:ti,ab,kw AND 
'effective coverage':ti,ab,kw 
OR 'care cascade':ti,ab,kw 
OR 'cascade of 
care':ti,ab,kw 
892 
PubMed (hypertension) AND 
(‘effective coverage’) 
 
492 (hypertension) AND (care) 
AND (cascade) 
158 (hypertension) AND ((care) 







81 Title, abstract, 
keywords: “hypertension” 
AND “cascade” 
363 “hypertension” AND 
“effective coverage” OR 
("care cascade" OR 
"cascade of care") 
719 




370 noft(hypertension) AND 
care AND noft(cascade) 
 
 
397 noft(hypertension) AND 
noft("effective coverage") 
OR noft("care cascade" OR 











ND ALL FIELDS: ("care 
cascade") OR ALL 




ND ALL FIELDS: ("care 
cascade") OR ALL 
FIELDS: ("cascade of 






Search conducted on 26 October, 2020 to add hypertension prevalence, awareness, control to 
search 
 
Search tags for LMICs were sourced from the Cochrane library: https://epoc.cochrane.org/lmic-
filters 
 
Searched for “hypertension” AND “prevalence” OR “awareness” AND “treatment” and 
“control” and “LMIC” in title/abstract 
 
Embase search terms below- 589 articles returned 
 
hypertension:ab,ti AND (prevalence:ab,ti OR awareness:ab,ti) AND treatment:ab,ti AND control:ab,ti 
AND (afghanistan:ti,ab,kw OR albania:ti,ab,kw OR algeria:ti,ab,kw OR (american:ti,ab,kw AND 
samoa:ti,ab,kw) OR angola:ti,ab,kw OR 'antigua and barbuda':ti,ab,kw OR antigua:ti,ab,kw OR 
barbuda:ti,ab,kw OR argentina:ti,ab,kw OR armenia:ti,ab,kw OR armenian:ti,ab,kw OR aruba:ti,ab,kw 
OR azerbaijan:ti,ab,kw OR bahrain:ti,ab,kw OR bangladesh:ti,ab,kw OR barbados:ti,ab,kw OR 
(republic:ti,ab,kw AND of:ti,ab,kw AND belarus:ti,ab,kw) OR belarus:ti,ab,kw OR byelarus:ti,ab,kw OR 
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belorussia:ti,ab,kw OR byelorussian:ti,ab,kw OR belize:ti,ab,kw OR (british:ti,ab,kw AND 
honduras:ti,ab,kw) OR benin:ti,ab,kw OR dahomey:ti,ab,kw OR bhutan:ti,ab,kw OR bolivia:ti,ab,kw OR 
'bosnia and herzegovina':ti,ab,kw OR bosnia:ti,ab,kw OR herzegovina:ti,ab,kw OR botswana:ti,ab,kw OR 
bechuanaland:ti,ab,kw OR brazil:ti,ab,kw OR brasil:ti,ab,kw OR bulgaria:ti,ab,kw OR (burkina:ti,ab,kw 
AND faso:ti,ab,kw) OR (burkina:ti,ab,kw AND fasso:ti,ab,kw) OR (upper:ti,ab,kw AND volta:ti,ab,kw) 
OR burundi:ti,ab,kw OR urundi:ti,ab,kw OR (cabo:ti,ab,kw AND verde:ti,ab,kw) OR (cape:ti,ab,kw 
AND verde:ti,ab,kw) OR cambodia:ti,ab,kw OR kampuchea:ti,ab,kw OR (khmer:ti,ab,kw AND 
republic:ti,ab,kw) OR cameroon:ti,ab,kw OR cameron:ti,ab,kw OR cameroun:ti,ab,kw OR 
(central:ti,ab,kw AND african:ti,ab,kw AND republic:ti,ab,kw) OR (ubangi:ti,ab,kw AND shari:ti,ab,kw) 
OR chad:ti,ab,kw OR chile:ti,ab,kw OR china:ti,ab,kw OR colombia:ti,ab,kw OR comoros:ti,ab,kw OR 
(comoro:ti,ab,kw AND islands:ti,ab,kw) OR (iles:ti,ab,kw AND comores:ti,ab,kw) OR mayotte:ti,ab,kw 
OR (democratic:ti,ab,kw AND republic:ti,ab,kw AND of:ti,ab,kw AND the:ti,ab,kw AND 
congo:ti,ab,kw) OR (democratic:ti,ab,kw AND republic:ti,ab,kw AND congo:ti,ab,kw) OR 
congo:ti,ab,kw OR zaire:ti,ab,kw OR (costa:ti,ab,kw AND rica:ti,ab,kw) OR (`cote:ti,ab,kw AND 
d:ti,ab,kw AND 'ivoire':ti,ab,kw) OR (`cote:ti,ab,kw AND d:ti,ab,kw AND 'ivoire':ti,ab,kw) OR 
(cote:ti,ab,kw AND divoire:ti,ab,kw) OR (cote:ti,ab,kw AND d:ti,ab,kw AND ivoire:ti,ab,kw) OR 
(ivory:ti,ab,kw AND coast:ti,ab,kw) OR croatia:ti,ab,kw OR cuba:ti,ab,kw OR cyprus:ti,ab,kw OR 
(czech:ti,ab,kw AND republic:ti,ab,kw) OR czechoslovakia:ti,ab,kw OR djibouti:ti,ab,kw OR 
(french:ti,ab,kw AND somaliland:ti,ab,kw) OR dominica:ti,ab,kw OR (dominican:ti,ab,kw AND 
republic:ti,ab,kw) OR ecuador:ti,ab,kw OR egypt:ti,ab,kw OR (united:ti,ab,kw AND arab:ti,ab,kw AND 
republic:ti,ab,kw) OR (el:ti,ab,kw AND salvador:ti,ab,kw) OR (equatorial:ti,ab,kw AND guinea:ti,ab,kw) 
OR (spanish:ti,ab,kw AND guinea:ti,ab,kw) OR eritrea:ti,ab,kw OR estonia:ti,ab,kw OR eswatini:ti,ab,kw 
OR swaziland:ti,ab,kw OR ethiopia:ti,ab,kw OR fiji:ti,ab,kw OR gabon:ti,ab,kw OR (gabonese:ti,ab,kw 
AND republic:ti,ab,kw) OR gambia:ti,ab,kw OR 'georgia (republic)':ti,ab,kw OR georgian:ti,ab,kw OR 
ghana:ti,ab,kw OR (gold:ti,ab,kw AND coast:ti,ab,kw) OR gibraltar:ti,ab,kw OR greece:ti,ab,kw OR 
grenada:ti,ab,kw OR guam:ti,ab,kw OR guatemala:ti,ab,kw OR (guinea:ti,ab,kw AND bissau:ti,ab,kw) 
OR guyana:ti,ab,kw OR (british:ti,ab,kw AND guiana:ti,ab,kw) OR haiti:ti,ab,kw OR hispaniola:ti,ab,kw 
OR honduras:ti,ab,kw OR hungary:ti,ab,kw OR india:ti,ab,kw OR indonesia:ti,ab,kw OR timor:ti,ab,kw 
OR iran:ti,ab,kw OR iraq:ti,ab,kw OR (isle:ti,ab,kw AND of:ti,ab,kw AND man:ti,ab,kw) OR 
jamaica:ti,ab,kw OR jordan:ti,ab,kw OR kazakhstan:ti,ab,kw OR kazakh:ti,ab,kw OR kenya:ti,ab,kw OR 
(`democratic:ti,ab,kw AND people:ti,ab,kw AND 's republic of korea':ti,ab,kw) OR (republic:ti,ab,kw 
AND of:ti,ab,kw AND korea:ti,ab,kw) OR (north:ti,ab,kw AND korea:ti,ab,kw) OR (south:ti,ab,kw AND 
korea:ti,ab,kw) OR korea:ti,ab,kw OR kosovo:ti,ab,kw OR kyrgyzstan:ti,ab,kw OR kirghizia:ti,ab,kw OR 
kirgizstan:ti,ab,kw OR (kyrgyz:ti,ab,kw AND republic:ti,ab,kw) OR kirghiz:ti,ab,kw OR laos:ti,ab,kw 
OR (lao:ti,ab,kw AND pdr:ti,ab,kw) OR (`lao:ti,ab,kw AND people:ti,ab,kw AND 's democratic 
republic':ti,ab,kw) OR latvia:ti,ab,kw OR lebanon:ti,ab,kw OR (lebanese:ti,ab,kw AND republic:ti,ab,kw) 
OR lesotho:ti,ab,kw OR basutoland:ti,ab,kw OR liberia:ti,ab,kw OR libya:ti,ab,kw OR (libyan:ti,ab,kw 
AND arab:ti,ab,kw AND jamahiriya:ti,ab,kw) OR lithuania:ti,ab,kw OR macau:ti,ab,kw OR 
macao:ti,ab,kw OR (republic:ti,ab,kw AND of:ti,ab,kw AND north:ti,ab,kw AND macedonia:ti,ab,kw) 
OR macedonia:ti,ab,kw OR madagascar:ti,ab,kw OR (malagasy:ti,ab,kw AND republic:ti,ab,kw) OR 
malawi:ti,ab,kw OR nyasaland:ti,ab,kw OR malaysia:ti,ab,kw OR (malay:ti,ab,kw AND 
federation:ti,ab,kw) OR (malaya:ti,ab,kw AND federation:ti,ab,kw) OR maldives:ti,ab,kw OR 
(indian:ti,ab,kw AND ocean:ti,ab,kw AND islands:ti,ab,kw) OR (indian:ti,ab,kw AND ocean:ti,ab,kw) 
OR mali:ti,ab,kw OR malta:ti,ab,kw OR micronesia:ti,ab,kw OR (federated:ti,ab,kw AND states:ti,ab,kw 
AND of:ti,ab,kw AND micronesia:ti,ab,kw) OR kiribati:ti,ab,kw OR (marshall:ti,ab,kw AND 
islands:ti,ab,kw) OR nauru:ti,ab,kw OR (northern:ti,ab,kw AND mariana:ti,ab,kw AND islands:ti,ab,kw) 
OR palau:ti,ab,kw OR tuvalu:ti,ab,kw OR mauritania:ti,ab,kw OR mauritius:ti,ab,kw OR mexico:ti,ab,kw 
OR moldova:ti,ab,kw OR moldovian:ti,ab,kw OR mongolia:ti,ab,kw OR montenegro:ti,ab,kw OR 
'montenegro (republic)':ti,ab,kw OR morocco:ti,ab,kw OR ifni:ti,ab,kw OR mozambique:ti,ab,kw OR 
(portuguese:ti,ab,kw AND east:ti,ab,kw AND africa:ti,ab,kw) OR myanmar:ti,ab,kw OR burma:ti,ab,kw 
OR namibia:ti,ab,kw OR nepal:ti,ab,kw OR (netherlands:ti,ab,kw AND antilles:ti,ab,kw) OR 
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nicaragua:ti,ab,kw OR niger:ti,ab,kw OR nigeria:ti,ab,kw OR oman:ti,ab,kw OR muscat:ti,ab,kw OR 
pakistan:ti,ab,kw OR panama:ti,ab,kw OR (papua:ti,ab,kw AND new:ti,ab,kw AND guinea:ti,ab,kw) OR 
(new:ti,ab,kw AND guinea:ti,ab,kw) OR paraguay:ti,ab,kw OR peru:ti,ab,kw OR philippines:ti,ab,kw OR 
philipines:ti,ab,kw OR phillipines:ti,ab,kw OR phillippines:ti,ab,kw OR poland:ti,ab,kw OR 
(`polish:ti,ab,kw AND people:ti,ab,kw AND 's republic':ti,ab,kw) OR portugal:ti,ab,kw OR 
(portuguese:ti,ab,kw AND republic:ti,ab,kw) OR (puerto:ti,ab,kw AND rico:ti,ab,kw) OR 
romania:ti,ab,kw OR russia:ti,ab,kw OR (russian:ti,ab,kw AND federation:ti,ab,kw) OR ussr:ti,ab,kw OR 
(soviet:ti,ab,kw AND union:ti,ab,kw) OR (union:ti,ab,kw AND of:ti,ab,kw AND soviet:ti,ab,kw AND 
socialist:ti,ab,kw AND republics:ti,ab,kw) OR rwanda:ti,ab,kw OR ruanda:ti,ab,kw OR samoa:ti,ab,kw 
OR (pacific:ti,ab,kw AND islands:ti,ab,kw) OR polynesia:ti,ab,kw OR (samoan:ti,ab,kw AND 
islands:ti,ab,kw) OR (navigator:ti,ab,kw AND island:ti,ab,kw) OR (navigator:ti,ab,kw AND 
islands:ti,ab,kw) OR 'sao tome and principe':ti,ab,kw OR (saudi:ti,ab,kw AND arabia:ti,ab,kw) OR 
senegal:ti,ab,kw OR serbia:ti,ab,kw OR seychelles:ti,ab,kw OR (sierra:ti,ab,kw AND leone:ti,ab,kw) OR 
slovakia:ti,ab,kw OR (slovak:ti,ab,kw AND republic:ti,ab,kw) OR slovenia:ti,ab,kw OR 
melanesia:ti,ab,kw OR (solomon:ti,ab,kw AND island:ti,ab,kw) OR (solomon:ti,ab,kw AND 
islands:ti,ab,kw) OR (norfolk:ti,ab,kw AND island:ti,ab,kw) OR (norfolk:ti,ab,kw AND islands:ti,ab,kw) 
OR somalia:ti,ab,kw OR (south:ti,ab,kw AND africa:ti,ab,kw) OR (south:ti,ab,kw AND sudan:ti,ab,kw) 
OR (sri:ti,ab,kw AND lanka:ti,ab,kw) OR ceylon:ti,ab,kw OR 'saint kitts and nevis':ti,ab,kw OR 'st. kitts 
and nevis':ti,ab,kw OR (saint:ti,ab,kw AND lucia:ti,ab,kw) OR 'st. lucia':ti,ab,kw OR 'saint vincent and 
the grenadines':ti,ab,kw OR (saint:ti,ab,kw AND vincent:ti,ab,kw) OR 'st. vincent':ti,ab,kw OR 
grenadines:ti,ab,kw OR sudan:ti,ab,kw OR suriname:ti,ab,kw OR surinam:ti,ab,kw OR (dutch:ti,ab,kw 
AND guiana:ti,ab,kw) OR (netherlands:ti,ab,kw AND guiana:ti,ab,kw) OR syria:ti,ab,kw OR 
(syrian:ti,ab,kw AND arab:ti,ab,kw AND republic:ti,ab,kw) OR tajikistan:ti,ab,kw OR 
tadjikistan:ti,ab,kw OR tadzhikistan:ti,ab,kw OR tadzhik:ti,ab,kw OR tanzania:ti,ab,kw OR 
tanganyika:ti,ab,kw OR thailand:ti,ab,kw OR siam:ti,ab,kw OR (timor:ti,ab,kw AND leste:ti,ab,kw) OR 
(east:ti,ab,kw AND timor:ti,ab,kw) OR togo:ti,ab,kw OR (togolese:ti,ab,kw AND republic:ti,ab,kw) OR 
tonga:ti,ab,kw OR 'trinidad and tobago':ti,ab,kw OR trinidad:ti,ab,kw OR tobago:ti,ab,kw OR 
tunisia:ti,ab,kw OR 'turkey (republic)':ti,ab,kw OR turkey:ti,ab,kw OR turkmenistan:ti,ab,kw OR 
turkmen:ti,ab,kw OR uganda:ti,ab,kw OR ukraine:ti,ab,kw OR uruguay:ti,ab,kw OR uzbekistan:ti,ab,kw 
OR uzbek:ti,ab,kw OR vanuatu:ti,ab,kw OR (new:ti,ab,kw AND hebrides:ti,ab,kw) OR 
venezuela:ti,ab,kw OR vietnam:ti,ab,kw OR (viet:ti,ab,kw AND nam:ti,ab,kw) OR (middle:ti,ab,kw AND 
east:ti,ab,kw) OR (west:ti,ab,kw AND bank:ti,ab,kw) OR gaza:ti,ab,kw OR palestine:ti,ab,kw OR 
yemen:ti,ab,kw OR yugoslavia:ti,ab,kw OR zambia:ti,ab,kw OR zimbabwe:ti,ab,kw OR 
(northern:ti,ab,kw AND rhodesia:ti,ab,kw) OR (global:ti,ab,kw AND south:ti,ab,kw) OR (africa:ti,ab,kw 
AND south:ti,ab,kw AND of:ti,ab,kw AND the:ti,ab,kw AND sahara:ti,ab,kw) OR 'sub saharan 
africa':ti,ab,kw OR (subsaharan:ti,ab,kw AND africa:ti,ab,kw) OR (africa,:ti,ab,kw AND central:ti,ab,kw) 
OR (central:ti,ab,kw AND africa:ti,ab,kw) OR (africa,:ti,ab,kw AND northern:ti,ab,kw) OR 
(north:ti,ab,kw AND africa:ti,ab,kw) OR (northern:ti,ab,kw AND africa:ti,ab,kw) OR magreb:ti,ab,kw 
OR maghrib:ti,ab,kw OR sahara:ti,ab,kw OR (africa,:ti,ab,kw AND southern:ti,ab,kw OR 
southern:ti,ab,kw) AND africa:ti,ab,kw OR (africa,:ti,ab,kw AND eastern:ti,ab,kw) OR (east:ti,ab,kw 
AND africa:ti,ab,kw) OR (eastern:ti,ab,kw AND africa:ti,ab,kw) OR (africa,:ti,ab,kw AND 
western:ti,ab,kw) OR (west:ti,ab,kw AND africa:ti,ab,kw) OR (western:ti,ab,kw AND africa:ti,ab,kw) OR 
(west:ti,ab,kw AND indies:ti,ab,kw) OR (indian:ti,ab,kw AND ocean:ti,ab,kw AND islands:ti,ab,kw) OR 
(caribbean:ti,ab,kw AND region:ti,ab,kw) OR (caribbean:ti,ab,kw AND islands:ti,ab,kw) OR 
caribbean:ti,ab,kw OR (central:ti,ab,kw AND america:ti,ab,kw) OR (latin:ti,ab,kw AND 
america:ti,ab,kw) OR 'south and central america':ti,ab,kw OR (south:ti,ab,kw AND america:ti,ab,kw) OR 
(asia,:ti,ab,kw AND central:ti,ab,kw) OR (central:ti,ab,kw AND asia:ti,ab,kw) OR (asia,:ti,ab,kw AND 
northern:ti,ab,kw) OR (north:ti,ab,kw AND asia:ti,ab,kw) OR (northern:ti,ab,kw AND asia:ti,ab,kw) OR 
(asia,:ti,ab,kw AND southeastern:ti,ab,kw) OR (southeastern:ti,ab,kw AND asia:ti,ab,kw) OR 
(south:ti,ab,kw AND eastern:ti,ab,kw AND asia:ti,ab,kw) OR (southeast:ti,ab,kw AND asia:ti,ab,kw) OR 
(south:ti,ab,kw AND east:ti,ab,kw AND asia:ti,ab,kw) OR (asia,:ti,ab,kw AND western:ti,ab,kw) OR 
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(western:ti,ab,kw AND asia:ti,ab,kw) OR (europe,:ti,ab,kw AND eastern:ti,ab,kw) OR (east:ti,ab,kw 
AND europe:ti,ab,kw) OR (eastern:ti,ab,kw AND europe:ti,ab,kw) OR (developing:ti,ab,kw AND 
country:ti,ab,kw) OR (developing:ti,ab,kw AND countries:ti,ab,kw) OR (developing:ti,ab,kw AND 
nation?:ti,ab,kw) OR (developing:ti,ab,kw AND population?:ti,ab,kw) OR (developing:ti,ab,kw AND 
world:ti,ab,kw) OR (less:ti,ab,kw AND developed:ti,ab,kw AND countr*:ti,ab,kw) OR (less:ti,ab,kw 
AND developed:ti,ab,kw AND nation?:ti,ab,kw) OR (less:ti,ab,kw AND developed:ti,ab,kw AND 
population?:ti,ab,kw) OR (less:ti,ab,kw AND developed:ti,ab,kw AND world:ti,ab,kw) OR 
(lesser:ti,ab,kw AND developed:ti,ab,kw AND countr*:ti,ab,kw) OR (lesser:ti,ab,kw AND 
developed:ti,ab,kw AND nation?:ti,ab,kw) OR (lesser:ti,ab,kw AND developed:ti,ab,kw AND 
population?:ti,ab,kw) OR (lesser:ti,ab,kw AND developed:ti,ab,kw AND world:ti,ab,kw) OR 
(under:ti,ab,kw AND developed:ti,ab,kw AND countr*:ti,ab,kw) OR (under:ti,ab,kw AND 
developed:ti,ab,kw AND nation?:ti,ab,kw) OR (under:ti,ab,kw AND developed:ti,ab,kw AND 
population?:ti,ab,kw) OR (under:ti,ab,kw AND developed:ti,ab,kw AND world:ti,ab,kw) OR 
(underdeveloped:ti,ab,kw AND countr*:ti,ab,kw) OR (underdeveloped:ti,ab,kw AND nation?:ti,ab,kw) 
OR (underdeveloped:ti,ab,kw AND population?:ti,ab,kw) OR (underdeveloped:ti,ab,kw AND 
world:ti,ab,kw) OR (middle:ti,ab,kw AND income:ti,ab,kw AND countr*:ti,ab,kw) OR (middle:ti,ab,kw 
AND income:ti,ab,kw AND nation?:ti,ab,kw) OR (middle:ti,ab,kw AND income:ti,ab,kw AND 
population?:ti,ab,kw) OR (low:ti,ab,kw AND income:ti,ab,kw AND countr*:ti,ab,kw) OR (low:ti,ab,kw 
AND income:ti,ab,kw AND nation?:ti,ab,kw) OR (low:ti,ab,kw AND income:ti,ab,kw AND 
population?:ti,ab,kw) OR (lower:ti,ab,kw AND income:ti,ab,kw AND countr*:ti,ab,kw) OR 
(lower:ti,ab,kw AND income:ti,ab,kw AND nation?:ti,ab,kw) OR (lower:ti,ab,kw AND income:ti,ab,kw 
AND population?:ti,ab,kw) OR (underserved:ti,ab,kw AND countr*:ti,ab,kw) OR (underserved:ti,ab,kw 
AND nation?:ti,ab,kw) OR (underserved:ti,ab,kw AND population?:ti,ab,kw) OR (underserved:ti,ab,kw 
AND world:ti,ab,kw) OR (under:ti,ab,kw AND served:ti,ab,kw AND countr*:ti,ab,kw) OR 
(under:ti,ab,kw AND served:ti,ab,kw AND nation?:ti,ab,kw) OR (under:ti,ab,kw AND served:ti,ab,kw 
AND population?:ti,ab,kw) OR (under:ti,ab,kw AND served:ti,ab,kw AND world:ti,ab,kw) OR 
(deprived:ti,ab,kw AND countr*:ti,ab,kw) OR (deprived:ti,ab,kw AND nation?:ti,ab,kw) OR 
(deprived:ti,ab,kw AND population?:ti,ab,kw) OR (deprived:ti,ab,kw AND world:ti,ab,kw) OR 
(poor:ti,ab,kw AND countr*:ti,ab,kw) OR (poor:ti,ab,kw AND nation?:ti,ab,kw) OR (poor:ti,ab,kw AND 
population?:ti,ab,kw) OR (poor:ti,ab,kw AND world:ti,ab,kw) OR (poorer:ti,ab,kw AND 
countr*:ti,ab,kw) OR (poorer:ti,ab,kw AND nation?:ti,ab,kw) OR (poorer:ti,ab,kw AND 
population?:ti,ab,kw) OR (poorer:ti,ab,kw AND world:ti,ab,kw) OR (developing:ti,ab,kw AND 
econom*:ti,ab,kw) OR (less:ti,ab,kw AND developed:ti,ab,kw AND econom*:ti,ab,kw) OR 
(lesser:ti,ab,kw AND developed:ti,ab,kw AND econom*:ti,ab,kw) OR (under:ti,ab,kw AND 
developed:ti,ab,kw AND econom*:ti,ab,kw) OR (underdeveloped:ti,ab,kw AND econom*:ti,ab,kw) OR 
(middle:ti,ab,kw AND income:ti,ab,kw AND econom*:ti,ab,kw) OR (low:ti,ab,kw AND income:ti,ab,kw 
AND econom*:ti,ab,kw) OR (lower:ti,ab,kw AND income:ti,ab,kw AND econom*:ti,ab,kw) OR 
(low:ti,ab,kw AND gdp:ti,ab,kw) OR (low:ti,ab,kw AND gnp:ti,ab,kw) OR (low:ti,ab,kw AND 
gross:ti,ab,kw AND domestic:ti,ab,kw) OR (low:ti,ab,kw AND gross:ti,ab,kw AND national:ti,ab,kw) 
OR (lower:ti,ab,kw AND gdp:ti,ab,kw) OR (lower:ti,ab,kw AND gnp:ti,ab,kw) OR (lower:ti,ab,kw AND 
gross:ti,ab,kw AND domestic:ti,ab,kw) OR (lower:ti,ab,kw AND gross:ti,ab,kw AND national:ti,ab,kw) 
OR lmic:ti,ab,kw OR lmics:ti,ab,kw OR (third:ti,ab,kw AND world:ti,ab,kw) OR (lami:ti,ab,kw AND 
countr*:ti,ab,kw) OR (transitional:ti,ab,kw AND countr*:ti,ab,kw) OR (emerging:ti,ab,kw AND 
economies:ti,ab,kw) OR (emerging:ti,ab,kw AND nation?:ti,ab,kw)) 
 
 
Pubmed search terms below- 750 articles returned 
 
(hypertension[Title/Abstract]) AND (prevalence[Title/Abstract] OR awareness[Title/Abstract]) AND 
(treatment[Title/Abstract]) AND (control[Title/Abstract]) AND (afghanistan[MeSH] OR albania[MeSH] 
OR algeria[MeSH] OR american samoa[MeSH] OR angola[MeSH] OR antigua and barbuda[MeSH] OR 
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argentina[MeSH] OR armenia[MeSH] OR aruba[MeSH] OR azerbaijan[MeSH] OR bahrain[MeSH] OR 
bangladesh[MeSH] OR barbados[MeSH] OR republic of belarus[MeSH] OR belize[MeSH] OR 
benin[MeSH] OR bhutan[MeSH] OR bolivia[MeSH] OR bosnia and herzegovina[MeSH] OR 
botswana[MeSH] OR brazil[MeSH] OR bulgaria[MeSH] OR burkina faso[MeSH] OR burundi[MeSH] 
OR cabo verde[MeSH] OR cambodia[MeSH] OR cameroon[MeSH] OR central african republic[MeSH] 
OR chad[MeSH] OR chile[MeSH] OR china[MeSH] OR colombia[MeSH] OR comoros[MeSH] OR 
democratic republic of the congo[MeSH] OR congo[MeSH] OR costa rica[MeSH] OR cote 
d’ivoire[MeSH] OR croatia[MeSH] OR cuba[MeSH] OR cyprus[MeSH] OR czech republic[MeSH] OR 
djibouti[MeSH] OR dominica[MeSH] OR dominican republic[MeSH] OR ecuador[MeSH] OR 
egypt[MeSH] OR el salvador[MeSH] OR equatorial guinea[MeSH] OR eritrea[MeSH] OR 
estonia[MeSH] OR swaziland[MeSH] OR ethiopia[MeSH] OR fiji[MeSH] OR gabon[MeSH] OR 
gambia[MeSH] OR georgia (republic)[MeSH] OR ghana[MeSH] OR gibraltar[MeSH] OR greece[MeSH] 
OR grenada[MeSH] OR guam[MeSH] OR guatemala[MeSH] OR guinea[MeSH] OR guinea 
bissau[MeSH] OR guyana[MeSH] OR haiti[MeSH] OR honduras[MeSH] OR hungary[MeSH] OR 
india[MeSH] OR indonesia[MeSH] OR iran[MeSH] OR iraq[MeSH] OR jamaica[MeSH] OR 
jordan[MeSH] OR kazakhstan[MeSH] OR kenya[MeSH] OR democratic people’s republic of 
korea[MeSH] OR republic of korea[MeSH] OR kosovo[MeSH] OR kyrgyzstan[MeSH] OR laos[MeSH] 
OR latvia[MeSH] OR lebanon[MeSH] OR lesotho[MeSH] OR liberia[MeSH] OR libya[MeSH] OR 
lithuania[MeSH] OR macau[MeSH] OR republic of north macedonia[MeSH] OR madagascar[MeSH] OR 
malawi[MeSH] OR malaysia[MeSH] OR indian ocean islands[MeSH] OR mali[MeSH] OR 
malta[MeSH] OR micronesia[MeSH] OR palau[MeSH] OR mauritania[MeSH] OR mauritius[MeSH] OR 
mexico[MeSH] OR moldova[MeSH] OR mongolia[MeSH] OR montenegro[MeSH] OR morocco[MeSH] 
OR mozambique[MeSH] OR myanmar[MeSH] OR namibia[MeSH] OR nepal[MeSH] OR netherlands 
antilles[MeSH] OR nicaragua[MeSH] OR niger[MeSH] OR nigeria[MeSH] OR oman[MeSH] OR 
pakistan[MeSH] OR panama[MeSH] OR papua new guinea[MeSH] OR paraguay[MeSH] OR 
peru[MeSH] OR philippines[MeSH] OR poland[MeSH] OR portugal[MeSH] OR puerto rico[MeSH] OR 
romania[MeSH] OR russia[MeSH] OR rwanda[MeSH] OR samoa[MeSH] OR sao tome and 
principe[MeSH] OR saudi arabia[MeSH] OR senegal[MeSH] OR serbia[MeSH] OR seychelles[MeSH] 
OR sierra leone[MeSH] OR slovakia[MeSH] OR slovenia[MeSH] OR melanesia[MeSH] OR 
somalia[MeSH] OR south africa[MeSH] OR south sudan[MeSH] OR sri lanka[MeSH] OR saint kitts and 
nevis[MeSH] OR saint lucia[MeSH] OR saint vincent and the grenadines[MeSH] OR sudan[MeSH] OR 
suriname[MeSH] OR syria[MeSH] OR tajikistan[MeSH] OR tanzania[MeSH] OR thailand[MeSH] OR 
timor leste[MeSH] OR togo[MeSH] OR tonga[MeSH] OR trinidad and tobago[MeSH] OR 
tunisia[MeSH] OR turkey[MeSH] OR turkmenistan[MeSH] OR uganda[MeSH] OR ukraine[MeSH] OR 
uruguay[MeSH] OR uzbekistan[MeSH] OR vanuatu[MeSH] OR venezuela[MeSH] OR vietnam[MeSH] 
OR middle east[MeSH] OR yemen[MeSH] OR yugoslavia[MeSH] OR zambia[MeSH] OR 
zimbabwe[MeSH] OR africa south of the sahara[MeSH] OR africa, central[MeSH] OR africa, 
northern[MeSH] OR africa, southern[MeSH] OR africa, eastern[MeSH] OR africa, western[MeSH] OR 
west indies[MeSH] OR indian ocean islands[MeSH] OR caribbean region[MeSH] OR central 
america[MeSH] OR latin america[MeSH] OR south america[MeSH] OR asia, central[MeSH] OR asia, 





Annex 3: Quality Assessment for Studies Included in Framework Development 
 
There is growing consensus that quality assessment is necessary for observational studies 
included in systematic review, yet there is disagreement about the method used to assess quality 
(Mallen, Peat, and Croft 2006; Sanderson, Tatt, and Higgins 2007; Lang and Kleijnen 2010). 
One major divergence in the current tools available for assessing quality in observational studies 
is the difference in tools designed to assess the quality of the actual study and tools designed to 
assess the quality of reporting (Ma et al. 2020). A common example of a tool to assess the 
quality of reporting in observational studies is the Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE) tool, however these guidelines are not meant to function as 
a quality assessment for studies (von Elm et al. 2007). Evaluating the quality of the underlying 
study is preferable in the context of translating findings into the development of a new 
framework. Two commonly used tools to assess quality of observational studies include the 
Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-
analysis and the Appraisal tool for Cross-Sectional Studies (AXIS tool). Previous researchers 
could not find materials describing the development process for the NOS tool published in peer-
reviewed journals (Stang 2010). On the other hand, the AXIS tool was developed with a 
systematic Delphi process, which was documented and published in a peer-reviewed journal 
(Downes et al. 2016). Therefore, this quality assessment relies on the AXIS tool to determine the 
quality of the studies which inform the development of a framework for measuring the cascade 
of hypertension management services. Additionally, the quality assessment compiles the scores 




AXIS Quality Assessment for Introduction and Methods Sections 
 Introduction Methods 












































to the aims 
of the 
study? 
Were the risk factor and 
outcome variables measured 
correctly using 
instruments/measurements 
that had been trialed, 
piloted, or previously 
published? 





















Y Y Y Y Y 















N N N N Y Y N/A N/A 
Bhandari 
(2015) 
Y Y Y Y Y Y Y Y 
N (outcome of blood 
pressure was adequately 
measured but adherence 













Y Y N N 
Chukwuma 
(2019) 
Y Y N Y N N N Y Y N/A Y 
Gabert 
(2017) 
Y Y N Y Y Y N Y 
Y (provided tools for 
household survey, process 





Y Y Y Y Y Y Y Y Y Y Y 
Hashiguichi 
(2019) 
Y Y N N N/A N Y Y 















as a result) 
Y Y Y Y 
Ikeda 
(2020) 
Y Y Y Y Y Y N Y Y Y Y 
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study? 
Were the risk factor and 
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correctly using 
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that had been trialed, 
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was a census) 
Y  N Y Y Y Y 
Khanam 
(2014) 
Y Y N Y Y Y N Y 
N (no description of items 









Y Y Y N Y Y Y Y 
Liu (2008) Y Y N Y Y Y N Y Y Y Y 
Lozano 
(2006) 
Y Y N Y 
N/A (all of the 
sampling 
information 






N/A N/A N/A N/A Y Y 
Mackino 
(2018) 
Y Y Y Y Y Y Y Y Y Y Y 
Thorogood 
(2007) 
Y Y N Y Y Y Y Y Y Y Y 
Wollum 
(2018) 
Y Y N Y N  
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data was from 
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AXIS Quality Assessment for Results, Discussion, and Other Sections 
 Results Discussion Other Judgement 

















































Why was this study included in 
the final framework? 
Agudelo 
(2019) 
Y Y Y Y Y Y Y Y Y 19 
High quality study which provided 
information about process quality 
(type of treatment and adherence) 
Arrendondo 
(2018) 
N N/A N Y Y Y Y Y N/A 9 
Not an observational study, but a 
discussion piece which defines 
effective coverage for 
hypertension management services 
Bhandari 
(2015) 
Y Y Y Y Y Y Y Y Y 19 
High quality study which provided 
information about process quality 
(type of treatment and adherence) 
Charoendee 
(2018) 
Y N/A N/A Y Y Y Y Y Y 14 
Defines effective coverage of 
hypertension screening services, 
which supports the need for an 
expanded care cascade 
Chukwuma 
(2019) 
Y N/A N/A Y Y Y Y Y Y 13 
Uses a hypertension care cascade 
with supply- and demand-side 
factors (including structural 
quality) to explain service 
coverage 
Gabert (2017) Y N N 
N (text did 
not match 
figures) 
Y Y Y Y Y 14 
Uses a hypertension care cascade 
with supply- and demand-side 
factors (including structural 
quality) to explain service 
coverage 





Y  Y Y Y Y Y Y 20 
High quality study which provided 
information about process quality 
(type of treatment) 
Hashiguichi 
(2019) 
Y N/A N Y Y Y Y Y Y 11 
Defines effective coverage for 
hypertension management services 
Heller (2020) Y Y Y Y Y Y Y Y Y 19 
High quality study which 
documents process quality 
(referral) throughout the 
hypertension care cascade (from 
screening to treatment to control) 
Ikeda (2020) Y 
N (response 
rate of about 
50%) 
N N Y Y Y Y N/A 16 
High quality study which defines 
effective coverage for 
hypertension management services 
Jayanna 
(2019) 
Y Y N Y Y Y Y Y Y 17 
High quality study which 




Y N/A N Y Y Y Y Y Y 15 
Describes process quality 
(adherence to treatment)  
Leslie (2019) Y N/A N Y Y Y Y Y Y 17 
High quality study which defines 
effective coverage for 
hypertension management services 
and multiple measures of outcome 
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Why was this study included in 
the final framework? 
quality (non-hospitalization and 
bp control) 
Liu (2008) Y N/A N Y Y Y Y Y Y 16 
High quality study which defines 
effective coverage for 
hypertension management services 
Lozano (2006) Y N/A N Y Y Y Y Y Y 12 
Process documentation for 
measuring effective coverage 
which clearly defines a measure 




Y Y N Y Y Y N Y Y 18 
High quality study which 
describes process quality 
(obtaining quality care) on a 







N Y Y Y N Y Y 16 
High quality study which 
describes barriers related to 




Y N/A Y Y Y Y Y Y Y 15 
Describes process quality and 
supply-side barriers to 
hypertension care 




Y Y Y Y Y Y Y 19 
High quality study which 
describes process quality (patient 
adherence) 
Zhao (2020) Y Y N Y Y Y Y Y Y 19 
High quality study which defines 
effective coverage for 
hypertension management services 
*Indicates questions that were revised from original AXIS tool so that affirmative answers were positively interpreted 
 
 185 



















Cohort study , patient 
files from clinics 













One or more 
visits within first 
3 months 
 
Visit or BP 
















Retention in care 





























Reported supply- and demand-side 
barriers in the continuum of care to 
screening/diagnosis, treatment initiation, 









patient file data 
extraction, focus group 
discussions with patients 
and care providers 
Samoa: two islands 
(Upolu and Savai’i) 
 























Reported barriers and facilitators at each 




Annex 5: Prescription Rating Protocol 
 
Clinical Vignettes  
1.    Prescriptions will be classified into three different categories:  
1.1. Appropriate: Correct type of medication was prescribed as indicated, with appropriate 
dosage, frequency, and duration.  
1.2. Inappropriate, but not harmful: Prescription was missing one or more key medications as 
indicated by the primary diagnosis. 
1.3. Inappropriate, and harmful: If one or more medication in the prescription may directly 
cause harm in patients, breastfed infants, or fetus based on the type of medication and/or 
dosage. 
2.    Prescriptions will be rated as a whole, rather than individual drugs. (i.e. if one medication is 
classified harmful, then complete prescription will be marked as inappropriate and harmful) 
3.    Incomplete prescription will be marked as inappropriate. (e.g. ORS not prescribed in 
diarrhea) 
4.    Reviewer, to the best of their ability, will search for the generic analog of any brand names 
prescribed and will rate each medication based on their generic component/ active ingredients. 
5.    Homeopathic medications not recognized by the reviewer will be highlighted and will be 
excluded from the rating. 
6.    If the medication is not prescribed for the main diagnosis (e.g. hypertension) and the 
secondary issue is taken care of (e.g. headache), therefore the prescription will be marked as 
inappropriate 
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7.    Drug appropriateness with diagnosis will be rated based on the primary diagnosis of the 
clinical vignettes and patient observation, differential diagnoses will be disregarded. For each 
relevant cases, the below clinical guidelines may be used: 
7.1. Diarrhea in children: WHO Integrated Management of Childhood Illness (IMCI),  
7.2. Acute respiratory infection (ARI) with fever in children: WHO Integrated Management 
of Childhood Illness (IMCI)  
7.3. Angina pectoris in adult: American Heart Association’s Advance Cardiac Life Support 
(pre-hospital section). 
7.4. Adult hypertension: India’s Standard Treatment Guideline of Hypertension by National 
Health Mission, Ministry of Health & Family Welfare Government of India 
8.    Drug-Drug interaction and drug-disease will be assessed, and if harmful interaction occurs,          
the prescription will be rated as inappropriate and harmful. 
10.  Unnecessary duplications of drug with the same indication will be rated as inappropriate. 
11. For patient observations, prescription appropriateness will be rated pertaining to each main 
diagnosis given by the provider. For cases where no diagnosis was given, prescription will be 




Annex 6: Analysis of Associated Factors of Hypertension Screening and Diagnosis 
 
 
Logistic regression analyses were conducted to determine predictors of individual receipt of 
services, specifically the probability of ever being screened, the probability of being diagnosed 
as hypertensive, and the probability of hypertensive individuals bypassing all local providers to 
seek care. For these analyses, individual variables were considered based on a conceptual 
framework for hypertension management. Considered variables included individual age, sex, 
occupation, education, caste, wealth quintile, average monthly income, religion, comorbidity, 
and current tobacco use, household variables such as other member of household with diagnosed 
hypertension and distance to PHC, and community level variables such as village-level wealth 
and service availability. For each regression analysis, collinearity of explanatory variables was 
assessed, a likelihood ratio test was conducted for each variable, effect modification was 
considered and tested, and the final model was compared with stepwise model selections. 
Hosmer-Lemeshow tests for goodness of fit were conducted and regression diagnostics were 
conducted to assess final model fit. 
 
Predictors of Hypertension Screening 
The probability of ever having blood pressure measured was assessed for all individuals over the 
age of 30 included in our study (n= 14,382). The final model suggests that the presence of 
comorbidities, age, sex, wealth quintile, household hypertension, education, religion, and caste 
all influence an individual’s probability of ever having blood pressure measured. Women were 
4.6 times more likely to report ever having their blood pressure measured than men (95% CI of 
3.4 to 6.2 times more likely) although this relationship was modified by age.  
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Logistic regression results for probability of having blood pressure measured 
 Variable  Coef.  St.Err.  t-value  p-value  [95% Conf  Interval]  Sig 
        
Comorbidity 7.978 1.5 11.05 0 5.519 11.532 *** 
        
Sex        
Female (ref) 1 . . . . .  
Male .217 .033 -10.06 0 .161 .292 *** 
        
Age and Sex        
Age (years) 1.004 .002 1.63 .104 .999 1.008  
Female * Age (ref) 1 . . . . .  
Male * Age 1.019 .003 6.23 0 1.013 1.026 *** 
        
Wealth        
Poorest wealth quintile 
(ref) 
1 . . . . .  
Poorer wealth quintile 1.214 .072 3.25 .001 1.08 1.365 *** 
Middle wealth quintile 1.241 .073 3.69 0 1.107 1.393 *** 
Richer wealth quintile 1.317 .089 4.06 0 1.153 1.504 *** 
Richest wealth quintile 1.83 .131 8.47 0 1.591 2.105 *** 
        
Household 
hypertension 
1.663 .119 7.09 0 1.445 1.914 *** 
        
Education        
No education (ref) 1 . . . . .  
Some schooling 1.196 .059 3.62 0 1.085 1.317 *** 
Higher secondary 
schooling or above 
1.548 .136 4.98 0 1.304 1.838 *** 
        
Religion        
Hindu (ref) 1 . . . . .  
Muslim 1.421 .113 4.42 0 1.216 1.661 *** 
        
Caste        
Scheduled Caste (ref) 1 . . . . .  
Scheduled Tribe 1.107 .199 0.57 .571 .779 1.574  
Other Backwards Caste 1.065 .051 1.31 .189 .969 1.171  
General Caste 1.379 .118 3.77 0 1.167 1.63 *** 
        
Constant 1.487 .216 2.73 .006 1.118 1.977 *** 
 
Mean dependent var 0.768 SD dependent var  0.422 
Pseudo r-squared  0.058 Number of obs   14330.000 
Chi-square   895.776 Prob > chi2  0.000 
Akaike crit. (AIC) 14671.443 Bayesian crit. (BIC) 14792.565 














Predictors of Hypertension Diagnosis 
 
Similar to the model for probability of hypertension screening, wealth, age, comorbidity, caste, 
education, and sex were significantly associated with the probability of hypertension diagnosis. 
Females were significantly more likely to be diagnosed than males at all ages, however there was 
a changing relationship in terms of probability of diagnosis starting at age 60. After age 60, the 
richer two wealth quintiles were significantly more likely to be diagnosed than the poorest three 




Regression results for individual probability of hypertension diagnosis 
 Variable  Coef.  St.Err.  t-value  p-value  [95% Conf  Interval]  Sig 
        
Wealth        
Poorest wealth quintile 
(ref) 
1 . . . . .  
Poorer wealth quintile 1.692 .775 1.15 .251 .69 4.15  
Middle wealth quintile 2.12 .938 1.70 .089 .891 5.045 * 
Richer wealth quintile .745 .369 -0.59 .553 .283 1.966  
Richest wealth quintile .924 .412 -0.18 .859 .386 2.213  
        
Age and Wealth        
Age (Years) 1.049 .006 8.43 0 1.037 1.06 *** 
Poorest quintile * Age 
(ref) 
1 . . . . .  
Poorer quintile * Age .994 .008 -0.82 .412 .978 1.009  
Middle quintile * Age .989 .007 -1.47 .142 .974 1.004  
Richer quintile * Age 1.009 .008 1.08 .279 .993 1.026  
Richest quintile * Age 1.007 .007 0.94 .349 .992 1.022  
        
Comorbidity 3.808 .339 15.01 0 3.198 4.535 *** 
        
Caste        
Scheduled Caste (ref) 1 . . . . .  
Scheduled Tribe 1.551 .535 1.27 .203 .789 3.049  
Other Backwards Caste 1.442 .144 3.67 0 1.186 1.753 *** 
General Caste 2.099 .264 5.90 0 1.641 2.685 *** 
        
Education        
No education (ref) 1 . . . . .  
Some schooling  1.404 .121 3.92 0 1.185 1.663 *** 
Higher secondary 
schooling or above 
1.793 .254 4.13 0 1.359 2.366 *** 
        
Sex        
Female (ref) 1 . . . . .  
Male  .565 .046 -6.97 0 .481 .663 *** 
        
Constant .003 .001 -16.84 0 .002 .006 *** 
 
Mean dependent var 0.066 SD dependent var  0.248 
Pseudo r-squared  0.114 Number of obs   14377.000 
Chi-square   796.134 Prob > chi2  0.000 
Akaike crit. (AIC) 6230.517 Bayesian crit. (BIC) 6359.264 












Predictors of Bypassing among Hypertensives 
 
In this analysis, bypassing was defined as those who travel more than 5 km beyond their local 
PHC to receive hypertension management services. Caste, wealth quintile, education, and 
comorbidities were all significantly associated with bypassing local options for hypertension 
management. In general, the most advantaged members of society (wealthiest and from general 
caste) receive care from different sources than the rest of society. Also, individuals with 





Regression results for individual probability of bypassing local providers for hypertension management 
services 
Variable  Coef.  St.Err.  t-value  p-value  [95% Conf  Interval]  Sig 
        
Caste        
Scheduled Caste 
(ref) 
1 . . . . .  
Scheduled Tribe 2.621 1.836 1.38 .169 .664 10.344  
Other Backwards 
Caste 
1.727 .412 2.29 .022 1.082 2.755 ** 
General Caste 2.262 .629 2.94 .003 1.312 3.901 *** 
        
Wealth        
Poorest wealth 
quintile (ref) 
1 . . . . .  
Poorer wealth 
quintile 
1.628 .412 1.93 .054 .992 2.674 * 
Middle wealth 
quintile 
1.224 .312 0.79 .428 .743 2.017  
Richer wealth 
quintile 
1.319 .344 1.06 .289 .791 2.198  
Richest wealth 
quintile 
1.799 .441 2.40 .017 1.113 2.91 ** 
        
Age 1.004 .006 0.71 .479 .993 1.016  
        
Sex        
Female (ref) 1 . . . . .  
Male  1.012 .195 0.06 .949 .695 1.475  
        
Education        
No education (ref) 1 . . . . .  




1.991 .601 2.28 .023 1.101 3.599 ** 
        
Comorbidity 2.476 .412 5.45 0 1.787 3.431 *** 




1.006 .014 0.41 .678 .979 1.034  
        
        
Constant .114 .049 -5.09 0 .049 .263 *** 
 
Mean dependent var 0.363 SD dependent var  0.481 
Pseudo r-squared  0.070 Number of obs   906.000 
Chi-square   83.645 Prob > chi2  0.000 
Akaike crit. (AIC) 1133.578 Bayesian crit. (BIC) 1205.713 





Annex 7: Age-Standardized Calculation of Hypertension Prevalence in Bihar, 
India 
 
 Men Women Total 
 Frequency Percent Frequency Percent Frequency Percent 
Hypertension Prevalence*  18.10%  15.80%  17.03% 
Percent of Adults over 30 Screened #  73.79%  80.63%  77.47% 
Percent of Adults 30-49 Screened #  67.95%  80.16%  75.03% 
Percent of Adults over 50 Screened #  79.41%  81.27%  80.32% 
Percent of Adults over 30 Diagnosed #  6.01%  7.12%  6.31% 
Percent of Adults 30-49 Diagnosed #  2.44%  3.26%  2.92% 
Percent of Adults over 50 Diagnosed #  9.08%  11.52%  10.28% 
       
Bihar Rural Population +        48,073,850            44,267,586          92,341,436   
Bihar Rural Adult (15 and older) Population +        29,866,777            25,996,835          55,863,613   
Bihar Rural Adult (15-49) Population +        23,482,572  78.62%          20,176,831  77.61%        43,659,404   
Bihar Rural Adult (50 and older) Population +          6,384,205  21.38%            5,820,004  22.39%        12,204,209   
       
Individuals with Hypertension     5,405,886.64  18.10%       4,107,499.93  15.80%     9,513,386.75  17.03% 
Age-standardized population ever screened   21,026,104.86  70.40%     20,903,664.98  80.41%   42,560,071.50  76.19% 
Age-standardized Diagnosed Individuals          1,308,435  4.38%            1,517,961  5.84%          2,885,810  5.17% 




Symbol Source Link Location Notes 
* 
NFHS-5 Bihar Fact Sheet http://rchiips.org/nfhs/NFHS-
5_FCTS/FactSheet_BR.pdf 










Bihar Assessment of 
Primary Health Care 
System 







Annex 8: Hypertension Vignette 
 
Interviewer explains to the provider: Thank you for your time and willingness to participate. 
We’d like to do an exercise. I will now come to you pretending to be a patient in four different 
scenarios. Please interact as if I were a real patient, and how you would approach a similar 
scenario. We would like you to ask all questions and demonstrate examination that you would 
do in a real situation (whether on this doll for a child, or on me for an adult patient), and then 
let us know what you would do for the patient. Do you have any questions, or aspect we can 
clarify? 
 
                                                                             Case 1 
Interviewer: I am a 55-year-old female patient coming to you with headache, and a prior high 
blood pressure 
 
Section I: History 
खंड 1 : इतिहास 
 
Interviewer: “What are ALL the important questions you will ask me now?” 
साक्षात्किाा : ‘‘आप अब मुझसे क्या-क्या महत्वपूर्ा प्रश्न पूछें गे/गी?’’ 
 
No. Provider Response 
प्रोवाइडर का ररसपांस 
Asked 1; Not Asked 
2 
पूछा - 1, नह ं पूछा - 2 
Type of Questions 
प्रश्नों का प्रकार 
Patient’s 
Response 
मर ज के उत्तर 
101   Where is your headache, and what is it like? Temples, dull 
ache, constant 
  Any other questions on the headache, respond 
No 
No 
102   
Do you smoke? 
Yes 
ह ां  
103   Do you have any other medical conditions? 
E.g. Diabetes? No 
104   Have you had any other symptoms? (Chest 
pains, dizziness, shortness of breath, swelling 
in lower limbs, blurry vision) 
No 
105  Have you been advised to or have you made 
any change in diet (increased vegetables, 
reduced salt in cooking_ No 
106  Have you been advised to or have you stopped 
smoking?  No 
107  Have you been advised to or have you stopped 
alcohol intake? No 
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108  Have you been advised to or have you 
increased your exercise? No 
109   Any additional question about other symptoms 
अन्य किसी लक्षण से जुड़े िोई प्रश्न 
No 
नह ां 
110  Any additional question about pattern/ 
duration/ type of illness etc 




मुझे य द नह ां 
111 No. of questions asked by the provider (record using tally marks): 
प्रदािा द्वारा पूछे गए प्रश्न(सखं्या को जोड़ का लिखे) 
 
Section II: Examination 
खंड II: प्रलिक्षर् 
Interviewer: “What physical examinations will you conduct?” 
साक्षात्कारकिाा:  ”आप कौन से िार ररक प्रलिक्षर् करेंगे?” 
No. Provider Response 
प्रोवाइडर का ररसपांस 
  Done 1; Not Done 
O 
  ककया – 1, नह ं ककया 
- 0 
Type of Examinations 
पररक्षर् का प्रकार 
Patient’s 
Response 
मर ज के उत्तर 
112   BP बबपप 150/90 
113  Second measure of BP 150/90 
114  Pulse Normal 
115   Used stethoscope to examine chest and heart 
स्टेथोस्िोप ि  इस्तेम ल िर िे छ ती और ह्रदय 
िी ज ांच िरें 
Normal 
स म न्य 
116  Any additional examination mentioned (or 
height or weight) 
अन्य िोई ज ांच ि  उल्लेख किय  गय  ( य  




स म न्य 
Section III: Final Diagnosis 
खंड 3:  सुतनश्श्िि रोग 
Interviewer: “What is your diagnosis based on the above information?” 
साक्षात्कारकिाा:  “ ऊपर द  हुई जानकार  के आधार पर आप ककस रोग की पहिान करेंगे?” 
117 1.  Hypertension/High BP  
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88.  Other. specify_  
Section IV: Treatment 
खंड IV: इिाज 
118 Interviewer: “How will you manage the case?” 
स क्ष त्ि रित न:  “ आप इस अवस्थ  ि  प्रबांधन िैसे िरेंगे?” 
(Read out the options below and circle the relevant one) 
(स रे पविल्प पढ़े और 1 सबसे उचचत जव ब में गोल  लग ए) 
  
No referral, treat the person at the facility itself  
िोई रेफरल नह ां, मर ज़ ि  इल ज़ स्व स््य सांस्थ  में ह  हो ज एग  
……………………..1 
Referral, with some treatment at this facility  
रेफर िरेंगे, स्व स््य सांस्थ  में प्र थममि इल ज़ िे ब द 
…………………………......................2 
Referral, without any treatment 
रेफर िरेंगे, बबन  किसी प्र थममि इल ज़ िे 
……………………….......................................3 
 
(If 1 or 2 
proceed to 117; 
if 3 proceed to 
next case) 
अगर 1 य  2  तो 
117 पर ज ए; 
अगर 3 तो अगले 
िेस पर ज ए 
 
119 Interviewer: Do you think there is a need for a follow-up check?”  
 




ह ां/ नह ां 
120 Interviewer: “What medicines will you prescribe?”  
स क्ष त्ित न : ‘‘आप क्य  इल ज प्रेस्र इब िरेंगे/गी?’’ 
  
Ask the provider and note the following details. 




(मलखें – गोमलय ां, 






रोज ककिनी बार     
Duration 
(days) 
ककिने ददनों िक 
A      
B      
C      
D      
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121 Interviewer: “What advice would you give to the patient?”  
 SELECT ALL THAT ARE MENTIONED BY THE PRACTITIONER 
साक्षात्किाा : ‘‘आप रोगी के लिए ककन अन्य िीजों की अनुिंसा करेंगे/गी?’’ 
 
1. No advice 
2. Explained that hypertension is a lifelong condition, needing daily 
medication and regular follow up and monitoring 
3. Alert to danger signs (persistent chest pain, dizziness/fainting, worsening 
shortness of breath) 
4. Alert to complications (heart attack/stroke, aneurysm, heart failure, etc.) 
5. Adequate diet, with reduced salt intake  
6. Regular exercise/physical activity 
7. Smoking cessation 
8. Monitor high blood pressure 
88. Others, specify 
 
 
122 Interviewer: Are there any danger signs that the patient should watch out for? 
SELECT ALL THAT ARE MENTIONED BY THE PRACTITIONER 
1. Persistent chest pain lasting more than a few minutes 
2. Dizziness/Fainting/severe light-headedness/lose consciousness 
3. Worsening shortness of breath, severe difficulty of breathing, swelling in feet 
4. Blurry vision 























Bhagalpur 37.6 2 51.9 3 51.4 4 52.7 1 
Darbhanga 35.9 6 51.7 4 52.3 3 46.6 6 
Kosi 37.3 3 52.7 2 53.3 2 50.3 3 
Magadh 35.7 7 50.1 5 50.1 5 46.3 7 
Munger 33.3 8 44.7 9 44.1 9 41.3 9 
Patna 37.1 4 48.3 7 48.4 8 47.0 4 
Purnia 39.7 1 56.9 1 54.3 1 50.9 2 
Saran 32.5 9 49.7 6 48.5 7 45.9 8 
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